Unnamed: 0.1,Unnamed: 0,action_type,activity_comment,activity_id,activity_properties,assay_chembl_id,assay_description,assay_type,assay_variant_accession,assay_variant_mutation,bao_endpoint,bao_format,bao_label,canonical_smiles,data_validity_comment,data_validity_description,document_chembl_id,document_journal,document_year,ligand_efficiency,molecule_chembl_id,molecule_pref_name,parent_molecule_chembl_id,pchembl_value,potential_duplicate,qudt_units,record_id,relation,src_id,standard_flag,standard_relation,standard_text_value,standard_type,standard_units,standard_upper_value,standard_value,target_chembl_id,target_organism,target_pref_name,target_tax_id,text_value,toid,type,units,uo_units,upper_value,value
178000,178000,,,5168200,[],CHEMBL1658753,Bactericidal activity against methicillin-susceptible coagulase-negative Staphylococcus epidermidis after 24 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322362,=,1,0,=,,MBC90,ug ml-1,,128.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MBC90,ug ml-1,UO_0000274,,128.0
178001,178001,,,5168210,[],CHEMBL1658754,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus haemolyticus after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322362,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MIC,ug ml-1,UO_0000274,,0.5
178002,178002,,,5168220,[],CHEMBL1658754,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus haemolyticus after 24 hrs by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322362,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MIC50,ug ml-1,UO_0000274,,0.5
178003,178003,,,5168230,[],CHEMBL1658754,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus haemolyticus after 24 hrs by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322362,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MIC90,ug ml-1,UO_0000274,,16.0
178004,178004,,,5169321,[],CHEMBL1658755,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus haemolyticus assessed as susceptible isolates after 24 hrs by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322362,=,1,0,=,,Activity,%,,50.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,Activity,%,UO_0000187,,50.0
178005,178005,,,5169329,[],CHEMBL1658756,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus haemolyticus assessed as resistant isolates after 24 hrs by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322362,=,1,0,=,,Activity,%,,27.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,Activity,%,UO_0000187,,27.0
178006,178006,,,5169336,[],CHEMBL1658757,Bactericidal activity against methicillin-susceptible coagulase-negative Staphylococcus haemolyticus after 24 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322362,=,1,0,=,,MBC,ug ml-1,,1.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MBC,ug ml-1,UO_0000274,,1.0
178007,178007,,,5169346,[],CHEMBL1658757,Bactericidal activity against methicillin-susceptible coagulase-negative Staphylococcus haemolyticus after 24 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322362,=,1,0,=,,MBC50,ug ml-1,,2.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MBC50,ug ml-1,UO_0000274,,2.0
178008,178008,,,5169356,[],CHEMBL1658757,Bactericidal activity against methicillin-susceptible coagulase-negative Staphylococcus haemolyticus after 24 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322362,=,1,0,=,,MBC90,ug ml-1,,128.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MBC90,ug ml-1,UO_0000274,,128.0
178009,178009,,,5169366,[],CHEMBL1658758,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus simulans after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322362,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL612425,Staphylococcus simulans,Staphylococcus simulans,1286.0,,,MIC,ug ml-1,UO_0000274,,0.5
178010,178010,,,5169376,[],CHEMBL1658758,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus simulans after 24 hrs by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322362,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL612425,Staphylococcus simulans,Staphylococcus simulans,1286.0,,,MIC50,ug ml-1,UO_0000274,,0.5
178011,178011,,,5169386,[],CHEMBL1658758,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus simulans after 24 hrs by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322362,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL612425,Staphylococcus simulans,Staphylococcus simulans,1286.0,,,MIC90,ug ml-1,UO_0000274,,16.0
178012,178012,,,5169396,[],CHEMBL1658759,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus simulans assessed as susceptible isolates after 24 hrs by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322362,=,1,0,=,,Activity,%,,50.0,CHEMBL612425,Staphylococcus simulans,Staphylococcus simulans,1286.0,,,Activity,%,UO_0000187,,50.0
178013,178013,,,5169404,[],CHEMBL1658760,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus simulans assessed as resistant isolates after 24 hrs by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322362,=,1,0,=,,Activity,%,,27.0,CHEMBL612425,Staphylococcus simulans,Staphylococcus simulans,1286.0,,,Activity,%,UO_0000187,,27.0
178014,178014,,,5169410,[],CHEMBL1658761,Bactericidal activity against methicillin-susceptible coagulase-negative Staphylococcus simulans after 24 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322362,=,1,0,=,,MBC,ug ml-1,,1.0,CHEMBL612425,Staphylococcus simulans,Staphylococcus simulans,1286.0,,,MBC,ug ml-1,UO_0000274,,1.0
178015,178015,,,5169420,[],CHEMBL1658761,Bactericidal activity against methicillin-susceptible coagulase-negative Staphylococcus simulans after 24 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322362,=,1,0,=,,MBC50,ug ml-1,,2.0,CHEMBL612425,Staphylococcus simulans,Staphylococcus simulans,1286.0,,,MBC50,ug ml-1,UO_0000274,,2.0
178016,178016,,,5169430,[],CHEMBL1658761,Bactericidal activity against methicillin-susceptible coagulase-negative Staphylococcus simulans after 24 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322362,=,1,0,=,,MBC90,ug ml-1,,128.0,CHEMBL612425,Staphylococcus simulans,Staphylococcus simulans,1286.0,,,MBC90,ug ml-1,UO_0000274,,128.0
178017,178017,,,5169440,[],CHEMBL1658762,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus sciuri after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322362,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL613150,Mammaliicoccus sciuri,Mammaliicoccus sciuri,1296.0,,,MIC,ug ml-1,UO_0000274,,0.5
178018,178018,,,5169450,[],CHEMBL1658762,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus sciuri after 24 hrs by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322362,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL613150,Mammaliicoccus sciuri,Mammaliicoccus sciuri,1296.0,,,MIC50,ug ml-1,UO_0000274,,0.5
178019,178019,,,5169460,[],CHEMBL1658762,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus sciuri after 24 hrs by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322362,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL613150,Mammaliicoccus sciuri,Mammaliicoccus sciuri,1296.0,,,MIC90,ug ml-1,UO_0000274,,16.0
178020,178020,,,5169470,[],CHEMBL1658763,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus sciuri assessed as susceptible isolates after 24 hrs by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322362,=,1,0,=,,Activity,%,,50.0,CHEMBL613150,Mammaliicoccus sciuri,Mammaliicoccus sciuri,1296.0,,,Activity,%,UO_0000187,,50.0
178021,178021,,,5169479,[],CHEMBL1658921,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus sciuri assessed as resistant isolates after 24 hrs by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322362,=,1,0,=,,Activity,%,,27.0,CHEMBL613150,Mammaliicoccus sciuri,Mammaliicoccus sciuri,1296.0,,,Activity,%,UO_0000187,,27.0
178022,178022,,,5169494,[],CHEMBL1658933,Antimicrobial activity against methicillin-resistant Staphylococcus aureus assessed as intermediate resistant isolates after 24 hrs by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322362,=,1,0,=,,Activity,%,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,0.0
178023,178023,,,5169499,[],CHEMBL1658934,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus assessed as intermediate resistant isolates after 24 hrs by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322362,=,1,0,=,,Activity,%,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,4.0
178024,178024,,,5169504,[],CHEMBL1658935,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus epidermidis assessed as intermediate resistant isolates after 24 hrs by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322362,=,1,0,=,,Activity,%,,15.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,15.0
178025,178025,,,5169509,[],CHEMBL1658936,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus haemolyticus assessed as intermediate resistant isolates after 24 hrs by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322362,=,1,0,=,,Activity,%,,15.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,Activity,%,UO_0000187,,15.0
178026,178026,,,5169514,[],CHEMBL1658937,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus simulans assessed as intermediate resistant isolates after 24 hrs by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322362,=,1,0,=,,Activity,%,,15.0,CHEMBL612425,Staphylococcus simulans,Staphylococcus simulans,1286.0,,,Activity,%,UO_0000187,,15.0
178027,178027,,,5169519,[],CHEMBL1658938,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus sciuri assessed as intermediate resistant isolates after 24 hrs by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322362,=,1,0,=,,Activity,%,,15.0,CHEMBL613150,Mammaliicoccus sciuri,Mammaliicoccus sciuri,1296.0,,,Activity,%,UO_0000187,,15.0
178028,178028,,,5169524,[],CHEMBL1658939,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus hominis assessed as intermediate resistant isolates after 24 hrs by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322362,=,1,0,=,,Activity,%,,23.0,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,,Activity,%,UO_0000187,,23.0
178029,178029,,,5169529,[],CHEMBL1658940,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus epidermidis assessed as intermediate resistant isolates after 24 hrs by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322362,=,1,0,=,,Activity,%,,23.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,23.0
178030,178030,,,5169534,[],CHEMBL1658941,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus haemolyticus assessed as intermediate resistant isolates after 24 hrs by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322362,=,1,0,=,,Activity,%,,23.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,Activity,%,UO_0000187,,23.0
178031,178031,,,5169539,[],CHEMBL1658942,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus simulans assessed as intermediate resistant isolates after 24 hrs by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322362,=,1,0,=,,Activity,%,,23.0,CHEMBL612425,Staphylococcus simulans,Staphylococcus simulans,1286.0,,,Activity,%,UO_0000187,,23.0
178032,178032,,,5169544,[],CHEMBL1658943,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus sciuri assessed as intermediate resistant isolates after 24 hrs by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322362,=,1,0,=,,Activity,%,,23.0,CHEMBL613150,Mammaliicoccus sciuri,Mammaliicoccus sciuri,1296.0,,,Activity,%,UO_0000187,,23.0
178033,178033,,,5169549,[],CHEMBL1658944,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus hominis assessed as intermediate resistant isolates after 24 hrs by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322362,=,1,0,=,,Activity,%,,15.0,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,,Activity,%,UO_0000187,,15.0
178034,178034,,,5169555,[],CHEMBL1658922,Bactericidal activity against methicillin-susceptible coagulase-negative Staphylococcus sciuri after 24 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322362,=,1,0,=,,MBC,ug ml-1,,1.0,CHEMBL613150,Mammaliicoccus sciuri,Mammaliicoccus sciuri,1296.0,,,MBC,ug ml-1,UO_0000274,,1.0
178035,178035,,,5169565,[],CHEMBL1658922,Bactericidal activity against methicillin-susceptible coagulase-negative Staphylococcus sciuri after 24 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322362,=,1,0,=,,MBC50,ug ml-1,,2.0,CHEMBL613150,Mammaliicoccus sciuri,Mammaliicoccus sciuri,1296.0,,,MBC50,ug ml-1,UO_0000274,,2.0
178036,178036,,,5169575,[],CHEMBL1658922,Bactericidal activity against methicillin-susceptible coagulase-negative Staphylococcus sciuri after 24 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322362,=,1,0,=,,MBC90,ug ml-1,,128.0,CHEMBL613150,Mammaliicoccus sciuri,Mammaliicoccus sciuri,1296.0,,,MBC90,ug ml-1,UO_0000274,,128.0
178037,178037,,,5172267,[],CHEMBL1652889,"Antimicrobial activity against erythromycin-, streptomycin-resistant Enterococcus faecium A expressing hylEfm gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649239,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322420,>,1,1,>,,MIC,ug.mL-1,,512.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,512.0
178038,178038,,,5172268,[],CHEMBL1652890,"Antimicrobial activity against fusidic acid-, rifampin-resistant Enterococcus faecium TX1330RF by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649239,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322420,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,0.5
178039,178039,,,5172269,[],CHEMBL1652891,"Antimicrobial activity against erythromycin-, streptomycin-resistant Enterococcus faecium TX1330RF-A1 conjugant expressing hylEfm gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649239,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322420,>,1,1,>,,MIC,ug.mL-1,,512.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,512.0
178040,178040,,,5172270,[],CHEMBL1653527,"Antimicrobial activity against vancomycin-, gentamicin-resistant Enterococcus faecium B expressing hylEfm gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649239,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322420,>,1,1,>,,MIC,ug.mL-1,,512.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,512.0
178041,178041,,,5172271,[],CHEMBL1653528,"Antimicrobial activity against erythromycin-, streptomycin-, vancomycin-, gentamicin-resistant Enterococcus faecium TX1330RF-B1 conjugant expressing hylEfm gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649239,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322420,>,1,1,>,,MIC,ug.mL-1,,512.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,512.0
178042,178042,,,5172272,[],CHEMBL1653529,"Antimicrobial activity against vancomycin-, gentamicin-resistant Enterococcus faecium TX1330RF-B2 conjugant expressing hylEfm gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649239,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322420,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,0.25
178043,178043,,,5172273,[],CHEMBL1653530,Antimicrobial activity against vancomycin-resistant Enterococcus faecium C expressing hylEfm gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649239,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322420,>,1,1,>,,MIC,ug.mL-1,,512.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,512.0
178044,178044,,,5172274,[],CHEMBL1653531,"Antimicrobial activity against pbp5 gene-deficient fusidic acid-, rifampin-resistant Enterococcus faecium D344SRF expressing hylEfm gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649239,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322420,=,1,1,=,,MIC,ug.mL-1,,512.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,512.0
178045,178045,,,5172275,[],CHEMBL1653532,"Antimicrobial activity against pbp5 gene-deficient vancomycin-, fusidic acid-, rifampin-resistant Enterococcus faecium D344SRF-C6 expressing hylEfm gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649239,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322420,>,1,1,>,,MIC,ug.mL-1,,512.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,512.0
178046,178046,,,5172735,[],CHEMBL1654758,Antimicrobial activity against Desulfovibrio sp. by Etest method,F,,,BAO_0003035,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649294,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323324,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,0.5
178047,178047,,,5172741,[],CHEMBL1654758,Antimicrobial activity against Desulfovibrio sp. by Etest method,F,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649294,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323324,=,1,1,=,,MIC90,ug.mL-1,,1.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,1.5
178048,178048,,,5172752,[],CHEMBL1654762,Antimicrobial activity against Desulfovibrio piger by Etest method,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649294,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323324,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.016
178049,178049,,,5172764,[],CHEMBL1654758,Antimicrobial activity against Desulfovibrio sp. by Etest method,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649294,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323324,=,1,1,=,,MIC,ug.mL-1,,0.064,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.064
178050,178050,,,5173803,[],CHEMBL1654760,Antimicrobial activity against Desulfovibrio desulfuricans Essex 6 by Etest method,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649294,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323324,=,1,1,=,,MIC,ug.mL-1,,0.38,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.38
178051,178051,,,5173804,[],CHEMBL1654761,Antimicrobial activity against Desulfovibrio desulfuricans MB by Etest method,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649294,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323324,=,1,1,=,,MIC,ug.mL-1,,0.38,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.38
178052,178052,,,5173808,[],CHEMBL1654759,Antimicrobial activity against Desulfovibrio fairfieldensis by Etest method,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649294,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323324,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.5
178053,178053,,,5175927,[],CHEMBL1665460,Antimycobacterial activity against Mycobacterium smegmatis MC2 155 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649573,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321857,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,mg/L,UO_0000274,,32.0
178054,178054,,,5175928,[],CHEMBL1665461,Antimycobacterial activity against Mycobacterium smegmatis MAR4 harboring disrupted PknGMsm gene by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649573,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321857,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,mg/L,UO_0000274,,4.0
178055,178055,,,5175929,[],CHEMBL1665462,Antimycobacterial activity against Mycobacterium smegmatis MC2 155 harboring PknG K181M mutant gene by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649573,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321857,=,1,1,=,,MIC,ug.mL-1,,12.0,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,mg/L,UO_0000274,,12.0
178056,178056,,,5175930,[],CHEMBL1665463,Antimycobacterial activity against PknGMsm-deficient Mycobacterium smegmatis by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649573,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321857,=,1,1,=,,MIC,ug.mL-1,,3.0,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,mg/L,UO_0000274,,3.0
178057,178057,,,5175931,[],CHEMBL1665464,Antimycobacterial activity against PknGMsm-deficient Mycobacterium smegmatis harboring PknG K181M mutant gene by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649573,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321857,=,1,1,=,,MIC,ug.mL-1,,3.0,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,mg/L,UO_0000274,,3.0
178058,178058,,,5175932,[],CHEMBL1665465,Antimycobacterial activity against PknGMsm-deficient Mycobacterium smegmatis harboring PknG Mtb gene by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649573,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321857,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,mg/L,UO_0000274,,32.0
178059,178059,,,5175933,[],CHEMBL1665466,Antimycobacterial activity against Mycobacterium smegmatis harboring PknG Msm gene by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649573,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321857,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,mg/L,UO_0000274,,32.0
178060,178060,,Not Active,5175962,[],CHEMBL1665467,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv at 100 mg/l after 7 days by microscopy,F,,,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649573,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1321857,,1,0,,,Activity,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,,,,
178061,178061,,Active,5175963,[],CHEMBL1665468,Antimycobacterial activity against PknGMtb-deficient Mycobacterium tuberculosis H37Rv at 100 mg/l after 7 days by microscopy,F,,,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649573,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1321857,,1,0,,,Activity,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,,,,
178062,178062,,,5176030,[],CHEMBL1665533,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate gz06051 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321872,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.25
178063,178063,,,5176100,[],CHEMBL1665469,Antimicrobial activity against SCCmec type II vancomycin-intermediate Staphylococcus aureus isolate 4sy32 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321872,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,1.0
178064,178064,,,5176163,[],CHEMBL1666913,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate b5k3578 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321872,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,2.0
178065,178065,,,5177317,[],CHEMBL1666916,Antimicrobial activity against SCCmec type IV vancomycin-intermediate Staphylococcus aureus isolate 06b41 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321872,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,128.0
178066,178066,,,5177321,[],CHEMBL1665470,Antimicrobial activity against SCCmec type II vancomycin-intermediate Staphylococcus aureus isolate 4sy39 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321872,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,256.0
178067,178067,,,5177335,[],CHEMBL1666920,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate 15b52 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321872,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,256.0
178068,178068,,,5177338,[],CHEMBL1665530,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate 5zjsau3 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321872,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,256.0
178069,178069,,,5177340,[],CHEMBL1665531,Antimicrobial activity against SCCmec type II vancomycin-intermediate Staphylococcus aureus isolate sh06024 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321872,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,256.0
178070,178070,,,5177341,[],CHEMBL1665532,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate gz06040 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321872,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,256.0
178071,178071,,,5177343,[],CHEMBL1666905,Antimicrobial activity against SCCmec type II vancomycin-intermediate Staphylococcus aureus isolate 6zjsau7 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321872,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,256.0
178072,178072,,,5177344,[],CHEMBL1666906,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate bd4768 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321872,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,256.0
178073,178073,,,5177346,[],CHEMBL1666907,Antimicrobial activity against SCCmec type II vancomycin-intermediate Staphylococcus aureus isolate b2k4781 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321872,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,256.0
178074,178074,,,5177347,[],CHEMBL1666908,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate b3k2345 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321872,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,256.0
178075,178075,,,5177348,[],CHEMBL1666909,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate b2k3421 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321872,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,256.0
178076,178076,,,5177349,[],CHEMBL1666910,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate b3k5923 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321872,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,256.0
178077,178077,,,5177350,[],CHEMBL1666911,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate b4k6307 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321872,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,256.0
178078,178078,,,5177352,[],CHEMBL1666912,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate b5k3529 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321872,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,256.0
178079,178079,,,5177355,[],CHEMBL1666914,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate b6k1642 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321872,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,256.0
178080,178080,,,5177356,[],CHEMBL1666915,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate b6k7974 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321872,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,256.0
178081,178081,,,5177357,[],CHEMBL1666917,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate 13b16 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321872,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,256.0
178082,178082,,,5177358,[],CHEMBL1666918,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate 11b091 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321872,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,256.0
178083,178083,,,5177359,[],CHEMBL1666919,Antimicrobial activity against SCCmec type II vancomycin-intermediate Staphylococcus aureus isolate 07b63 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321872,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,256.0
178084,178084,,,5177361,[],CHEMBL1666921,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate zj07028 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321872,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,256.0
178085,178085,,,5177362,[],CHEMBL1666922,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate sh07043 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321872,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,256.0
178086,178086,,,5177364,[],CHEMBL1666923,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate xa07029 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321872,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,256.0
178087,178087,,,5177366,[],CHEMBL1666924,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate gz07030 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321872,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,256.0
178088,178088,,,5177367,[],CHEMBL1666925,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate gs07022 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321872,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,256.0
178089,178089,,,5177906,[],CHEMBL1659089,Antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 29213 by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322809,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,1.0
178090,178090,,,5177913,[],CHEMBL1659090,Antibacterial activity against community-acquired methicillin-resistant Staphylococcus aureus 144 by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322809,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,32.0
178091,178091,,,5177920,[],CHEMBL1659091,Antibacterial activity against community-acquired methicillin-resistant Staphylococcus aureus 156 by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322809,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,32.0
178092,178092,,,5177925,[],CHEMBL1659092,Antibacterial activity against community-acquired methicillin-resistant Staphylococcus aureus 147 by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322809,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,32.0
178093,178093,,,5177932,[],CHEMBL1659093,Antibacterial activity against hospital-acquired methicillin-resistant Staphylococcus aureus 56 by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322809,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,32.0
178094,178094,,,5177939,[],CHEMBL1659094,Antibacterial activity against hospital-acquired methicillin-resistant Staphylococcus aureus 152 by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322809,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,1.0
178095,178095,,,5180244,[],CHEMBL1659532,Antimicrobial activity against Acinetobacter baumannii ATCC 19606 expressing open reading frame orf3 encoded efflux pump CraA by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649205,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321932,=,1,1,=,,MIC,ug.mL-1,,1.5,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,1.5
178096,178096,,,5180245,[],CHEMBL1659533,Antimicrobial activity against Acinetobacter baumannii JVAB01 expressing disrupted open reading frame orf3 mutant deficient in efflux pump CraA by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649205,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321932,=,1,1,=,,MIC,ug.mL-1,,1.5,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,1.5
178097,178097,,,5180246,[],CHEMBL1659534,Antimicrobial activity against efflux pump CraA deficient Acinetobacter baumannii JVAB01 receiving pJV103 harboring open reading frame orf3 encoded efflux pump CraA by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649205,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321932,=,1,1,=,,MIC,ug.mL-1,,1.5,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,1.5
178098,178098,,,5180331,[],CHEMBL1659698,Antimicrobial activity against Mycobacterium chelonae ATCC 35752 by resazurine microtiter assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649207,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321952,=,1,1,=,,MIC,ug.mL-1,,20.0,CHEMBL612641,Mycobacteroides chelonae,Mycobacteroides chelonae,1774.0,,,MIC,ug ml-1,UO_0000274,,20.0
178099,178099,,,5180353,[],CHEMBL1659699,Antimicrobial activity against Mycobacterium chelonae ATCC 35752 harboring pZS01 carrying mspA gene by resazurine microtiter assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649207,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321952,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL612641,Mycobacteroides chelonae,Mycobacteroides chelonae,1774.0,,,MIC,ug ml-1,UO_0000274,,0.25
178100,178100,,,5180373,[],CHEMBL1659700,Antimicrobial activity against Mycobacterium chelonae 9917 by resazurine microtiter assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649207,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321952,=,1,1,=,,MIC,ug.mL-1,,500.0,CHEMBL612641,Mycobacteroides chelonae,Mycobacteroides chelonae,1774.0,,,MIC,ug ml-1,UO_0000274,,500.0
178101,178101,,,5180395,[],CHEMBL1659701,Antimicrobial activity against Mycobacterium chelonae 9917 harboring pZS01 carrying mspA gene by resazurine microtiter assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649207,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321952,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL612641,Mycobacteroides chelonae,Mycobacteroides chelonae,1774.0,,,MIC,ug ml-1,UO_0000274,,1.0
178102,178102,,,5181201,[],CHEMBL1667245,Antibacterial activity against Staphylococcus aureus RN4220 by CLSI method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649544,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327080,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
178103,178103,,,5181202,[],CHEMBL1667246,"Antibacterial activity against Staphylococcus aureus RN4220 harboring aadD, tet(L), dfrK and vga(C) gene by CLSI method",F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649544,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327080,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
178104,178104,,,5181203,[],CHEMBL1667247,"Antibacterial activity against Staphylococcus aureus RN4220 harboring tet(L), dfrK gene by CLSI method",F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649544,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327080,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
178105,178105,,,5181204,[],CHEMBL1667248,Antibacterial activity against Staphylococcus aureus RN4220 harboring aadD and tet(L) gene by CLSI method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649544,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327080,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
178106,178106,,,5181934,[],CHEMBL1660400,Antimicrobial activity against Staphylococcus aureus clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322862,>=,1,1,>=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
178107,178107,,,5181945,[],CHEMBL1660399,Antimicrobial activity against oxacillin-susceptible Staphylococcus aureus clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322862,>=,1,1,>=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
178108,178108,,,5181952,[],CHEMBL1660398,Antimicrobial activity against oxacillin-resistant Staphylococcus aureus clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322862,>=,1,1,>=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
178109,178109,,,5181959,[],CHEMBL1660397,Antimicrobial activity against Staphylococcus epidermidis clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322862,>=,1,1,>=,,MIC,ug.mL-1,,0.06,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.06
178110,178110,,,5181966,[],CHEMBL1660396,Antimicrobial activity against oxacillin-susceptible Staphylococcus epidermidis clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322862,>=,1,1,>=,,MIC,ug.mL-1,,0.06,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.06
178111,178111,,,5181973,[],CHEMBL1660395,Antimicrobial activity against oxacillin-resistant Staphylococcus epidermidis clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322862,>=,1,1,>=,,MIC,ug.mL-1,,0.12,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.12
178112,178112,,,5181980,[],CHEMBL1660394,Antimicrobial activity against Staphylococcus haemolyticus clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322862,>=,1,1,>=,,MIC,ug.mL-1,,0.12,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MIC,ug ml-1,UO_0000274,,0.12
178113,178113,,,5181987,[],CHEMBL1660393,Antimicrobial activity against oxacillin-susceptible Staphylococcus haemolyticus clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322862,>=,1,1,>=,,MIC,ug.mL-1,,0.12,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MIC,ug ml-1,UO_0000274,,0.12
178114,178114,,,5181995,[],CHEMBL1660392,Antimicrobial activity against oxacillin-resistant Staphylococcus haemolyticus clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322862,>=,1,1,>=,,MIC,ug.mL-1,,0.12,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MIC,ug ml-1,UO_0000274,,0.12
178115,178115,,,5182078,[],CHEMBL1660381,Antimicrobial activity against Streptococcus agalactiae clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322862,>=,1,1,>=,,MIC,ug.mL-1,,0.015,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC,ug ml-1,UO_0000274,,0.015
178116,178116,,,5182084,[],CHEMBL1660380,Antimicrobial activity against erythromycin-susceptible Streptococcus agalactiae clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322862,<=,1,1,<=,,MIC,ug.mL-1,,0.015,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC,ug ml-1,UO_0000274,,0.015
178117,178117,,,5182090,[],CHEMBL1660379,Antimicrobial activity against erythromycin-nonsusceptible Streptococcus agalactiae clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322862,>,1,1,>,,MIC,ug.mL-1,,0.5,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC,ug ml-1,UO_0000274,,0.5
178118,178118,,,5182096,[],CHEMBL1660378,Antimicrobial activity against Streptococcus pyogenes clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322862,>=,1,1,>=,,MIC,ug.mL-1,,0.015,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.015
178119,178119,,,5182102,[],CHEMBL1660377,Antimicrobial activity against erythromycin-susceptible Streptococcus pyogenes clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322862,<=,1,1,<=,,MIC,ug.mL-1,,0.015,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.015
178120,178120,,,5182108,[],CHEMBL1660376,Antimicrobial activity against erythromycin-nonsusceptible Streptococcus pyogenes clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322862,>,1,1,>,,MIC,ug.mL-1,,0.5,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.5
178121,178121,,,5182114,[],CHEMBL1660375,Antimicrobial activity against Streptococcus Group C clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322862,>=,1,1,>=,,MIC,ug.mL-1,,0.015,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.015
178122,178122,,,5182120,[],CHEMBL1660374,Antimicrobial activity against erythromycin-susceptible Streptococcus Group C clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322862,<=,1,1,<=,,MIC,ug.mL-1,,0.015,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.015
178123,178123,,,5182126,[],CHEMBL1660373,Antimicrobial activity against erythromycin-nonsusceptible Streptococcus Group C clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322862,>,1,1,>,,MIC,ug.mL-1,,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.5
178124,178124,,,5182132,[],CHEMBL1660372,Antimicrobial activity against Streptococcus Group G clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322862,>=,1,1,>=,,MIC,ug.mL-1,,0.015,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.015
178125,178125,,,5182138,[],CHEMBL1660371,Antimicrobial activity against erythromycin-susceptible Streptococcus Group G clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322862,<=,1,1,<=,,MIC,ug.mL-1,,0.015,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.015
178126,178126,,,5182144,[],CHEMBL1660370,Antimicrobial activity against erythromycin-nonsusceptible Streptococcus Group G clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322862,>,1,1,>,,MIC,ug.mL-1,,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.5
178127,178127,,,5182150,[],CHEMBL1660369,Antimicrobial activity against Streptococcus Group F clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322862,>=,1,1,>=,,MIC,ug.mL-1,,0.015,CHEMBL612313,Streptococcus,Streptococcus,1301.0,,,MIC,ug ml-1,UO_0000274,,0.015
178128,178128,,,5182156,[],CHEMBL1660368,Antimicrobial activity against erythromycin-susceptible Streptococcus Group F clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322862,<=,1,1,<=,,MIC,ug.mL-1,,0.015,CHEMBL612313,Streptococcus,Streptococcus,1301.0,,,MIC,ug ml-1,UO_0000274,,0.015
178129,178129,,,5182162,[],CHEMBL1660367,Antimicrobial activity against erythromycin-nonsusceptible Streptococcus Group F clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322862,>,1,1,>,,MIC,ug.mL-1,,0.5,CHEMBL612313,Streptococcus,Streptococcus,1301.0,,,MIC,ug ml-1,UO_0000274,,0.5
178130,178130,,,5182168,[],CHEMBL1652892,Antimicrobial activity against Streptococcus pneumoniae clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322862,>=,1,1,>=,,MIC,ug.mL-1,,0.015,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.015
178131,178131,,,5182178,[],CHEMBL1652894,Antimicrobial activity against penicillin-susceptible Streptococcus pneumoniae clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322862,>=,1,1,>=,,MIC,ug.mL-1,,0.015,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.015
178132,178132,,,5182188,[],CHEMBL1652896,Antimicrobial activity against penicillin-intermediate Streptococcus pneumoniae clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322862,>=,1,1,>=,,MIC,ug.mL-1,,0.015,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.015
178133,178133,,,5182198,[],CHEMBL1652898,Antimicrobial activity against penicillin-resistant Streptococcus pneumoniae clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322862,>,1,1,>,,MIC,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.03
178134,178134,,,5183247,[],CHEMBL1660400,Antimicrobial activity against Staphylococcus aureus clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322862,>,1,1,>,,MIC90,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,8.0
178135,178135,,,5183254,[],CHEMBL1660399,Antimicrobial activity against oxacillin-susceptible Staphylococcus aureus clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322862,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,8.0
178136,178136,,,5183261,[],CHEMBL1660398,Antimicrobial activity against oxacillin-resistant Staphylococcus aureus clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322862,>,1,1,>,,MIC90,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,8.0
178137,178137,,,5183268,[],CHEMBL1660397,Antimicrobial activity against Staphylococcus epidermidis clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322862,>,1,1,>,,MIC90,ug.mL-1,,8.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC90,ug ml-1,UO_0000274,,8.0
178138,178138,,,5183275,[],CHEMBL1660396,Antimicrobial activity against oxacillin-susceptible Staphylococcus epidermidis clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322862,>,1,1,>,,MIC90,ug.mL-1,,8.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC90,ug ml-1,UO_0000274,,8.0
178139,178139,,,5183282,[],CHEMBL1660395,Antimicrobial activity against oxacillin-resistant Staphylococcus epidermidis clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322862,>,1,1,>,,MIC90,ug.mL-1,,8.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC90,ug ml-1,UO_0000274,,8.0
178140,178140,,,5183289,[],CHEMBL1660394,Antimicrobial activity against Staphylococcus haemolyticus clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322862,>,1,1,>,,MIC90,ug.mL-1,,8.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MIC90,ug ml-1,UO_0000274,,8.0
178141,178141,,,5183296,[],CHEMBL1660393,Antimicrobial activity against oxacillin-susceptible Staphylococcus haemolyticus clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322862,>,1,1,>,,MIC90,ug.mL-1,,8.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MIC90,ug ml-1,UO_0000274,,8.0
178142,178142,,,5183304,[],CHEMBL1660392,Antimicrobial activity against oxacillin-resistant Staphylococcus haemolyticus clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322862,>,1,1,>,,MIC90,ug.mL-1,,8.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MIC90,ug ml-1,UO_0000274,,8.0
178143,178143,,,5183387,[],CHEMBL1660381,Antimicrobial activity against Streptococcus agalactiae clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322862,>,1,1,>,,MIC90,ug.mL-1,,2.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC90,ug ml-1,UO_0000274,,2.0
178144,178144,,,5183393,[],CHEMBL1660380,Antimicrobial activity against erythromycin-susceptible Streptococcus agalactiae clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322862,=,1,1,=,,MIC90,ug.mL-1,,0.06,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC90,ug ml-1,UO_0000274,,0.06
178145,178145,,,5183399,[],CHEMBL1660379,Antimicrobial activity against erythromycin-nonsusceptible Streptococcus agalactiae clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322862,>,1,1,>,,MIC90,ug.mL-1,,2.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC90,ug ml-1,UO_0000274,,2.0
178146,178146,,,5183405,[],CHEMBL1660378,Antimicrobial activity against Streptococcus pyogenes clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322862,>,1,1,>,,MIC90,ug.mL-1,,2.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC90,ug ml-1,UO_0000274,,2.0
178147,178147,,,5183411,[],CHEMBL1660377,Antimicrobial activity against erythromycin-susceptible Streptococcus pyogenes clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322862,=,1,1,=,,MIC90,ug.mL-1,,0.06,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC90,ug ml-1,UO_0000274,,0.06
178148,178148,,,5183417,[],CHEMBL1660376,Antimicrobial activity against erythromycin-nonsusceptible Streptococcus pyogenes clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322862,>,1,1,>,,MIC90,ug.mL-1,,2.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC90,ug ml-1,UO_0000274,,2.0
178149,178149,,,5183424,[],CHEMBL1652900,Antimicrobial activity against erythromycin-nonsusceptible Streptococcus Group F clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322862,=,1,0,=,,Activity,%,,0.0,CHEMBL612313,Streptococcus,Streptococcus,1301.0,,,Activity,%,UO_0000187,,0.0
178150,178150,,,5183429,[],CHEMBL1652901,Antimicrobial activity against erythromycin-susceptible Streptococcus Group F clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322862,=,1,0,=,,Activity,%,,100.0,CHEMBL612313,Streptococcus,Streptococcus,1301.0,,,Activity,%,UO_0000187,,100.0
178151,178151,,,5183433,[],CHEMBL1652902,Antimicrobial activity against Streptococcus Group F clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322862,=,1,0,=,,Activity,%,,79.8,CHEMBL612313,Streptococcus,Streptococcus,1301.0,,,Activity,%,UO_0000187,,79.8
178152,178152,,,5183438,[],CHEMBL1652903,Antimicrobial activity against erythromycin-nonsusceptible Streptococcus Group G clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322862,=,1,0,=,,Activity,%,,0.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Activity,%,UO_0000187,,0.0
178153,178153,,,5183443,[],CHEMBL1652904,Antimicrobial activity against erythromycin-susceptible Streptococcus Group G clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322862,=,1,0,=,,Activity,%,,100.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Activity,%,UO_0000187,,100.0
178154,178154,,,5183447,[],CHEMBL1652905,Antimicrobial activity against Streptococcus Group G clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322862,=,1,0,=,,Activity,%,,79.8,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Activity,%,UO_0000187,,79.8
178155,178155,,,5183452,[],CHEMBL1652906,Antimicrobial activity against erythromycin-nonsusceptible Streptococcus Group C clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322862,=,1,0,=,,Activity,%,,0.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Activity,%,UO_0000187,,0.0
178156,178156,,,5183457,[],CHEMBL1652907,Antimicrobial activity against erythromycin-susceptible Streptococcus Group C clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322862,=,1,0,=,,Activity,%,,100.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Activity,%,UO_0000187,,100.0
178157,178157,,,5183461,[],CHEMBL1652908,Antimicrobial activity against Streptococcus Group C clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322862,=,1,0,=,,Activity,%,,79.8,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Activity,%,UO_0000187,,79.8
178158,178158,,,5183466,[],CHEMBL1652909,Antimicrobial activity against erythromycin-nonsusceptible Streptococcus pyogenes clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322862,=,1,0,=,,Activity,%,,0.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,Activity,%,UO_0000187,,0.0
178159,178159,,,5183471,[],CHEMBL1652910,Antimicrobial activity against erythromycin-susceptible Streptococcus pyogenes clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322862,=,1,0,=,,Activity,%,,100.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,Activity,%,UO_0000187,,100.0
178160,178160,,,5183476,[],CHEMBL1652911,Antimicrobial activity against Streptococcus pyogenes clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322862,=,1,0,=,,Activity,%,,86.3,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,Activity,%,UO_0000187,,86.3
178161,178161,,,5183481,[],CHEMBL1652912,Antimicrobial activity against erythromycin-nonsusceptible Streptococcus agalactiae clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322862,=,1,0,=,,Activity,%,,0.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,Activity,%,UO_0000187,,0.0
178162,178162,,,5183486,[],CHEMBL1652913,Antimicrobial activity against erythromycin-susceptible Streptococcus agalactiae clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322862,=,1,0,=,,Activity,%,,100.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,Activity,%,UO_0000187,,100.0
178163,178163,,,5183491,[],CHEMBL1652914,Antimicrobial activity against Streptococcus agalactiae clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322862,=,1,0,=,,Activity,%,,70.6,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,Activity,%,UO_0000187,,70.6
178164,178164,,,5183567,[],CHEMBL1653024,Antimicrobial activity against oxacillin-resistant Staphylococcus haemolyticus clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322862,=,1,0,=,,Activity,%,,11.7,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,Activity,%,UO_0000187,,11.7
178165,178165,,,5183573,[],CHEMBL1653025,Antimicrobial activity against oxacillin-susceptible Staphylococcus haemolyticus clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322862,=,1,0,=,,Activity,%,,48.6,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,Activity,%,UO_0000187,,48.6
178166,178166,,,5183580,[],CHEMBL1653026,Antimicrobial activity against Staphylococcus haemolyticus clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322862,=,1,0,=,,Activity,%,,21.6,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,Activity,%,UO_0000187,,21.6
178167,178167,,,5183585,[],CHEMBL1653036,Antimicrobial activity against Streptococcus pneumoniae clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322862,=,1,0,=,,Activity,%,,67.3,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,67.3
178168,178168,,,5183837,[],CHEMBL1664540,Antimicrobial activity against Bacillus sp. BS-01 expressing multiple resistance gene cfr and phenolic resistance gene fexA obtained from swine feces,F,,,BAO_0002146,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649326,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323813,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,64.0
178169,178169,,,5183847,[],CHEMBL1664541,Antimicrobial activity against Staphylococcus aureus RN4220 harboring pBS-01multiple resistance gene cfr and phenolic resistance gene fexA obtained from swine feces,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649326,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323813,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
178170,178170,,,5183857,[],CHEMBL1664542,Antimicrobial activity against Staphylococcus aureus RN4220,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649326,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323813,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
178171,178171,,,5184183,[],CHEMBL1654399,Antibacterial activity against methicillin-resistant Staphylococcus aureus,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649553,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327137,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
178172,178172,,,5184646,[],CHEMBL1653038,Antimicrobial activity against penicillin-susceptible Streptococcus pneumoniae clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322862,=,1,0,=,,Activity,%,,88.1,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,88.1
178173,178173,,,5184655,[],CHEMBL1653040,Antimicrobial activity against penicillin-intermediate Streptococcus pneumoniae clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322862,=,1,0,=,,Activity,%,,41.2,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,41.2
178174,178174,,,5184664,[],CHEMBL1653042,Antimicrobial activity against penicillin-resistant Streptococcus pneumoniae clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322862,=,1,0,=,,Activity,%,,14.9,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,14.9
178175,178175,,,5184672,[],CHEMBL1653035,Antimicrobial activity against erythromycin-nonsusceptible Streptococcus Group F clinical isolates assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322862,=,1,0,=,,Activity,%,,82.4,CHEMBL612313,Streptococcus,Streptococcus,1301.0,,,Activity,%,UO_0000187,,82.4
178176,178176,,,5184676,[],CHEMBL1653034,Antimicrobial activity against erythromycin-susceptible Streptococcus Group F clinical isolates assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322862,=,1,0,=,,Activity,%,,0.0,CHEMBL612313,Streptococcus,Streptococcus,1301.0,,,Activity,%,UO_0000187,,0.0
178177,178177,,,5184680,[],CHEMBL1653033,Antimicrobial activity against Streptococcus Group F clinical isolates assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322862,=,1,0,=,,Activity,%,,16.7,CHEMBL612313,Streptococcus,Streptococcus,1301.0,,,Activity,%,UO_0000187,,16.7
178178,178178,,,5184684,[],CHEMBL1653044,Antimicrobial activity against erythromycin-nonsusceptible Streptococcus Group G clinical isolates assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322862,=,1,0,=,,Activity,%,,82.4,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Activity,%,UO_0000187,,82.4
178179,178179,,,5184688,[],CHEMBL1653045,Antimicrobial activity against erythromycin-susceptible Streptococcus Group G clinical isolates assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322862,=,1,0,=,,Activity,%,,0.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Activity,%,UO_0000187,,0.0
178180,178180,,,5184692,[],CHEMBL1653046,Antimicrobial activity against Streptococcus Group G clinical isolates assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322862,=,1,0,=,,Activity,%,,16.7,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Activity,%,UO_0000187,,16.7
178181,178181,,,5184696,[],CHEMBL1653047,Antimicrobial activity against erythromycin-nonsusceptible Streptococcus Group C clinical isolates assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322862,=,1,0,=,,Activity,%,,82.4,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Activity,%,UO_0000187,,82.4
178182,178182,,,5184700,[],CHEMBL1653818,Antimicrobial activity against erythromycin-susceptible Streptococcus Group C clinical isolates assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322862,=,1,0,=,,Activity,%,,0.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Activity,%,UO_0000187,,0.0
178183,178183,,,5184704,[],CHEMBL1653819,Antimicrobial activity against Streptococcus Group C clinical isolates assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322862,=,1,0,=,,Activity,%,,16.7,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Activity,%,UO_0000187,,16.7
178184,178184,,,5184708,[],CHEMBL1653820,Antimicrobial activity against erythromycin-nonsusceptible Streptococcus pyogenes clinical isolates assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322862,=,1,0,=,,Activity,%,,99.2,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,Activity,%,UO_0000187,,99.2
178185,178185,,,5184712,[],CHEMBL1653821,Antimicrobial activity against erythromycin-susceptible Streptococcus pyogenes clinical isolates assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322862,=,1,0,=,,Activity,%,,0.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,Activity,%,UO_0000187,,0.0
178186,178186,,,5184716,[],CHEMBL1653822,Antimicrobial activity against Streptococcus pyogenes clinical isolates assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322862,=,1,0,=,,Activity,%,,13.6,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,Activity,%,UO_0000187,,13.6
178187,178187,,,5184721,[],CHEMBL1653823,Antimicrobial activity against erythromycin-nonsusceptible Streptococcus agalactiae clinical isolates assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322862,=,1,0,=,,Activity,%,,97.5,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,Activity,%,UO_0000187,,97.5
178188,178188,,,5184726,[],CHEMBL1653824,Antimicrobial activity against erythromycin-susceptible Streptococcus agalactiae clinical isolates assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322862,=,1,0,=,,Activity,%,,0.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,Activity,%,UO_0000187,,0.0
178189,178189,,,5184731,[],CHEMBL1653825,Antimicrobial activity against Streptococcus agalactiae clinical isolates assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322862,=,1,0,=,,Activity,%,,28.7,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,Activity,%,UO_0000187,,28.7
178190,178190,,,5184796,[],CHEMBL1653836,Antimicrobial activity against oxacillin-resistant Staphylococcus haemolyticus clinical isolates assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322862,=,1,0,=,,Activity,%,,88.3,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,Activity,%,UO_0000187,,88.3
178191,178191,,,5184800,[],CHEMBL1653837,Antimicrobial activity against oxacillin-susceptible Staphylococcus haemolyticus clinical isolates assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322862,=,1,0,=,,Activity,%,,51.4,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,Activity,%,UO_0000187,,51.4
178192,178192,,,5184805,[],CHEMBL1653838,Antimicrobial activity against Staphylococcus haemolyticus clinical isolates assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322862,=,1,0,=,,Activity,%,,78.4,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,Activity,%,UO_0000187,,78.4
178193,178193,,,5184809,[],CHEMBL1653839,Antimicrobial activity against oxacillin-resistant Staphylococcus epidermidis clinical isolates assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322862,=,1,0,=,,Activity,%,,75.3,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,75.3
178194,178194,,,5184813,[],CHEMBL1653840,Antimicrobial activity against oxacillin-susceptible Staphylococcus epidermidis clinical isolates assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322862,=,1,0,=,,Activity,%,,45.4,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,45.4
178195,178195,,,5184817,[],CHEMBL1653841,Antimicrobial activity against Staphylococcus epidermidis clinical isolates assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322862,=,1,0,=,,Activity,%,,67.2,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,67.2
178196,178196,,,5184821,[],CHEMBL1653842,Antimicrobial activity against oxacillin-resistant Staphylococcus aureus clinical isolates assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322862,=,1,0,=,,Activity,%,,90.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,90.5
178197,178197,,,5184825,[],CHEMBL1653843,Antimicrobial activity against oxacillin-susceptible Staphylococcus aureus clinical isolates assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322862,=,1,0,=,,Activity,%,,35.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,35.9
178198,178198,,,5184829,[],CHEMBL1653844,Antimicrobial activity against Staphylococcus aureus clinical isolates assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322862,=,1,0,=,,Activity,%,,65.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,65.3
178199,178199,,,5184832,[],CHEMBL1653845,Antimicrobial activity against Streptococcus pneumoniae clinical isolates assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322862,=,1,0,=,,Activity,%,,32.4,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,32.4
178200,178200,,,5184840,[],CHEMBL1653847,Antimicrobial activity against penicillin-susceptible Streptococcus pneumoniae clinical isolates assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322862,=,1,0,=,,Activity,%,,11.6,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,11.6
178201,178201,,,5184848,[],CHEMBL1653849,Antimicrobial activity against penicillin-intermediate Streptococcus pneumoniae clinical isolates assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322862,=,1,0,=,,Activity,%,,58.8,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,58.8
178202,178202,,,5184856,[],CHEMBL1653951,Antimicrobial activity against penicillin-resistant Streptococcus pneumoniae clinical isolates assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322862,=,1,0,=,,Activity,%,,84.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,84.5
178203,178203,,,5184866,[],CHEMBL1653027,Antimicrobial activity against oxacillin-resistant Staphylococcus epidermidis clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322862,=,1,0,=,,Activity,%,,24.1,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,24.1
178204,178204,,,5184872,[],CHEMBL1653028,Antimicrobial activity against oxacillin-susceptible Staphylococcus epidermidis clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322862,=,1,0,=,,Activity,%,,53.8,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,53.8
178205,178205,,,5184878,[],CHEMBL1653029,Antimicrobial activity against Staphylococcus epidermidis clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322862,=,1,0,=,,Activity,%,,32.2,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,32.2
178206,178206,,,5184884,[],CHEMBL1653030,Antimicrobial activity against oxacillin-resistant Staphylococcus aureus clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322862,=,1,0,=,,Activity,%,,8.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,8.4
178207,178207,,,5184890,[],CHEMBL1653031,Antimicrobial activity against oxacillin-susceptible Staphylococcus aureus clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322862,=,1,0,=,,Activity,%,,60.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,60.7
178208,178208,,,5184896,[],CHEMBL1653032,Antimicrobial activity against Staphylococcus aureus clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1322862,=,1,0,=,,Activity,%,,32.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,32.6
178209,178209,,,5184915,[],CHEMBL1660375,Antimicrobial activity against Streptococcus Group C clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322862,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,2.0
178210,178210,,,5184916,[],CHEMBL1660372,Antimicrobial activity against Streptococcus Group G clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322862,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,2.0
178211,178211,,,5184917,[],CHEMBL1660369,Antimicrobial activity against Streptococcus Group F clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322862,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL612313,Streptococcus,Streptococcus,1301.0,,,MIC90,ug ml-1,UO_0000274,,2.0
178212,178212,,,5184936,[],CHEMBL1660374,Antimicrobial activity against erythromycin-susceptible Streptococcus Group C clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322862,=,1,1,=,,MIC90,ug.mL-1,,0.06,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,0.06
178213,178213,,,5184937,[],CHEMBL1660371,Antimicrobial activity against erythromycin-susceptible Streptococcus Group G clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322862,=,1,1,=,,MIC90,ug.mL-1,,0.06,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,0.06
178214,178214,,,5184938,[],CHEMBL1660368,Antimicrobial activity against erythromycin-susceptible Streptococcus Group F clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322862,=,1,1,=,,MIC90,ug.mL-1,,0.06,CHEMBL612313,Streptococcus,Streptococcus,1301.0,,,MIC90,ug ml-1,UO_0000274,,0.06
178215,178215,,,5184939,[],CHEMBL1660373,Antimicrobial activity against erythromycin-nonsusceptible Streptococcus Group C clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322862,>,1,1,>,,MIC90,ug.mL-1,,2.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,2.0
178216,178216,,,5184940,[],CHEMBL1660370,Antimicrobial activity against erythromycin-nonsusceptible Streptococcus Group G clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322862,>,1,1,>,,MIC90,ug.mL-1,,2.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,2.0
178217,178217,,,5184941,[],CHEMBL1660367,Antimicrobial activity against erythromycin-nonsusceptible Streptococcus Group F clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322862,>,1,1,>,,MIC90,ug.mL-1,,2.0,CHEMBL612313,Streptococcus,Streptococcus,1301.0,,,MIC90,ug ml-1,UO_0000274,,2.0
178218,178218,,,5184979,[],CHEMBL1652892,Antimicrobial activity against Streptococcus pneumoniae clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322862,>,1,1,>,,MIC90,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,2.0
178219,178219,,,5184980,[],CHEMBL1652894,Antimicrobial activity against penicillin-susceptible Streptococcus pneumoniae clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322862,>,1,1,>,,MIC90,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,2.0
178220,178220,,,5184981,[],CHEMBL1652896,Antimicrobial activity against penicillin-intermediate Streptococcus pneumoniae clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322862,>,1,1,>,,MIC90,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,2.0
178221,178221,,,5184982,[],CHEMBL1652898,Antimicrobial activity against penicillin-resistant Streptococcus pneumoniae clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322862,>,1,1,>,,MIC90,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,2.0
178222,178222,,,5203683,[],CHEMBL1671349,Antimicrobial activity against erythromycin-susceptible Streptococcus pneumoniae ATCC 49619 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1667745,Eur J Med Chem,2011.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327785,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.03
178223,178223,,,5203684,[],CHEMBL1671350,Antimicrobial activity against erythromycin-resistant Streptococcus pneumoniae B1 expressing the erm gene by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1667745,Eur J Med Chem,2011.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327785,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,128.0
178224,178224,,,5203685,[],CHEMBL1671351,Antimicrobial activity against erythromycin-resistant Streptococcus pneumoniae A22072 expressing the mef gene by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1667745,Eur J Med Chem,2011.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327785,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
178225,178225,,,5203686,[],CHEMBL1671352,Antimicrobial activity against erythromycin-resistant Streptococcus pneumoniae AB11 expressing the erm and mef gene by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1667745,Eur J Med Chem,2011.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327785,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,256.0
178226,178226,,,5203687,[],CHEMBL1671353,Antimicrobial activity against erythromycin-susceptible Staphylococcus aureus ATCC 25923 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1667745,Eur J Med Chem,2011.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327785,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
178227,178227,,,5203688,[],CHEMBL1671354,Antimicrobial activity against penicillin-susceptible Staphylococcus aureus P1 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1667745,Eur J Med Chem,2011.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327785,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
178228,178228,,,5203689,[],CHEMBL1671355,Antimicrobial activity against erythromycin-susceptible Streptococcus pyogenes S2 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1667745,Eur J Med Chem,2011.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327785,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.03
178229,178229,,,5203690,[],CHEMBL1671356,Antimicrobial activity against erythromycin-resistant Streptococcus pyogenes R2 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1667745,Eur J Med Chem,2011.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327785,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,4.0
178230,178230,,,5209610,[],CHEMBL1680722,Antibacterial activity against Escherichia coli ATCC 25992 by Etest method in presence of 1 ug/ml NAB7061,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331723,=,1,1,=,,MIC,ug.mL-1,,6.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,6.0
178231,178231,,,5209615,[],CHEMBL1680723,Antibacterial activity against Escherichia coli ATCC 25992 by Etest method in presence of 2 ug/ml NAB7062,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331723,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
178232,178232,,,5209620,[],CHEMBL1680724,Antibacterial activity against Escherichia coli ATCC 25992 by Etest method in presence of 4 ug/ml NAB7064,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331723,=,1,1,=,,MIC,ug.mL-1,,0.75,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.75
178233,178233,,,5209625,[],CHEMBL1680725,Ratio of the MIC for Escherichia coli ATCC 25992 in the absence of NAB7061 to MIC for Escherichia coli ATCC 25992 in the presence of 4 ug/ml of NAB7061,F,,,BAO_0000193,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1331723,=,1,0,=,,Ratio,,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,32.0
178234,178234,,,5209630,[],CHEMBL1680726,Antibacterial activity against Escherichia coli IH3080 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331723,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,16.0
178235,178235,,,5209635,[],CHEMBL1680727,Antibacterial activity against Escherichia coli IH3080 by Etest method in presence of 1 ug/ml NAB7061,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331723,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.0
178236,178236,,,5209640,[],CHEMBL1680728,Antibacterial activity against Escherichia coli IH3080 by Etest method in presence of 2 ug/ml NAB7062,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331723,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
178237,178237,,,5209645,[],CHEMBL1680729,Antibacterial activity against Escherichia coli IH3080 by Etest method in presence of 4 ug/ml NAB7064,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331723,=,1,1,=,,MIC,ug.mL-1,,0.38,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.38
178238,178238,,,5209650,[],CHEMBL1680730,Ratio of the MIC for Escherichia coli IH3080 in the absence of NAB7061 to MIC for Escherichia coli IH3080 in the presence of 4 ug/ml of NAB7061,F,,,BAO_0000193,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1331723,=,1,0,=,,Ratio,,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,32.0
178239,178239,,,5209655,[],CHEMBL1680731,Antibacterial activity against Escherichia coli IH3080 by Etest method in presence of NAB7061,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331723,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
178240,178240,,,5209660,[],CHEMBL1680732,Antibacterial activity against Klebsiella pneumoniae ATCC 13883 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331723,=,1,1,=,,MIC,ug.mL-1,,24.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,24.0
178241,178241,,,5209665,[],CHEMBL1680733,Antibacterial activity against Klebsiella pneumoniae ATCC 13883 by Etest method in presence of 1 ug/ml NAB7061,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331723,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,4.0
178242,178242,,,5209670,[],CHEMBL1680734,Antibacterial activity against Klebsiella pneumoniae ATCC 13883 by Etest method in presence of 2 ug/ml NAB7061,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331723,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,2.0
178243,178243,,,5209675,[],CHEMBL1680735,Antibacterial activity against Klebsiella pneumoniae ATCC 13883 by Etest method in presence of 4 ug/ml NAB7061,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331723,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.5
178244,178244,,,5209680,[],CHEMBL1680736,Ratio of the MIC for Klebsiella pneumoniae ATCC 13883 in the absence of NAB7061 to MIC for Klebsiella pneumoniae ATCC 13883 in the presence of 4 ug/ml of NAB7061,F,,,BAO_0000193,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1331723,=,1,0,=,,Ratio,,,24.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,Ratio,,,,24.0
178245,178245,,,5209685,[],CHEMBL1680737,Antibacterial activity against Klebsiella pneumoniae ATCC 13883 by Etest method in presence of NAB7061,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331723,<=,1,1,<=,,MIC,ug.mL-1,,0.143,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.143
178246,178246,,,5209690,[],CHEMBL1680738,Antibacterial activity against Enterobacter cloacae ATCC 23355 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331723,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,64.0
178247,178247,,,5209695,[],CHEMBL1680739,Antibacterial activity against Enterobacter cloacae ATCC 23355 ATCC 13883 by Etest method in presence of 1 ug/ml NAB7061,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331723,=,1,1,=,,MIC,ug.mL-1,,48.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,48.0
178248,178248,,,5209700,[],CHEMBL1680740,Antibacterial activity against Enterobacter cloacae ATCC 23355 ATCC 13883 by Etest method in presence of 2 ug/ml NAB7062,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331723,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,8.0
178249,178249,,,5209705,[],CHEMBL1680741,Antibacterial activity against Enterobacter cloacae ATCC 23355 ATCC 13883 by Etest method in presence of 4 ug/ml NAB7064,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331723,=,1,1,=,,MIC,ug.mL-1,,1.5,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,1.5
178250,178250,,,5209710,[],CHEMBL1680742,Ratio of the MIC for Enterobacter cloacae ATCC 23355 in the absence of NAB7061 to MIC for Enterobacter cloacae ATCC 23355 ATCC 13883 in the presence of 4 ug/ml of NAB7061,F,,,BAO_0000193,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1331723,=,1,0,=,,Ratio,,,21.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,Ratio,,,,21.0
178251,178251,,,5209715,[],CHEMBL1680743,Antibacterial activity against Enterobacter cloacae ATCC 23355 ATCC 13883 by Etest method in presence of NAB7061,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331723,=,1,1,=,,MIC,ug.mL-1,,0.375,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.375
178252,178252,,,5211906,[],CHEMBL1675696,Antimicrobial activity against Staphylococcus epidermidis SW029 expressing icaA gene,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332148,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,128.0
178253,178253,,,5211907,[],CHEMBL1675697,Antimicrobial activity against Staphylococcus epidermidis SW036,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332148,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,128.0
178254,178254,,,5211910,[],CHEMBL1676488,Antimicrobial activity against compound pretreated Staphylococcus epidermidis biofilms,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332148,>=,1,1,>=,,MIC,ug.mL-1,,32.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,32.0
178255,178255,,,5211911,[],CHEMBL1676486,Antimicrobial activity against Staphylococcus epidermidis lacking compound-induced biofilms,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332148,>=,1,1,>=,,MIC,ug.mL-1,,16.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,16.0
178256,178256,,,5211912,[],CHEMBL1676487,Antimicrobial activity against Staphylococcus epidermidis lacking compound-induced biofilms assessed as biofilm formation at 1/4 X MIC relative to untreated control,F,,,BAO_0000193,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1332148,=,1,0,=,,Ratio,,,1.02,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Ratio,,,,1.02
178257,178257,,,5211913,[],CHEMBL1676485,Antimicrobial activity against compound pretreated Staphylococcus epidermidis assessed as biofilm formation at 1/4 X MIC relative to untreated control,F,,,BAO_0000193,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1332148,=,1,0,=,,Ratio,,,2.51,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Ratio,,,,2.51
178258,178258,,Active,5211914,[],CHEMBL1675698,Antimicrobial activity against Staphylococcus epidermidis SW036 at 1/1024 X MIC,F,,,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1332148,,1,0,,,Activity,,,,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,,,,
178259,178259,,,5211915,[],CHEMBL1675699,Antimicrobial activity against Staphylococcus epidermidis SW029 expressing icaA gene assessed as enhancement of biofilm formation after 18 hrs by microtiter plate assay,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1332148,=,1,0,=,,Activity,%,,173.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,173.0
178260,178260,,,5211916,[],CHEMBL1675700,Antimicrobial activity against Staphylococcus epidermidis SW036 assessed as enhancement of biofilm formation after 18 hrs by microtiter plate assay,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1332148,=,1,0,=,,Activity,%,,100.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,100.0
178261,178261,,,5211939,[],CHEMBL1676458,Enhancement of biofilm formation Staphylococcus epidermidis ATCC 35984 expressing icaA gene at 1/4 X MIC by microtiter plate assay,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1332148,=,1,0,=,,Activity,%,,7.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,7.0
178262,178262,,,5211940,[],CHEMBL1676459,Enhancement of biofilm formation Staphylococcus epidermidis SW027 expressing icaA gene at 1/4 X MIC by microtiter plate assay,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1332148,=,1,0,=,,Activity,%,,60.4,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,60.4
178263,178263,,,5211941,[],CHEMBL1676460,Enhancement of biofilm formation Staphylococcus epidermidis SW029 expressing icaA gene at 1/4 X MIC by microtiter plate assay,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1332148,=,1,0,=,,Activity,%,,159.6,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,159.6
178264,178264,,,5211942,[],CHEMBL1676461,Enhancement of biofilm formation Staphylococcus epidermidis SW032 expressing icaA gene at 1/4 X MIC by microtiter plate assay,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1332148,=,1,0,=,,Activity,%,,78.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,78.5
178265,178265,,,5211943,[],CHEMBL1676462,Enhancement of biofilm formation Staphylococcus epidermidis SW045 expressing icaA gene at 1/4 X MIC by microtiter plate assay,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1332148,=,1,0,=,,Activity,%,,47.2,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,47.2
178266,178266,,,5211944,[],CHEMBL1676463,Enhancement of biofilm formation Staphylococcus epidermidis SW058 expressing icaA gene at 1/4 X MIC by microtiter plate assay,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1332148,=,1,0,=,,Activity,%,,37.9,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,37.9
178267,178267,,,5211945,[],CHEMBL1676464,Enhancement of biofilm formation Staphylococcus epidermidis SW061 expressing icaA gene at 1/4 X MIC by microtiter plate assay,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1332148,=,1,0,=,,Activity,%,,50.8,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,50.8
178268,178268,,,5211946,[],CHEMBL1676465,Enhancement of biofilm formation Staphylococcus epidermidis SW067 expressing icaA gene at 1/4 X MIC by microtiter plate assay,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1332148,=,1,0,=,,Activity,%,,150.3,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,150.3
178269,178269,,,5211947,[],CHEMBL1676466,Enhancement of biofilm formation Staphylococcus epidermidis SW085 expressing icaA gene at 1/4 X MIC by microtiter plate assay,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1332148,=,1,0,=,,Activity,%,,297.8,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,297.8
178270,178270,,,5211948,[],CHEMBL1676467,Enhancement of biofilm formation Staphylococcus epidermidis SW098 expressing icaA gene at 1/4 X MIC by microtiter plate assay,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1332148,=,1,0,=,,Activity,%,,93.9,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,93.9
178271,178271,,,5211949,[],CHEMBL1676468,Enhancement of biofilm formation Staphylococcus epidermidis SW104 expressing icaA gene at 1/4 X MIC by microtiter plate assay,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1332148,=,1,0,=,,Activity,%,,63.2,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,63.2
178272,178272,,,5211950,[],CHEMBL1676469,Enhancement of biofilm formation Staphylococcus epidermidis SW126 expressing icaA gene at 1/4 X MIC by microtiter plate assay,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1332148,=,1,0,=,,Activity,%,,56.1,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,56.1
178273,178273,,,5211951,[],CHEMBL1676470,Enhancement of biofilm formation Staphylococcus epidermidis SW015 at 1/4 X MIC by microtiter plate assay,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1332148,=,1,0,=,,Activity,%,,87.8,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,87.8
178274,178274,,,5211952,[],CHEMBL1676471,Enhancement of biofilm formation Staphylococcus epidermidis SW021 at 1/4 X MIC by microtiter plate assay,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1332148,=,1,0,=,,Activity,%,,34.7,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,34.7
178275,178275,,,5211953,[],CHEMBL1676472,Enhancement of biofilm formation Staphylococcus epidermidis SW036 at 1/4 X MIC by microtiter plate assay,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1332148,=,1,0,=,,Activity,%,,284.3,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,284.3
178276,178276,,,5211954,[],CHEMBL1676473,Enhancement of biofilm formation Staphylococcus epidermidis SW070 at 1/4 X MIC by microtiter plate assay,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1332148,=,1,0,=,,Activity,%,,172.2,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,172.2
178277,178277,,,5211955,[],CHEMBL1676474,Enhancement of biofilm formation Staphylococcus epidermidis SW071 at 1/4 X MIC by microtiter plate assay,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1332148,=,1,0,=,,Activity,%,,230.4,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,230.4
178278,178278,,,5211956,[],CHEMBL1676475,Enhancement of biofilm formation Staphylococcus epidermidis SW082 at 1/4 X MIC by microtiter plate assay,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1332148,=,1,0,=,,Activity,%,,58.7,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,58.7
178279,178279,,,5211957,[],CHEMBL1676476,Enhancement of biofilm formation Staphylococcus epidermidis SW088 at 1/4 X MIC by microtiter plate assay,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1332148,=,1,0,=,,Activity,%,,163.1,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,163.1
178280,178280,,,5211958,[],CHEMBL1676477,Enhancement of biofilm formation Staphylococcus epidermidis SW099 at 1/4 X MIC by microtiter plate assay,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1332148,=,1,0,=,,Activity,%,,55.7,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,55.7
178281,178281,,,5211959,[],CHEMBL1676478,Enhancement of biofilm formation Staphylococcus epidermidis SW115 at 1/4 X MIC by microtiter plate assay,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1332148,=,1,0,=,,Activity,%,,166.8,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,166.8
178282,178282,,,5211960,[],CHEMBL1676479,Enhancement of biofilm formation Staphylococcus epidermidis SW120 at 1/4 X MIC by microtiter plate assay,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1332148,=,1,0,=,,Activity,%,,69.4,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,69.4
178283,178283,,Not Active,5211983,[],CHEMBL1676482,Effect on polysaccharide secretion in Staphylococcus epidermidis SW029 expressing icaA gene at 12 hrs by SEM,F,,,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1332148,,1,0,,,Activity,,,,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,,,,
178284,178284,,Not Active,5211984,[],CHEMBL1676480,Antimicrobial activity against Staphylococcus epidermidis SW029 expressing icaA gene assessed as formation of multilayer biofilms at 48 hrs by SEM,F,,,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1332148,,1,0,,,Activity,,,,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,,,,
178285,178285,,Not Active,5211985,[],CHEMBL1676481,Antimicrobial activity against Staphylococcus epidermidis SW029 expressing icaA gene assessed as increased biofilm formation at 6 to 12 hrs by CLSM,F,,,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1332148,,1,0,,,Activity,,,,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,,,,
178286,178286,,,5211986,[],CHEMBL1675701,Upregulation of icaA gene expression in Staphylococcus epidermidis SW029 at 8 ug/ml after 6 hrs by RT-PCR relative to untreated control,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1332148,=,1,0,=,,FC,,,1.2,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,FC,,,,1.2
178287,178287,,,5211987,[],CHEMBL1675702,Upregulation of atlE gene expression in Staphylococcus epidermidis SW029 at 8 ug/ml after 6 hrs by RT-PCR relative to untreated control,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1332148,=,1,0,=,,FC,,,6.2,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,FC,,,,6.2
178288,178288,,,5211988,[],CHEMBL1675703,Upregulation of fruA gene expression in Staphylococcus epidermidis SW029 at 8 ug/ml after 6 hrs by RT-PCR relative to untreated control,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1332148,=,1,0,=,,FC,,,4.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,FC,,,,4.5
178289,178289,,,5211989,[],CHEMBL1675704,Upregulation of pyrR gene expression in Staphylococcus epidermidis SW029 at 8 ug/ml after 6 hrs by RT-PCR relative to untreated control,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1332148,=,1,0,=,,FC,,,3.7,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,FC,,,,3.7
178290,178290,,,5211990,[],CHEMBL1675705,Upregulation of sarA gene expression in Staphylococcus epidermidis SW029 at 8 ug/ml after 6 hrs by RT-PCR relative to untreated control,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1332148,=,1,0,=,,FC,,,1.7,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,FC,,,,1.7
178291,178291,,,5211991,[],CHEMBL1675706,Upregulation of sigB gene expression in Staphylococcus epidermidis SW029 at 8 ug/ml after 6 hrs by RT-PCR relative to untreated control,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1332148,=,1,0,=,,FC,,,2.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,FC,,,,2.0
178292,178292,,,5211992,[],CHEMBL1675707,Upregulation of icaA gene expression in Staphylococcus epidermidis SW029 at 8 ug/ml after 24 hrs by RT-PCR relative to untreated control,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1332148,=,1,0,=,,FC,,,2.8,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,FC,,,,2.8
178293,178293,,,5211993,[],CHEMBL1675708,Upregulation of atlE gene expression in Staphylococcus epidermidis SW029 at 8 ug/ml after 24 hrs by RT-PCR relative to untreated control,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1332148,=,1,0,=,,FC,,,2.4,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,FC,,,,2.4
178294,178294,,Not Determined,5211994,[],CHEMBL1675709,Upregulation of fruA gene expression in Staphylococcus epidermidis SW029 at 8 ug/ml after 24 hrs by RT-PCR relative to untreated control,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1332148,,1,0,,,FC,,,,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,FC,,,,
178295,178295,,Not Determined,5211995,[],CHEMBL1675710,Upregulation of pyrR gene expression in Staphylococcus epidermidis SW029 at 8 ug/ml after 24 hrs by RT-PCR relative to untreated control,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1332148,,1,0,,,FC,,,,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,FC,,,,
178296,178296,,,5211996,[],CHEMBL1676340,Upregulation of sarA gene expression in Staphylococcus epidermidis SW029 at 8 ug/ml after 24 hrs by RT-PCR relative to untreated control,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1332148,=,1,0,=,,FC,,,6.9,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,FC,,,,6.9
178297,178297,,,5211997,[],CHEMBL1676341,Downregulation of sigB gene expression in Staphylococcus epidermidis SW029 at 8 ug/ml after 24 hrs by RT-PCR relative to untreated control,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1332148,=,1,0,=,,FC,,,0.6,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,FC,,,,0.6
178298,178298,,,5211998,[],CHEMBL1676342,Upregulation of atlE gene expression in Staphylococcus epidermidis SW036 at 8 ug/ml after 6 hrs by RT-PCR relative to untreated control,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1332148,=,1,0,=,,FC,,,1.8,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,FC,,,,1.8
178299,178299,,,5211999,[],CHEMBL1676454,Upregulation of fruA gene expression in Staphylococcus epidermidis SW036 at 8 ug/ml after 6 hrs by RT-PCR relative to untreated control,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1332148,=,1,0,=,,FC,,,2.4,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,FC,,,,2.4
178300,178300,,,5212000,[],CHEMBL1676455,Upregulation of pyrR gene expression in Staphylococcus epidermidis SW036 at 8 ug/ml after 6 hrs by RT-PCR relative to untreated control,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1332148,=,1,0,=,,FC,,,2.4,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,FC,,,,2.4
178301,178301,,,5212001,[],CHEMBL1676456,Upregulation of sarA gene expression in Staphylococcus epidermidis SW036 at 8 ug/ml after 6 hrs by RT-PCR relative to untreated control,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1332148,=,1,0,=,,FC,,,1.7,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,FC,,,,1.7
178302,178302,,,5212002,[],CHEMBL1676457,Upregulation of sigB gene expression in Staphylococcus epidermidis SW036 at 8 ug/ml after 6 hrs by RT-PCR relative to untreated control,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1332148,=,1,0,=,,FC,,,1.4,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,FC,,,,1.4
178303,178303,,,5212232,[],CHEMBL1675069,Antimicrobial activity against community-associated methicillin-resistant Staphylococcus aureus USA300,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671748,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332660,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
178304,178304,,,5212243,[],CHEMBL1675070,Antimicrobial activity against community-associated methicillin-resistant Staphylococcus aureus Sanger 252,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671748,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332660,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
178305,178305,,Active,5212250,[],CHEMBL1675071,Increase in PSMalpha levels in Staphylococcus aureus USA300 at subinhibitory concentrations after 24 hrs by RP-HPLC/ESI- MS,F,,,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671748,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1332660,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
178306,178306,,Not Active,5212260,[],CHEMBL1675075,Decrease in delta toxin levels in Staphylococcus aureus Sanger 252 at subinhibitory concentrations after 24 hrs by RP-HPLC/ESI- MS,F,,,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671748,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1332660,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
178307,178307,,Not Active,5212269,[],CHEMBL1675076,Decrease in delta toxin levels in Staphylococcus aureus USA300 at subinhibitory concentrations after 24 hrs by RP-HPLC/ESI- MS,F,,,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671748,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1332660,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
178308,178308,,Active,5212278,[],CHEMBL1675078,Decrease in PSMbeta1 levels in Staphylococcus aureus USA300 at subinhibitory concentration after 24 hrs by RP-HPLC/ESI-MS,F,,,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671748,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1332660,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
178309,178309,,Active,5212287,[],CHEMBL1675077,Decrease in PSMbeta1 levels in Staphylococcus aureus Sanger 252 at subinhibitory concentrations after 24 hrs by RP-HPLC/ESI- MS,F,,,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671748,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1332660,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
178310,178310,,,5213060,[],CHEMBL1677043,Antimicrobial activity against Streptococcus pneumoniae serotype 19A assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1332158,=,1,0,=,,Activity,%,,26.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,26.5
178311,178311,,,5213234,[],CHEMBL1676499,Antimicrobial activity against Streptococcus pneumoniae serotype 3 by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332158,<=,1,1,<=,,MIC50,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.25
178312,178312,,,5213237,[],CHEMBL1676499,Antimicrobial activity against Streptococcus pneumoniae serotype 3 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332158,<=,1,1,<=,,MIC90,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.25
178313,178313,,,5213240,[],CHEMBL1676500,Antimicrobial activity against Streptococcus pneumoniae serotype 35B by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332158,<=,1,1,<=,,MIC50,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.25
178314,178314,,,5213244,[],CHEMBL1676501,Antimicrobial activity against Streptococcus pneumoniae serotype 7F by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332158,<=,1,1,<=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
178315,178315,,,5213247,[],CHEMBL1676501,Antimicrobial activity against Streptococcus pneumoniae serotype 7F by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332158,<=,1,1,<=,,MIC50,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.25
178316,178316,,,5213250,[],CHEMBL1676501,Antimicrobial activity against Streptococcus pneumoniae serotype 7F by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332158,<=,1,1,<=,,MIC90,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.25
178317,178317,,,5213253,[],CHEMBL1676618,Antimicrobial activity against Streptococcus pneumoniae serotype 11A by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332158,<=,1,1,<=,,MIC50,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.25
178318,178318,,,5213347,[],CHEMBL1676498,Antimicrobial activity against Streptococcus pneumoniae serotype 19A by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332158,>,1,1,>,,MIC50,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,2.0
178319,178319,,,5213349,[],CHEMBL1676498,Antimicrobial activity against Streptococcus pneumoniae serotype 19A by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332158,>,1,1,>,,MIC90,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,2.0
178320,178320,,,5213351,[],CHEMBL1676500,Antimicrobial activity against Streptococcus pneumoniae serotype 35B by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332158,>,1,1,>,,MIC90,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,2.0
178321,178321,,,5213352,[],CHEMBL1676618,Antimicrobial activity against Streptococcus pneumoniae serotype 11A by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332158,>,1,1,>,,MIC90,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,2.0
178322,178322,,,5213353,[],CHEMBL1676619,Antimicrobial activity against Streptococcus pneumoniae serotype 6C by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332158,>,1,1,>,,MIC50,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,2.0
178323,178323,,,5213354,[],CHEMBL1676619,Antimicrobial activity against Streptococcus pneumoniae serotype 6C by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332158,>,1,1,>,,MIC90,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,2.0
178324,178324,,,5213362,[],CHEMBL1676620,Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 19A by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332158,>,1,1,>,,MIC50,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,8.0
178325,178325,,,5213364,[],CHEMBL1676620,Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 19A by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332158,>,1,1,>,,MIC90,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,8.0
178326,178326,,,5213365,[],CHEMBL1676621,Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 19F by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332158,>,1,1,>,,MIC50,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,8.0
178327,178327,,,5213367,[],CHEMBL1676621,Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 19F by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332158,>,1,1,>,,MIC90,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,8.0
178328,178328,,,5213368,[],CHEMBL1676622,Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 6B by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332158,>,1,1,>,,MIC50,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,8.0
178329,178329,,,5213370,[],CHEMBL1676622,Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 6B by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332158,>,1,1,>,,MIC90,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,8.0
178330,178330,,,5214017,[],CHEMBL1674079,Antibacterial activity against methicillin-susceptible Staphylococcus aureus by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331820,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,0.5
178331,178331,,,5214027,[],CHEMBL1674080,Antibacterial activity against methicillin-susceptible Staphylococcus aureus assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1331820,=,1,0,=,,Activity,%,,65.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,65.2
178332,178332,,,5214036,[],CHEMBL1674081,Antibacterial activity against methicillin-susceptible Staphylococcus aureus assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1331820,=,1,0,=,,Activity,%,,32.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,32.5
178333,178333,,,5214046,[],CHEMBL1674082,Antibacterial activity against methicillin-resistant Staphylococcus aureus by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331820,>,1,1,>,,MIC50,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,8.0
178334,178334,,,5214056,[],CHEMBL1674083,Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1331820,=,1,0,=,,Activity,%,,4.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,4.5
178335,178335,,,5214065,[],CHEMBL1674198,Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1331820,=,1,0,=,,Activity,%,,94.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,94.4
178336,178336,,,5214075,[],CHEMBL1674199,Antibacterial activity against coagulase-negative and oxacillin-susceptible Staphylococcus aureus by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331820,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,1.0
178337,178337,,,5214085,[],CHEMBL1674200,Antibacterial activity against coagulase-negative and oxacillin-susceptible Staphylococcus aureus assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1331820,=,1,0,=,,Activity,%,,49.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,49.8
178338,178338,,,5214444,[],CHEMBL1676620,Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 19A by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332158,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
178339,178339,,,5214445,[],CHEMBL1676621,Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 19F by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332158,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
178340,178340,,,5214446,[],CHEMBL1676622,Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 6B by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332158,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
178341,178341,,,5214457,[],CHEMBL1677044,Antimicrobial activity against Streptococcus pneumoniae serotype 3 assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1332158,=,1,0,=,,Activity,%,,95.1,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,95.1
178342,178342,,,5214468,[],CHEMBL1677045,Antimicrobial activity against Streptococcus pneumoniae serotype 35B assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1332158,=,1,0,=,,Activity,%,,64.4,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,64.4
178343,178343,,,5214479,[],CHEMBL1677046,Antimicrobial activity against Streptococcus pneumoniae serotype 7F assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1332158,=,1,0,=,,Activity,%,,64.4,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,64.4
178344,178344,,,5214491,[],CHEMBL1677047,Antimicrobial activity against Streptococcus pneumoniae serotype 11A assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1332158,=,1,0,=,,Activity,%,,75.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,75.5
178345,178345,,,5214503,[],CHEMBL1677048,Antimicrobial activity against Streptococcus pneumoniae serotype 6C assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1332158,=,1,0,=,,Activity,%,,41.9,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,41.9
178346,178346,,,5214515,[],CHEMBL1677049,Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 19A assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1332158,=,1,0,=,,Activity,%,,0.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,0.0
178347,178347,,,5214527,[],CHEMBL1677050,Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 19F assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1332158,=,1,0,=,,Activity,%,,0.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,0.0
178348,178348,,,5214539,[],CHEMBL1677051,Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 6B assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1332158,=,1,0,=,,Activity,%,,0.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,0.0
178349,178349,,,5214574,[],CHEMBL1677175,Antimicrobial activity against Streptococcus pneumoniae serotype 15A assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1332158,=,1,0,=,,Activity,%,,5.3,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,5.3
178350,178350,,,5214575,[],CHEMBL1677176,Antimicrobial activity against Streptococcus pneumoniae serotype 22F assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1332158,=,1,0,=,,Activity,%,,88.6,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,88.6
178351,178351,,,5214576,[],CHEMBL1677179,Antimicrobial activity against Streptococcus pneumoniae serotype 23A assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1332158,=,1,0,=,,Activity,%,,78.8,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,78.8
178352,178352,,,5214577,[],CHEMBL1677177,Antimicrobial activity against Streptococcus pneumoniae serotype 23B assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1332158,=,1,0,=,,Activity,%,,75.8,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,75.8
178353,178353,,,5214578,[],CHEMBL1677178,Antimicrobial activity against Streptococcus pneumoniae serotype 19F assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1332158,=,1,0,=,,Activity,%,,17.2,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,17.2
178354,178354,,,5214792,[],CHEMBL1676703,Antibacterial activity against 10'4 to 10'5 CFU Haemophilus influenzae after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332733,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,64.0
178355,178355,,,5214807,[],CHEMBL1676703,Antibacterial activity against 10'4 to 10'5 CFU Haemophilus influenzae after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332733,=,1,1,=,,MIC50,ug.mL-1,,64.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC50,ug ml-1,UO_0000274,,64.0
178356,178356,,,5214822,[],CHEMBL1676703,Antibacterial activity against 10'4 to 10'5 CFU Haemophilus influenzae after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332733,>,1,1,>,,MIC90,ug.mL-1,,64.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC90,ug ml-1,UO_0000274,,64.0
178357,178357,,,5214909,[],CHEMBL1677456,Antimicrobial activity against Chlamydia trachomatis serovar D infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332744,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MIC,ug ml-1,UO_0000274,,0.5
178358,178358,,,5214910,[],CHEMBL1677457,Antimicrobial activity against Chlamydia trachomatis serovar E infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332744,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MIC,ug ml-1,UO_0000274,,0.5
178359,178359,,,5214911,[],CHEMBL1677458,Antimicrobial activity against Chlamydia trachomatis serovar F infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332744,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MIC,ug ml-1,UO_0000274,,0.5
178360,178360,,,5214912,[],CHEMBL1677459,Antimicrobial activity against Chlamydia trachomatis serovar G infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332744,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MIC,ug ml-1,UO_0000274,,0.5
178361,178361,,,5214913,[],CHEMBL1677460,Antimicrobial activity against Chlamydia trachomatis serovar H infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332744,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MIC,ug ml-1,UO_0000274,,0.5
178362,178362,,,5214914,[],CHEMBL1677461,Antimicrobial activity against Chlamydia trachomatis serovar I infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332744,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MIC,ug ml-1,UO_0000274,,0.5
178363,178363,,,5214915,[],CHEMBL1677462,Antimicrobial activity against Chlamydia trachomatis serovar J infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332744,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MIC,ug ml-1,UO_0000274,,1.0
178364,178364,,,5214916,[],CHEMBL1677463,Antimicrobial activity against Chlamydia trachomatis serovar K infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332744,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MIC,ug ml-1,UO_0000274,,0.5
178365,178365,,,5214917,[],CHEMBL1677464,Bactericidal activity against Chlamydia trachomatis serovar D infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332744,=,1,0,=,,MBC,ug ml-1,,1.0,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MBC,ug ml-1,UO_0000274,,1.0
178366,178366,,,5214918,[],CHEMBL1677465,Bactericidal activity against Chlamydia trachomatis serovar E infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332744,=,1,0,=,,MBC,ug ml-1,,1.0,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MBC,ug ml-1,UO_0000274,,1.0
178367,178367,,,5214919,[],CHEMBL1677466,Bactericidal activity against Chlamydia trachomatis serovar F infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332744,=,1,0,=,,MBC,ug ml-1,,1.0,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MBC,ug ml-1,UO_0000274,,1.0
178368,178368,,,5214920,[],CHEMBL1677467,Bactericidal activity against Chlamydia trachomatis serovar G infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332744,=,1,0,=,,MBC,ug ml-1,,1.0,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MBC,ug ml-1,UO_0000274,,1.0
178369,178369,,,5214921,[],CHEMBL1677468,Bactericidal activity against Chlamydia trachomatis serovar H infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332744,=,1,0,=,,MBC,ug ml-1,,1.0,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MBC,ug ml-1,UO_0000274,,1.0
178370,178370,,,5214922,[],CHEMBL1677469,Bactericidal activity against Chlamydia trachomatis serovar I infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332744,=,1,0,=,,MBC,ug ml-1,,1.0,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MBC,ug ml-1,UO_0000274,,1.0
178371,178371,,,5214923,[],CHEMBL1677470,Bactericidal activity against Chlamydia trachomatis serovar J infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332744,=,1,0,=,,MBC,ug ml-1,,2.0,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MBC,ug ml-1,UO_0000274,,2.0
178372,178372,,,5214924,[],CHEMBL1677471,Bactericidal activity against Chlamydia trachomatis serovar K infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332744,=,1,0,=,,MBC,ug ml-1,,1.0,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MBC,ug ml-1,UO_0000274,,1.0
178373,178373,,,5214925,[],CHEMBL1677472,Antimicrobial activity against Chlamydia trachomatis Ic Cal-8 serovar D infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332744,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MIC,ug ml-1,UO_0000274,,0.5
178374,178374,,,5214926,[],CHEMBL1677473,Antimicrobial activity against Chlamydia trachomatis Bour serovar E infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,,,BAO_0002146,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332744,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MIC,ug ml-1,UO_0000274,,0.5
178375,178375,,,5214927,[],CHEMBL1677474,Antimicrobial activity against Chlamydia trachomatis 580 serovar H infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332744,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MIC,ug ml-1,UO_0000274,,1.0
178376,178376,,,5214928,[],CHEMBL1677475,Antimicrobial activity against Chlamydia trachomatis UW-36 serovar J infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,,,BAO_0002146,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332744,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MIC,ug ml-1,UO_0000274,,0.5
178377,178377,,,5214993,[],CHEMBL1677472,Antimicrobial activity against Chlamydia trachomatis Ic Cal-8 serovar D infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332744,=,1,0,=,,MBC,ug ml-1,,1.0,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MBC,ug ml-1,UO_0000274,,1.0
178378,178378,,,5215128,[],CHEMBL1674201,Antibacterial activity against coagulase-negative and oxacillin-susceptible Staphylococcus aureus assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1331820,=,1,0,=,,Activity,%,,49.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,49.3
178379,178379,,,5215138,[],CHEMBL1674202,Antibacterial activity against coagulase-negative and oxacillin-resistant Staphylococcus aureus by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331820,>,1,1,>,,MIC50,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,8.0
178380,178380,,,5215148,[],CHEMBL1674203,Antibacterial activity against coagulase-negative and oxacillin-resistant Staphylococcus aureus assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1331820,=,1,0,=,,Activity,%,,18.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,18.4
178381,178381,,,5215157,[],CHEMBL1674204,Antibacterial activity against coagulase-negative and oxacillin-resistant Staphylococcus aureus assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1331820,=,1,0,=,,Activity,%,,81.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,81.3
178382,178382,,,5215167,[],CHEMBL1674205,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331820,=,1,1,=,,MIC50,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.03
178383,178383,,,5215173,[],CHEMBL1674206,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1331820,=,1,0,=,,Activity,%,,89.1,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,89.1
178384,178384,,,5215179,[],CHEMBL1674207,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1331820,=,1,0,=,,Activity,%,,9.9,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,9.9
178385,178385,,,5215186,[],CHEMBL1674208,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331820,=,1,1,=,,MIC50,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,8.0
178386,178386,,,5215192,[],CHEMBL1674209,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1331820,=,1,0,=,,Activity,%,,28.4,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,28.4
178387,178387,,,5215198,[],CHEMBL1674210,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1331820,=,1,0,=,,Activity,%,,71.6,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,71.6
178388,178388,,,5215205,[],CHEMBL1674211,Antibacterial activity against erythromycin-susceptible Streptococcus pyogenes by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331820,=,1,1,=,,MIC50,ug.mL-1,,0.03,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC50,ug ml-1,UO_0000274,,0.03
178389,178389,,,5215213,[],CHEMBL1674212,Antibacterial activity against erythromycin-susceptible Streptococcus pyogenes assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1331820,=,1,0,=,,Activity,%,,100.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,Activity,%,UO_0000187,,100.0
178390,178390,,,5215218,[],CHEMBL1674213,Antibacterial activity against erythromycin-susceptible Streptococcus pyogenes assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1331820,=,1,0,=,,Activity,%,,0.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,Activity,%,UO_0000187,,0.0
178391,178391,,,5215224,[],CHEMBL1674214,Antibacterial activity against erythromycin-nonsusceptible Streptococcus pyogenes by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331820,=,1,1,=,,MIC50,ug.mL-1,,8.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC50,ug ml-1,UO_0000274,,8.0
178392,178392,,,5215232,[],CHEMBL1674215,Antibacterial activity against erythromycin-nonsusceptible Streptococcus pyogenes assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1331820,=,1,0,=,,Activity,%,,0.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,Activity,%,UO_0000187,,0.0
178393,178393,,,5215237,[],CHEMBL1674216,Antibacterial activity against erythromycin-nonsusceptible Streptococcus pyogenes assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1331820,=,1,0,=,,Activity,%,,80.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,Activity,%,UO_0000187,,80.0
178394,178394,,,5215241,[],CHEMBL1674217,Antibacterial activity against erythromycin-susceptible Streptococcus agalactiae assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1331820,=,1,0,=,,Activity,%,,100.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,Activity,%,UO_0000187,,100.0
178395,178395,,,5215250,[],CHEMBL1674218,Antibacterial activity against erythromycin-susceptible Streptococcus agalactiae by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331820,=,1,1,=,,MIC50,ug.mL-1,,0.03,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC50,ug ml-1,UO_0000274,,0.03
178396,178396,,,5215259,[],CHEMBL1674220,Antibacterial activity against erythromycin-nonsusceptible Streptococcus agalactiae assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1331820,=,1,0,=,,Activity,%,,0.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,Activity,%,UO_0000187,,0.0
178397,178397,,,5215268,[],CHEMBL1674221,Antibacterial activity against erythromycin-nonsusceptible Streptococcus agalactiae by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331820,=,1,1,=,,MIC50,ug.mL-1,,16.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC50,ug ml-1,UO_0000274,,16.0
178398,178398,,,5215274,[],CHEMBL1674222,Antibacterial activity against erythromycin-nonsusceptible Streptococcus agalactiae assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1331820,=,1,0,=,,Activity,%,,92.9,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,Activity,%,UO_0000187,,92.9
178399,178399,,,5215280,[],CHEMBL1674223,Antibacterial activity against penicillin-susceptible Streptococcus viridans by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331820,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,,MIC50,ug ml-1,UO_0000274,,0.06
178400,178400,,,5215288,[],CHEMBL1674224,Antibacterial activity against penicillin-susceptible Streptococcus viridans assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1331820,=,1,0,=,,Activity,%,,58.6,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,,Activity,%,UO_0000187,,58.6
178401,178401,,,5215294,[],CHEMBL1674225,Antibacterial activity against penicillin-susceptible Streptococcus viridans assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1331820,=,1,0,=,,Activity,%,,40.2,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,,Activity,%,UO_0000187,,40.2
178402,178402,,,5215302,[],CHEMBL1674226,Antibacterial activity against penicillin-nonsusceptible Streptococcus viridans by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331820,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,,MIC50,ug ml-1,UO_0000274,,2.0
178403,178403,,,5215310,[],CHEMBL1674227,Antibacterial activity against penicillin-nonsusceptible Streptococcus viridans assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1331820,=,1,0,=,,Activity,%,,21.4,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,,Activity,%,UO_0000187,,21.4
178404,178404,,,5215317,[],CHEMBL1674228,Antibacterial activity against penicillin-nonsusceptible Streptococcus viridans assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1331820,=,1,0,=,,Activity,%,,71.4,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,,Activity,%,UO_0000187,,71.4
178405,178405,,,5215325,[],CHEMBL1674229,Antibacterial activity against vancomycin-susceptible Enterococcus faecalis by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331820,>,1,1,>,,MIC50,ug.mL-1,,8.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC50,ug ml-1,UO_0000274,,8.0
178406,178406,,,5215333,[],CHEMBL1674230,Antibacterial activity against vancomycin-susceptible Enterococcus faecalis assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1331820,=,1,0,=,,Activity,%,,10.2,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,%,UO_0000187,,10.2
178407,178407,,,5215339,[],CHEMBL1674231,Antibacterial activity against vancomycin-susceptible Enterococcus faecalis assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1331820,=,1,0,=,,Activity,%,,59.9,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,%,UO_0000187,,59.9
178408,178408,,,5215348,[],CHEMBL1674232,Antibacterial activity against vancomycin-resistant Enterococcus faecalis by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331820,>,1,1,>,,MIC50,ug.mL-1,,8.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC50,ug ml-1,UO_0000274,,8.0
178409,178409,,,5215356,[],CHEMBL1674233,Antibacterial activity against vancomycin-resistant Enterococcus faecalis assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1331820,=,1,0,=,,Activity,%,,0.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,%,UO_0000187,,0.0
178410,178410,,,5215362,[],CHEMBL1674234,Antibacterial activity against vancomycin-resistant Enterococcus faecalis assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1331820,=,1,0,=,,Activity,%,,96.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,%,UO_0000187,,96.0
178411,178411,,,5215371,[],CHEMBL1674235,Antibacterial activity against vancomycin-resistant Enterococcus faecium by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331820,>,1,1,>,,MIC50,ug.mL-1,,8.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC50,ug ml-1,UO_0000274,,8.0
178412,178412,,,5215379,[],CHEMBL1674236,Antibacterial activity against vancomycin-resistant Enterococcus faecium assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1331820,=,1,0,=,,Activity,%,,0.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,Activity,%,UO_0000187,,0.0
178413,178413,,,5215385,[],CHEMBL1674237,Antibacterial activity against vancomycin-resistant Enterococcus faecium assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1331820,=,1,0,=,,Activity,%,,92.3,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,Activity,%,UO_0000187,,92.3
178414,178414,,,5215842,[],CHEMBL1677406,Antibacterial activity against Listeria monocytogenes isolated from humans with putative chromosomal mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671693,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332174,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,,MIC,ug ml-1,UO_0000274,,256.0
178415,178415,,,5216825,[],CHEMBL1675173,Antibacterial activity against beta lactamase-positive Moraxella catarrhalis by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331820,<=,1,1,<=,,MIC50,ug.mL-1,,0.12,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,MIC50,ug ml-1,UO_0000274,,0.12
178416,178416,,,5216833,[],CHEMBL1675174,Antibacterial activity against beta lactamase-positive Moraxella catarrhalis assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1331820,=,1,0,=,,Activity,%,,100.0,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,Activity,%,UO_0000187,,100.0
178417,178417,,,5216835,[],CHEMBL1675175,Antibacterial activity against beta lactamase-positive Moraxella catarrhalis assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1331820,=,1,0,=,,Activity,%,,0.0,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,Activity,%,UO_0000187,,0.0
178418,178418,,,5216839,[],CHEMBL1675176,Antibacterial activity against Pasteurella multocida by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331820,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL614409,Pasteurella multocida,Pasteurella multocida,747.0,,,MIC50,ug ml-1,UO_0000274,,2.0
178419,178419,,,5216845,[],CHEMBL1675177,Antibacterial activity against Pasteurella multocida assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1331820,=,1,0,=,,Activity,%,,4.5,CHEMBL614409,Pasteurella multocida,Pasteurella multocida,747.0,,,Activity,%,UO_0000187,,4.5
178420,178420,,,5217638,[],CHEMBL1676574,Antimicrobial activity against mecA-deficient Staphylococcus sciuri assessed as resistant isolates,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671763,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1332723,=,1,0,=,,Activity,%,,0.0,CHEMBL613150,Mammaliicoccus sciuri,Mammaliicoccus sciuri,1296.0,,,Activity,%,UO_0000187,,0.0
178421,178421,,,5217639,[],CHEMBL1676575,Antimicrobial activity against mecA-positive Staphylococcus sciuri assessed as resistant isolates,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671763,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1332723,=,1,0,=,,Activity,%,,0.0,CHEMBL613150,Mammaliicoccus sciuri,Mammaliicoccus sciuri,1296.0,,,Activity,%,UO_0000187,,0.0
178422,178422,,,5217640,[],CHEMBL1676576,Antimicrobial activity against mecA-deficient Staphylococcus sciuri harboring staphylococcus aureus mecA gene assessed as resistant isolates,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671763,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1332723,=,1,0,=,,Activity,%,,33.3,CHEMBL613150,Mammaliicoccus sciuri,Mammaliicoccus sciuri,1296.0,,,Activity,%,UO_0000187,,33.3
178423,178423,,,5217641,[],CHEMBL1676577,Antimicrobial activity against mecA-positive Staphylococcus sciuri harboring staphylococcus aureus mecA gene assessed as resistant isolates,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671763,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1332723,=,1,0,=,,Activity,%,,23.1,CHEMBL613150,Mammaliicoccus sciuri,Mammaliicoccus sciuri,1296.0,,,Activity,%,UO_0000187,,23.1
178424,178424,,,5217669,[],CHEMBL1677448,Antibacterial activity against 10'4 to 10'5 CFU methicillin-susceptible Staphylococcus aureus after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332733,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
178425,178425,,,5217677,[],CHEMBL1677448,Antibacterial activity against 10'4 to 10'5 CFU methicillin-susceptible Staphylococcus aureus after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332733,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,0.25
178426,178426,,,5217685,[],CHEMBL1677448,Antibacterial activity against 10'4 to 10'5 CFU methicillin-susceptible Staphylococcus aureus after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332733,>,1,1,>,,MIC90,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,64.0
178427,178427,,,5217693,[],CHEMBL1677447,Antibacterial activity against 10'4 to 10'5 CFU methicillin-resistant Staphylococcus aureus after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332733,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
178428,178428,,,5217701,[],CHEMBL1676711,Antibacterial activity against 10'4 to 10'5 CFU methicillin-susceptible coagulase-negative Staphylococcus after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332733,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,MIC,ug ml-1,UO_0000274,,0.06
178429,178429,,,5217709,[],CHEMBL1676709,Antibacterial activity against 10'4 to 10'5 CFU methicillin-resistant coagulase-negative Staphylococcus after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332733,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,MIC,ug ml-1,UO_0000274,,0.06
178430,178430,,,5217717,[],CHEMBL1676710,Antibacterial activity against 10'4 to 10'5 CFU Streptococcus pneumoniae after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332733,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.008
178431,178431,,,5217725,[],CHEMBL1677447,Antibacterial activity against 10'4 to 10'5 CFU methicillin-resistant Staphylococcus aureus after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332733,>,1,1,>,,MIC50,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,64.0
178432,178432,,,5217733,[],CHEMBL1676711,Antibacterial activity against 10'4 to 10'5 CFU methicillin-susceptible coagulase-negative Staphylococcus after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332733,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,MIC50,ug ml-1,UO_0000274,,0.25
178433,178433,,,5217741,[],CHEMBL1676709,Antibacterial activity against 10'4 to 10'5 CFU methicillin-resistant coagulase-negative Staphylococcus after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332733,>,1,1,>,,MIC50,ug.mL-1,,64.0,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,MIC50,ug ml-1,UO_0000274,,64.0
178434,178434,,,5217749,[],CHEMBL1676710,Antibacterial activity against 10'4 to 10'5 CFU Streptococcus pneumoniae after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332733,=,1,1,=,,MIC50,ug.mL-1,,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,64.0
178435,178435,,,5217757,[],CHEMBL1677447,Antibacterial activity against 10'4 to 10'5 CFU methicillin-resistant Staphylococcus aureus after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332733,>,1,1,>,,MIC90,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,64.0
178436,178436,,,5217765,[],CHEMBL1676711,Antibacterial activity against 10'4 to 10'5 CFU methicillin-susceptible coagulase-negative Staphylococcus after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332733,>,1,1,>,,MIC90,ug.mL-1,,64.0,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,MIC90,ug ml-1,UO_0000274,,64.0
178437,178437,,,5217773,[],CHEMBL1676709,Antibacterial activity against 10'4 to 10'5 CFU methicillin-resistant coagulase-negative Staphylococcus after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332733,>,1,1,>,,MIC90,ug.mL-1,,64.0,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,MIC90,ug ml-1,UO_0000274,,64.0
178438,178438,,,5217781,[],CHEMBL1676710,Antibacterial activity against 10'4 to 10'5 CFU Streptococcus pneumoniae after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332733,>,1,1,>,,MIC90,ug.mL-1,,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,64.0
178439,178439,,,5217789,[],CHEMBL1676708,Antibacterial activity against 10'4 to 10'5 CFU Streptococcus pyogenes after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332733,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.008
178440,178440,,,5217797,[],CHEMBL1676707,Antibacterial activity against 10'4 to 10'5 CFU Enterococcus faecalis after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332733,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.125
178441,178441,,,5217805,[],CHEMBL1676706,Antibacterial activity against 10'4 to 10'5 CFU Enterococcus faecium after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332733,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,0.125
178442,178442,,,5217813,[],CHEMBL1676705,Antibacterial activity against 10'4 to 10'5 CFU vancomycin-resistant Enterococcus after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332733,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,,MIC,ug ml-1,UO_0000274,,64.0
178443,178443,,,5217821,[],CHEMBL1676708,Antibacterial activity against 10'4 to 10'5 CFU Streptococcus pyogenes after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332733,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC50,ug ml-1,UO_0000274,,0.06
178444,178444,,,5217829,[],CHEMBL1676707,Antibacterial activity against 10'4 to 10'5 CFU Enterococcus faecalis after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332733,>,1,1,>,,MIC50,ug.mL-1,,64.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC50,ug ml-1,UO_0000274,,64.0
178445,178445,,,5217837,[],CHEMBL1676706,Antibacterial activity against 10'4 to 10'5 CFU Enterococcus faecium after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332733,>,1,1,>,,MIC50,ug.mL-1,,64.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC50,ug ml-1,UO_0000274,,64.0
178446,178446,,,5217845,[],CHEMBL1676705,Antibacterial activity against 10'4 to 10'5 CFU vancomycin-resistant Enterococcus after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332733,>,1,1,>,,MIC50,ug.mL-1,,64.0,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,,MIC50,ug ml-1,UO_0000274,,64.0
178447,178447,,,5217853,[],CHEMBL1676708,Antibacterial activity against 10'4 to 10'5 CFU Streptococcus pyogenes after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332733,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC90,ug ml-1,UO_0000274,,2.0
178448,178448,,,5217861,[],CHEMBL1676707,Antibacterial activity against 10'4 to 10'5 CFU Enterococcus faecalis after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332733,>,1,1,>,,MIC90,ug.mL-1,,64.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC90,ug ml-1,UO_0000274,,64.0
178449,178449,,,5217869,[],CHEMBL1676706,Antibacterial activity against 10'4 to 10'5 CFU Enterococcus faecium after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332733,>,1,1,>,,MIC90,ug.mL-1,,64.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC90,ug ml-1,UO_0000274,,64.0
178450,178450,,,5217877,[],CHEMBL1676705,Antibacterial activity against 10'4 to 10'5 CFU vancomycin-resistant Enterococcus after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332733,>,1,1,>,,MIC90,ug.mL-1,,64.0,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,,MIC90,ug ml-1,UO_0000274,,64.0
178451,178451,,,5217883,[],CHEMBL1675178,Antibacterial activity against Pasteurella multocida assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1331820,=,1,0,=,,Activity,%,,77.3,CHEMBL614409,Pasteurella multocida,Pasteurella multocida,747.0,,,Activity,%,UO_0000187,,77.3
178452,178452,,,5217913,[],CHEMBL1674079,Antibacterial activity against methicillin-susceptible Staphylococcus aureus by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331820,>,1,1,>,,MIC90,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,8.0
178453,178453,,,5217924,[],CHEMBL1674079,Antibacterial activity against methicillin-susceptible Staphylococcus aureus by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331820,>=,1,1,>=,,MIC,ug.mL-1,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.12
178454,178454,,,5217935,[],CHEMBL1674082,Antibacterial activity against methicillin-resistant Staphylococcus aureus by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331820,>,1,1,>,,MIC90,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,8.0
178455,178455,,,5217946,[],CHEMBL1674082,Antibacterial activity against methicillin-resistant Staphylococcus aureus by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331820,>,1,1,>,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
178456,178456,,,5217957,[],CHEMBL1674199,Antibacterial activity against coagulase-negative and oxacillin-susceptible Staphylococcus aureus by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331820,>,1,1,>,,MIC90,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,8.0
178457,178457,,,5217968,[],CHEMBL1674199,Antibacterial activity against coagulase-negative and oxacillin-susceptible Staphylococcus aureus by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331820,>=,1,1,>=,,MIC,ug.mL-1,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.12
178458,178458,,,5217979,[],CHEMBL1674202,Antibacterial activity against coagulase-negative and oxacillin-resistant Staphylococcus aureus by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331820,>,1,1,>,,MIC90,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,8.0
178459,178459,,,5217990,[],CHEMBL1674202,Antibacterial activity against coagulase-negative and oxacillin-resistant Staphylococcus aureus by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331820,>=,1,1,>=,,MIC,ug.mL-1,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.12
178460,178460,,,5218001,[],CHEMBL1674205,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331820,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.5
178461,178461,,,5218010,[],CHEMBL1674205,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331820,>=,1,1,>=,,MIC,ug.mL-1,,0.015,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.015
178462,178462,,,5218019,[],CHEMBL1674208,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331820,>,1,1,>,,MIC90,ug.mL-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,16.0
178463,178463,,,5218028,[],CHEMBL1674208,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331820,>=,1,1,>=,,MIC,ug.mL-1,,0.015,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.015
178464,178464,,,5218037,[],CHEMBL1674211,Antibacterial activity against erythromycin-susceptible Streptococcus pyogenes by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331820,=,1,1,=,,MIC90,ug.mL-1,,0.06,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC90,ug ml-1,UO_0000274,,0.06
178465,178465,,,5218047,[],CHEMBL1674211,Antibacterial activity against erythromycin-susceptible Streptococcus pyogenes by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331820,<=,1,1,<=,,MIC,ug.mL-1,,0.015,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.015
178466,178466,,,5218057,[],CHEMBL1674214,Antibacterial activity against erythromycin-nonsusceptible Streptococcus pyogenes by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331820,>,1,1,>,,MIC90,ug.mL-1,,16.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC90,ug ml-1,UO_0000274,,16.0
178467,178467,,,5218067,[],CHEMBL1674214,Antibacterial activity against erythromycin-nonsusceptible Streptococcus pyogenes by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331820,>,1,1,>,,MIC,ug.mL-1,,0.5,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.5
178468,178468,,,5218077,[],CHEMBL1674218,Antibacterial activity against erythromycin-susceptible Streptococcus agalactiae by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331820,=,1,1,=,,MIC90,ug.mL-1,,0.06,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC90,ug ml-1,UO_0000274,,0.06
178469,178469,,,5218087,[],CHEMBL1674218,Antibacterial activity against erythromycin-susceptible Streptococcus agalactiae by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331820,<=,1,1,<=,,MIC,ug.mL-1,,0.015,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC,ug ml-1,UO_0000274,,0.015
178470,178470,,,5218097,[],CHEMBL1674221,Antibacterial activity against erythromycin-nonsusceptible Streptococcus agalactiae by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331820,>,1,1,>,,MIC90,ug.mL-1,,16.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC90,ug ml-1,UO_0000274,,16.0
178471,178471,,,5218107,[],CHEMBL1674221,Antibacterial activity against erythromycin-nonsusceptible Streptococcus agalactiae by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331820,>,1,1,>,,MIC,ug.mL-1,,0.5,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC,ug ml-1,UO_0000274,,0.5
178472,178472,,,5218117,[],CHEMBL1674223,Antibacterial activity against penicillin-susceptible Streptococcus viridans by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331820,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,,MIC90,ug ml-1,UO_0000274,,4.0
178473,178473,,,5218127,[],CHEMBL1674223,Antibacterial activity against penicillin-susceptible Streptococcus viridans by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331820,>=,1,1,>=,,MIC,ug.mL-1,,0.015,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,,MIC,ug ml-1,UO_0000274,,0.015
178474,178474,,,5218137,[],CHEMBL1674226,Antibacterial activity against penicillin-nonsusceptible Streptococcus viridans by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331820,>,1,1,>,,MIC90,ug.mL-1,,16.0,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,,MIC90,ug ml-1,UO_0000274,,16.0
178475,178475,,,5218147,[],CHEMBL1674226,Antibacterial activity against penicillin-nonsusceptible Streptococcus viridans by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331820,>,1,1,>,,MIC,ug.mL-1,,0.12,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,,MIC,ug ml-1,UO_0000274,,0.12
178476,178476,,,5218157,[],CHEMBL1674229,Antibacterial activity against vancomycin-susceptible Enterococcus faecalis by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331820,>,1,1,>,,MIC90,ug.mL-1,,8.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC90,ug ml-1,UO_0000274,,8.0
178477,178477,,,5218168,[],CHEMBL1674229,Antibacterial activity against vancomycin-susceptible Enterococcus faecalis by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331820,>=,1,1,>=,,MIC,ug.mL-1,,0.12,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.12
178478,178478,,,5218179,[],CHEMBL1674232,Antibacterial activity against vancomycin-resistant Enterococcus faecalis by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331820,>,1,1,>,,MIC90,ug.mL-1,,8.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC90,ug ml-1,UO_0000274,,8.0
178479,178479,,,5218190,[],CHEMBL1674232,Antibacterial activity against vancomycin-resistant Enterococcus faecalis by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331820,>,1,1,>,,MIC,ug.mL-1,,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,1.0
178480,178480,,,5218201,[],CHEMBL1674235,Antibacterial activity against vancomycin-resistant Enterococcus faecium by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331820,>,1,1,>,,MIC90,ug.mL-1,,8.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC90,ug ml-1,UO_0000274,,8.0
178481,178481,,,5218212,[],CHEMBL1674235,Antibacterial activity against vancomycin-resistant Enterococcus faecium by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331820,>,1,1,>,,MIC,ug.mL-1,,2.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,2.0
178482,178482,,,5218862,[],CHEMBL1678578,Antimicrobial activity against Staphylococcus aureus USA300 isolate harboring pSK41 plasmid assessed resistant isolates,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671712,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1332353,=,1,0,=,,Activity,%,,85.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,85.0
178483,178483,,,5219586,[],CHEMBL1675173,Antibacterial activity against beta lactamase-positive Moraxella catarrhalis by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331820,<=,1,1,<=,,MIC90,ug.mL-1,,0.12,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,MIC90,ug ml-1,UO_0000274,,0.12
178484,178484,,,5219595,[],CHEMBL1675173,Antibacterial activity against beta lactamase-positive Moraxella catarrhalis by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331820,<=,1,1,<=,,MIC,ug.mL-1,,0.12,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,MIC,ug ml-1,UO_0000274,,0.12
178485,178485,,,5219604,[],CHEMBL1675176,Antibacterial activity against Pasteurella multocida by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331820,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL614409,Pasteurella multocida,Pasteurella multocida,747.0,,,MIC90,ug ml-1,UO_0000274,,4.0
178486,178486,,Active,5219953,[],CHEMBL1678826,Antimicrobial activity against Neisseria gonorrhoeae isolate 254921 NG-MAST sequence type 649 selected after 4 mg/L of erythromycin by Etest,F,,,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671714,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1332360,,1,0,,,Activity,,,,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,,Activity,,,,
178487,178487,,,5219954,[],CHEMBL1678825,Antimicrobial activity against Neisseria gonorrhoeae isolate 254921 NG-MAST sequence type 649 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671714,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332360,=,1,1,=,,MIC,ug.mL-1,,3.0,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,,MIC,mg/L,UO_0000274,,3.0
178488,178488,,,5219955,[],CHEMBL1678827,Antimicrobial activity against Neisseria gonorrhoeae isolate 254921 NG-MAST sequence type 649 selected after 2 to 8 mg/L of compound by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671714,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332360,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,,MIC,mg/L,UO_0000274,,4.0
178489,178489,,,5220669,[],CHEMBL1675176,Antibacterial activity against Pasteurella multocida by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331820,>,1,1,>,,MIC,ug.mL-1,,0.25,CHEMBL614409,Pasteurella multocida,Pasteurella multocida,747.0,,,MIC,ug ml-1,UO_0000274,,0.25
178490,178490,,,5225315,[],CHEMBL1673626,Antibacterial activity against Escherichia coli MG1655 harboring plasmid pBR322 carrying blaTEM-1 and tetA(C) genes grown as planktonic cells after 24 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671674,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332062,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
178491,178491,,,5225321,[],CHEMBL1673627,Antibacterial activity against Escherichia coli MG1655 grown as biofilms harboring plasmid pBR322 carrying blaTEM-1 and tetA(C) genes after 24 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671674,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332062,=,1,1,=,,MIC,ug.mL-1,,5.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,5.0
178492,178492,,,5225619,[],CHEMBL1677353,Antimicrobial activity against methicillin-resistant Staphylococcus aureus isolate NRS70 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671719,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332392,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
178493,178493,,,5225638,[],CHEMBL1677355,Antimicrobial activity against methicillin-resistant Staphylococcus aureus isolate NRS71 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671719,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332392,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
178494,178494,,,5225648,[],CHEMBL1677356,Antimicrobial activity against methicillin-resistant Staphylococcus aureus isolate NRS123 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671719,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332392,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
178495,178495,,,5225660,[],CHEMBL1677357,Antimicrobial activity against vancomycin-resistant Staphylococcus aureus VRS1 by broth microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671719,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332392,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
178496,178496,,,5225670,[],CHEMBL1677358,Antimicrobial activity against vancomycin-resistant Staphylococcus aureus VRS2 by broth microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671719,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332392,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
178497,178497,,,5225680,[],CHEMBL1677359,Antimicrobial activity against vancomycin-resistant Staphylococcus aureus VRS3 by broth microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671719,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332392,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
178498,178498,,Not Determined,5225754,[],CHEMBL1677380,Inhibition of acrAB AcrAB-TolC-mediated Nile Red efflux in Escherichia coli K-12 3-AG100 overexpressing acrAB AcrAB-TolC assessed as time needed for 50% efflux after energization with 50 mM glucose at 200 uM by spectrofluorometric assay,B,,,BAO_0002114,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671720,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1332422,,1,0,,,Time,,,,CHEMBL612545,,Unchecked,,,,Time,,,,
178499,178499,,,5225781,[],CHEMBL1677379,Inhibition of acrAB AcrAB-TolC-mediated Nile Red efflux in Escherichia coli K-12 3-AG100 overexpressing acrAB AcrAB-TolC assessed as time needed for 50% efflux after energization with 50 mM glucose at 1000 uM by spectrofluorometric assay,B,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671720,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Hour,1332422,=,1,1,=,,TIME,hr,,0.005556,CHEMBL612545,,Unchecked,,,,Time,s,UO_0000032,,20.0
178500,178500,,Not Active,5225821,[],CHEMBL1677370,Inhibition of acrAB AcrAB-TolC-mediated Nile Red efflux in Escherichia coli K-12 3-AG100 overexpressing acrAB AcrAB-TolC assessed as time needed for 50% efflux after energization with 50 mM glucose upto 2 mM by spectrofluorometric assay,B,,,BAO_0000201,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671720,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1332422,,1,0,,,Inhibition,%,,,CHEMBL612545,,Unchecked,,,,INH,,UO_0000187,,
178501,178501,,,5227886,[],CHEMBL1681010,Antimicrobial activity against tylosin pre-exposed compound-resistant Campylobacter jejuni,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,>,1,1,>,,MIC,ug.mL-1,,512.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,512.0
178502,178502,,,5227887,[],CHEMBL1681009,Antimicrobial activity against compound-resistant Campylobacter jejuni,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,8.0
178503,178503,,,5227888,[],CHEMBL1680009,Antimicrobial activity against Campylobacter jejuni DC7 harboring protein L4 G74D mutant by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,8.0
178504,178504,,,5227889,[],CHEMBL1680011,Antimicrobial activity against Campylobacter jejuni DC9 harboring 23S rRNA A2074G mutant by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,>,1,1,>,,MIC,ug.mL-1,,512.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,512.0
178505,178505,,,5227890,[],CHEMBL1681005,Antimicrobial activity against Campylobacter jejuni DC2 infected in 15 days old chicken by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,32.0
178506,178506,,,5227891,[],CHEMBL1681002,Antimicrobial activity against Campylobacter jejuni DC2 infected in 15 days old chicken by agar dilution method in presence of feed with tylosin,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,32.0
178507,178507,,,5227892,[],CHEMBL1681008,Antimicrobial activity against Campylobacter jejuni DC26 infected in 15 days old chicken by agar dilution method in presence of food with tylosin,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,64.0
178508,178508,,,5227893,[],CHEMBL1681006,Antimicrobial activity against Campylobacter jejuni DC2 infected in 3 days old chicken by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,32.0
178509,178509,,,5227894,[],CHEMBL1681007,Antimicrobial activity against Campylobacter jejuni DC6 infected in 3 days old chicken by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,>,1,1,>,,MIC,ug.mL-1,,512.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,512.0
178510,178510,,,5227902,[],CHEMBL1680999,Antimicrobial activity against Campylobacter jejuni harboring mutation in cmeB by agar dilution method relative to wild type Campylobacter jejuni,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1331879,=,1,0,=,,FC,,,8.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,FC,,,,8.0
178511,178511,,,5227903,[],CHEMBL1680002,Antimicrobial activity against Campylobacter jejuni NCTC 11168 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,1.0
178512,178512,,,5227904,[],CHEMBL1680003,Antimicrobial activity against Campylobacter jejuni DC1 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,8.0
178513,178513,,,5227905,[],CHEMBL1680004,Antimicrobial activity against Campylobacter jejuni DC2 harboring protein L4 G74D mutant by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,32.0
178514,178514,,,5227906,[],CHEMBL1680005,Antimicrobial activity against Campylobacter jejuni DC3 harboring 23S rRNA A2074G mutant by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,>,1,1,>,,MIC,ug.mL-1,,512.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,512.0
178515,178515,,,5227907,[],CHEMBL1680006,Antimicrobial activity against Campylobacter jejuni DC4 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,8.0
178516,178516,,,5227908,[],CHEMBL1680007,Antimicrobial activity against Campylobacter jejuni DC5 harboring protein L4 G74D mutant by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,8.0
178517,178517,,,5227909,[],CHEMBL1680008,Antimicrobial activity against Campylobacter jejuni DC6 harboring 23S rRNA A2074G mutant by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,>,1,1,>,,MIC,ug.mL-1,,512.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,512.0
178518,178518,,,5227910,[],CHEMBL1680010,Antimicrobial activity against Campylobacter jejuni DC8 harboring protein L4 G74D mutant by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,32.0
178519,178519,,,5227911,[],CHEMBL1680012,Antimicrobial activity against Campylobacter jejuni DC10 harboring protein L4 G57D mutant by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,16.0
178520,178520,,,5227912,[],CHEMBL1680013,Antimicrobial activity against Campylobacter jejuni DC11 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,64.0
178521,178521,,,5227913,[],CHEMBL1680014,Antimicrobial activity against Campylobacter jejuni DC12 harboring protein L4 G74D mutant by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,64.0
178522,178522,,,5227914,[],CHEMBL1680015,Antimicrobial activity against Campylobacter jejuni DC13 harboring protein L4 G74D mutant by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,32.0
178523,178523,,,5227915,[],CHEMBL1680016,Antimicrobial activity against Campylobacter jejuni DC14 harboring protein L4 G74D mutant by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,32.0
178524,178524,,,5227916,[],CHEMBL1680017,Antimicrobial activity against Campylobacter jejuni DC15 harboring protein L4 G74D mutant by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,32.0
178525,178525,,,5227917,[],CHEMBL1680018,Antimicrobial activity against Campylobacter jejuni DC16 harboring protein L4 G74D mutant by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,32.0
178526,178526,,,5227918,[],CHEMBL1680019,Antimicrobial activity against Campylobacter jejuni DC17 harboring protein L4 G74D mutant by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,8.0
178527,178527,,,5227919,[],CHEMBL1680020,Antimicrobial activity against Campylobacter jejuni DC18 harboring protein L4 G74D mutant by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,16.0
178528,178528,,,5227920,[],CHEMBL1680021,Antimicrobial activity against Campylobacter jejuni DC19 harboring protein L4 G74D mutant by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,16.0
178529,178529,,,5227921,[],CHEMBL1680022,Antimicrobial activity against Campylobacter jejuni DC20 harboring protein L4 G74D mutant by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,16.0
178530,178530,,,5227922,[],CHEMBL1680023,Antimicrobial activity against Campylobacter jejuni DC21 harboring protein L4 G74D mutant by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,32.0
178531,178531,,,5227923,[],CHEMBL1680024,Antimicrobial activity against Campylobacter jejuni DC22 harboring protein L4 G74D mutant by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,32.0
178532,178532,,,5227924,[],CHEMBL1680025,Antimicrobial activity against Campylobacter jejuni DC23 harboring protein L4 G74D mutant by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,64.0
178533,178533,,,5227925,[],CHEMBL1680026,Antimicrobial activity against Campylobacter jejuni DC24 harboring protein L4 G74D mutant by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,32.0
178534,178534,,,5227926,[],CHEMBL1680027,Antimicrobial activity against Campylobacter jejuni DC25 harboring protein L4 G74D mutant by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,64.0
178535,178535,,,5227927,[],CHEMBL1680028,Antimicrobial activity against Campylobacter jejuni DC26 harboring protein L4 G74D mutant by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,64.0
178536,178536,,,5227928,[],CHEMBL1680029,Antimicrobial activity against Campylobacter jejuni DC27 harboring protein L4 G74D mutant by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,64.0
178537,178537,,,5227929,[],CHEMBL1680030,Antimicrobial activity against Campylobacter jejuni DC28 harboring protein L4 G74D mutant by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,8.0
178538,178538,,,5227930,[],CHEMBL1680031,Antimicrobial activity against Campylobacter jejuni DC29 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,4.0
178539,178539,,,5227931,[],CHEMBL1680032,Antimicrobial activity against Campylobacter jejuni DC30 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,1.0
178540,178540,,,5227932,[],CHEMBL1680033,Antimicrobial activity against Campylobacter jejuni DC31 harboring 23S rRNA A2074G mutant by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,>,1,1,>,,MIC,ug.mL-1,,512.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,512.0
178541,178541,,,5227933,[],CHEMBL1680869,Antimicrobial activity against Campylobacter jejuni DC32 harboring 23S rRNA A2074G mutant by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,>,1,1,>,,MIC,ug.mL-1,,512.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,512.0
178542,178542,,,5227934,[],CHEMBL1680870,Antimicrobial activity against Campylobacter jejuni DC33 harboring 23S rRNA A2074G mutant by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,>,1,1,>,,MIC,ug.mL-1,,512.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,512.0
178543,178543,,,5227935,[],CHEMBL1680871,Antimicrobial activity against Campylobacter jejuni DC34 harboring protein L4 G74D mutant by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,128.0
178544,178544,,,5227936,[],CHEMBL1680872,Antimicrobial activity against Campylobacter jejuni DC35 harboring protein L4 G74D mutant by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,128.0
178545,178545,,,5227937,[],CHEMBL1680873,Antimicrobial activity against Campylobacter jejuni DC36 harboring protein L4 G74D mutant by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,128.0
178546,178546,,,5227938,[],CHEMBL1680874,Antimicrobial activity against Campylobacter jejuni DC37 harboring protein L4 G74D mutant by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,128.0
178547,178547,,,5227939,[],CHEMBL1680875,Antimicrobial activity against Campylobacter jejuni DC38 harboring protein L4 G74D mutant by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,128.0
178548,178548,,,5227940,[],CHEMBL1680876,Antimicrobial activity against Campylobacter jejuni DC39 harboring protein L4 G74D and G57V mutant by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,256.0
178549,178549,,,5227941,[],CHEMBL1680877,Antimicrobial activity against Campylobacter jejuni JL276 selected at 4 ug/ml after 3 to 4 days by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,16.0
178550,178550,,,5227942,[],CHEMBL1680878,Antimicrobial activity against Campylobacter jejuni JL277 selected at 4 to 16 times MIC after 3 to 4 days by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,8.0
178551,178551,,,5227943,[],CHEMBL1680879,Antimicrobial activity against Campylobacter jejuni JL278 selected at 4 to 16 times MIC after 3 to 4 days by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,8.0
178552,178552,,,5227944,[],CHEMBL1680880,Antimicrobial activity against Campylobacter jejuni JL279 selected at 4 to 16 times MIC after 3 to 4 days by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,8.0
178553,178553,,,5227945,[],CHEMBL1680881,Antimicrobial activity against Campylobacter jejuni JL283 selected at 4 to 16 times MIC after 3 to 4 days by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,64.0
178554,178554,,,5227946,[],CHEMBL1680882,Antimicrobial activity against Campylobacter jejuni JL284 selected at 4 to 16 times MIC after 3 to 4 days by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,128.0
178555,178555,,,5227947,[],CHEMBL1680883,Antimicrobial activity against Campylobacter jejuni JL285 selected at 4 to 16 times MIC after 3 to 4 days by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,128.0
178556,178556,,,5227948,[],CHEMBL1680884,Antimicrobial activity against Campylobacter jejuni JL286 selected at 4 to 16 times MIC after 3 to 4 days by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,128.0
178557,178557,,,5227949,[],CHEMBL1680885,Antimicrobial activity against Campylobacter jejuni JL287 harboring 23S rRNA A2074C mutant selected at 4 to 16 times MIC after 3 to 4 days by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,>,1,1,>,,MIC,ug.mL-1,,512.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,512.0
178558,178558,,,5227950,[],CHEMBL1680886,Antimicrobial activity against Campylobacter jejuni JL288 harboring 23S rRNA A2074C mutant selected at 4 to 16 times MIC after 3 to 4 days by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,>,1,1,>,,MIC,ug.mL-1,,512.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,512.0
178559,178559,,,5227951,[],CHEMBL1680887,Antimicrobial activity against Campylobacter jejuni JL289 harboring 23S rRNA A2074C mutant selected at 4 to 16 times MIC after 3 to 4 days by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,>,1,1,>,,MIC,ug.mL-1,,512.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,512.0
178560,178560,,,5227952,[],CHEMBL1680888,Antimicrobial activity against Campylobacter jejuni JL290 harboring protein L22 with insertion of amino acid TSH at position 98 selected at 8 ug/ml after 3 to 4 days by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,32.0
178561,178561,,,5227953,[],CHEMBL1680889,Antimicrobial activity against Campylobacter jejuni JL291 harboring protein L22 with insertion of amino acid TSH at position 98 selected at 4 to 16 times MIC after 3 to 4 days by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,32.0
178562,178562,,,5227954,[],CHEMBL1680890,Antimicrobial activity against Campylobacter jejuni JL292 selected at 4 to 16 times MIC after 3 to 4 days by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,8.0
178563,178563,,,5227955,[],CHEMBL1680891,Antimicrobial activity against Campylobacter jejuni JL293 selected at 4 to 16 times MIC after 3 to 4 days by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,8.0
178564,178564,,,5227956,[],CHEMBL1680892,Antimicrobial activity against Campylobacter jejuni JL294 selected at 4 to 16 times MIC after 3 to 4 days by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,8.0
178565,178565,,,5227957,[],CHEMBL1680893,Antimicrobial activity against Campylobacter jejuni JL295 selected at 2 ug/ml after 3 to 4 days by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,8.0
178566,178566,,,5227958,[],CHEMBL1680894,Antimicrobial activity against Campylobacter jejuni JL296 selected at 4 to 16 times MIC after 3 to 4 days by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,8.0
178567,178567,,,5227959,[],CHEMBL1680895,Antimicrobial activity against Campylobacter jejuni JL297 selected at 4 to 16 times MIC after 3 to 4 days by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,8.0
178568,178568,,,5227960,[],CHEMBL1680896,Antimicrobial activity against Campylobacter jejuni JL298 selected at 4 to 16 times MIC after 3 to 4 days by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,8.0
178569,178569,,,5227961,[],CHEMBL1680897,Antimicrobial activity against Campylobacter jejuni JL299 harboring protein L22 with insertion of amino acid TSH at position 98 selected at 4 to 16 times MIC after 3 to 4 days by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,64.0
178570,178570,,,5227962,[],CHEMBL1680898,Antimicrobial activity against Campylobacter jejuni JL300 harboring protein L22 with insertion of amino acid TSH at position 98 selected at 4 to 16 times MIC after 3 to 4 days by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,128.0
178571,178571,,,5227963,[],CHEMBL1680899,Antimicrobial activity against Campylobacter jejuni JL301 harboring protein L22 with insertion of amino acid TSH at position 98 selected at 4 to 16 times MIC after 3 to 4 days by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,=,1,1,=,,MIC,ug.mL-1,,512.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,512.0
178572,178572,,,5227964,[],CHEMBL1680900,Antimicrobial activity against Campylobacter jejuni JL302 harboring protein L22 with insertion of amino acid TSH at position 98 selected at 4 to 16 times MIC after 3 to 4 days by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,=,1,1,=,,MIC,ug.mL-1,,512.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,512.0
178573,178573,,,5227965,[],CHEMBL1680901,Antimicrobial activity against Campylobacter jejuni JL303 harboring protein L22 with insertion of amino acid TSH at position 98 selected at 4 to 16 times MIC after 3 to 4 days by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,256.0
178574,178574,,,5227966,[],CHEMBL1680902,Antimicrobial activity against Campylobacter jejuni JL304 harboring protein L22 with insertion of amino acid TSH at position 98 selected at 4 to 16 times MIC after 3 to 4 days by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,256.0
178575,178575,,,5227967,[],CHEMBL1680903,Antimicrobial activity against Campylobacter jejuni JL305 harboring protein L22 with insertion of amino acid TSH at position 98 selected at 4 to 16 times MIC after 3 to 4 days by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,256.0
178576,178576,,,5227968,[],CHEMBL1680904,Antimicrobial activity against Campylobacter jejuni JL306 harboring protein L22 with insertion of amino acid TSH at position 98 selected at 4 to 16 times MIC after 3 to 4 days by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,64.0
178577,178577,,,5227969,[],CHEMBL1680905,Antimicrobial activity against Campylobacter jejuni JL307 harboring protein L22 with insertion of amino acid TSH at position 98 selected at 4 to 16 times MIC after 3 to 4 days by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,256.0
178578,178578,,,5227970,[],CHEMBL1680998,Antimicrobial activity against Campylobacter jejuni JL308 harboring protein L22 with insertion of amino acid TSH at position 98 selected at 4 to 16 times MIC after 3 to 4 days by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671637,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331879,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,64.0
178579,178579,,,5228079,[],CHEMBL1679709,Antibacterial activity against Escherichia coli KAM32 harboring plasmid pUC18 by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671677,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332074,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.0
178580,178580,,,5228080,[],CHEMBL1679710,Antibacterial activity against Escherichia coli KAM32 harboring plasmid pUC18 by CLSI broth microdilution method in presence of 25 ug/ml efflux pump inhibitor CCCP,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671677,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332074,<,1,1,<,,MIC,ug.mL-1,,0.05,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.05
178581,178581,,,5228081,[],CHEMBL1679711,Antibacterial activity against Escherichia coli KAM32 harboring recombinant plasmid pVBS1 encoding Acinetobacter baumannii abeS gene by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671677,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332074,=,1,1,=,,MIC,ug.mL-1,,24.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,24.0
178582,178582,,,5228082,[],CHEMBL1679712,Antibacterial activity against Escherichia coli KAM32 harboring recombinant plasmid pVBS1 encoding Acinetobacter baumannii abeS gene by CLSI broth microdilution method in presence of 25 ug/ml efflux pump inhibitor CCCP,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671677,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332074,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
178583,178583,,,5228083,[],CHEMBL1680414,Ratio of MIC for Escherichia coli KAM32 harboring plasmid pUC18 to MIC for Escherichia coli KAM32 harboring recombinant plasmid pVBS1 encoding Acinetobacter baumannii abeS gene,F,,,BAO_0000193,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671677,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1332074,=,1,0,=,,Ratio,,,6.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,6.0
178584,178584,,,5228084,[],CHEMBL1680415,Antibacterial activity against Acinetobacter baumannii AC0037 by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671677,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332074,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,64.0
178585,178585,,,5228085,[],CHEMBL1680416,Antibacterial activity against abeS-deficient Acinetobacter baumannii AC0037 by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671677,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332074,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,8.0
178586,178586,,,5228086,[],CHEMBL1680417,Ratio of MIC for Acinetobacter baumannii AC0037 to MIC for abeS-deficient Acinetobacter baumannii AC0037,F,,,BAO_0000193,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671677,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1332074,=,1,0,=,,Ratio,,,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,Ratio,,,,8.0
178587,178587,,,5228087,[],CHEMBL1680418,Antibacterial activity against abeS sigma abeS-deficient Acinetobacter baumannii AC0037 by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671677,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332074,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,32.0
178588,178588,,,5229223,[],CHEMBL1679884,Ratio of MIC for Escherichia coli K-12 3-AG300 harboring AcrB-615-628MexB-M626I mutant gene to MIC for Escherichia coli K-12 3-AG300,F,,,BAO_0000193,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671642,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1331912,=,1,0,=,,Ratio,,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,4.0
178589,178589,,,5229226,[],CHEMBL1679883,Ratio of MIC for Escherichia coli K-12 3-AG300 harboring AcrB-615-628MexB mutant gene to MIC for Escherichia coli K-12 3-AG300,F,,,BAO_0000193,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671642,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1331912,=,1,0,=,,Ratio,,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,4.0
178590,178590,,,5229234,[],CHEMBL1679882,Ratio of MIC for Escherichia coli K-12 3-AG300 harboring acrB::rpsLneo mutant gene to MIC for Escherichia coli K-12 3-AG300,F,,,BAO_0000193,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671642,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1331912,=,1,0,=,,Ratio,,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,4.0
178591,178591,,Not Determined,5229247,[],CHEMBL1679881,Antimicrobial activity against Escherichia coli K-12 3-AG300 harboring AcrB-N623S-Q624S mutant gene,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671642,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1331912,,1,0,,,MIC,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,,,,
178592,178592,,,5229265,[],CHEMBL1679880,Antimicrobial activity against Escherichia coli K-12 3-AG300 harboring AcrB-G616N mutant gene,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671642,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331912,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,128.0
178593,178593,,,5229279,[],CHEMBL1679174,Antimicrobial activity against Escherichia coli K-12 3-AG300 harboring AcrB-I626M mutant gene,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671642,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331912,=,1,1,=,,MIC,ug.mL-1,,512.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,512.0
178594,178594,,,5229292,[],CHEMBL1679173,Antimicrobial activity against Escherichia coli K-12 3-AG300 harboring AcrB-615-628MexB-M626I mutant gene,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671642,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331912,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,128.0
178595,178595,,,5229307,[],CHEMBL1679172,Antimicrobial activity against Escherichia coli K-12 3-AG300 harboring AcrB-615-628MexB-N616 mutant gene,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671642,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331912,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,256.0
178596,178596,,,5229318,[],CHEMBL1679171,Antimicrobial activity against Escherichia coli K-12 3-AG300 harboring AcrB-615-628MexB mutant gene,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671642,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331912,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,128.0
178597,178597,,,5229332,[],CHEMBL1679170,Antimicrobial activity against Escherichia coli K-12 3-AG300 harboring acrB::rpsLneo mutant gene,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671642,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331912,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.0
178598,178598,,,5229346,[],CHEMBL1679169,Antimicrobial activity against Escherichia coli K-12 3-AG300 harboring AcrB-F628F mutant gene,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671642,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331912,=,1,1,=,,MIC,ug.mL-1,,512.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,512.0
178599,178599,,,5229355,[],CHEMBL1679885,Ratio of MIC for Escherichia coli K-12 3-AG300 harboring AcrB-G616N mutant gene to MIC for Escherichia coli K-12 3-AG300,F,,,BAO_0000193,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671642,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1331912,=,1,0,=,,Ratio,,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,4.0
178600,178600,,,5229363,[],CHEMBL1679886,Antimicrobial activity against Escherichia coli K-12 3-AG300 harboring AcrB-615-628MexB-S623N mutant gene,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671642,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331912,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,256.0
178601,178601,,,5229659,[],CHEMBL1678264,Antimicrobial activity against erythromycin-resistant Streptococcus pneumoniae assessed as susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671681,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1332117,=,1,0,=,,Activity,%,,0.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,0.0
178602,178602,,,5229685,[],CHEMBL1678266,Antimicrobial activity against erythromycin-resistant Streptococcus pneumoniae assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671681,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1332117,=,1,0,=,,Activity,%,,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,100.0
178603,178603,,,5229697,[],CHEMBL1678262,Antimicrobial activity against erythromycin-resistant Streptococcus pneumoniae by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671681,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332117,>,1,1,>,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
178604,178604,,,5229711,[],CHEMBL1678262,Antimicrobial activity against erythromycin-resistant Streptococcus pneumoniae by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671681,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332117,>,1,1,>,,MIC50,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,2.0
178605,178605,,,5229725,[],CHEMBL1678262,Antimicrobial activity against erythromycin-resistant Streptococcus pneumoniae by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671681,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332117,>,1,1,>,,MIC90,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,2.0
178606,178606,,,5230442,[],CHEMBL1679830,Antibacterial activity against Escherichia coli ATCC 25992 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331723,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,32.0
178607,178607,,,5230448,[],CHEMBL1679827,Antibacterial activity against Escherichia coli ATCC 25992 by Etest method in presence of NAB7061,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1331723,=,1,0,=,,FICI,,,0.188,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FICI,,,,0.188
178608,178608,,,5296341,[],CHEMBL1691262,Antibacterial activity against Escherichia coli KAM32 harboring Staphylococcus aureus cloned pSP72 lmrS by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687808,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338206,=,1,1,=,,MIC,ug.mL-1,,15.63,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,15.63
178609,178609,,,5296358,[],CHEMBL1691263,Antibacterial activity against Escherichia coli KAM32 harboring pSP72 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687808,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338206,=,1,1,=,,MIC,ug.mL-1,,1.9,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.9
178610,178610,,,5296375,[],CHEMBL1691264,Ratio of MIC for Escherichia coli KAM32 harboring cloned pSP72 lmrS to MIC for Escherichia coli KAM32 harboring pSP72,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687808,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338206,=,1,1,=,,MIC,ug.mL-1,,8.2,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.2
178611,178611,,,5296397,[],CHEMBL1691269,"Antimicrobial activity against methicillin-resistant Staphylococcus aureus ST398 isolate 11 containing apmA, erm(B), tet(L), tet(M), tet(K), dfrK, aadD, mecA, blaZ resistance genes by CLSI M31-A3 method",F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687809,Antimicrob Agents Chemother,2011.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338220,>=,1,1,>=,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
178612,178612,,,5296398,[],CHEMBL1691270,Antimicrobial activity against Staphylococcus aureus RN4220 by CLSI M31-A3 method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687809,Antimicrob Agents Chemother,2011.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338220,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.12
178613,178613,,,5296399,[],CHEMBL1691271,"Antimicrobial activity against Staphylococcus aureus RN4220 carrying pAFS11-apmA, erm(B), tet(L), dfrK, aadD resistance genes by CLSI M31-A3 method",F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687809,Antimicrob Agents Chemother,2011.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338220,>=,1,1,>=,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
178614,178614,,,5296495,[],CHEMBL1692065,Antibacterial activity against wild type Escherichia coli BW25113,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687812,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338239,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,32.0
178615,178615,,,5296496,[],CHEMBL1692066,Antibacterial activity against tolC deficient Escherichia coli GD100,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687812,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338239,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
178616,178616,,,5296497,[],CHEMBL1692067,Antibacterial activity against speE deficient Escherichia coli JW0117-1,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687812,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338239,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,32.0
178617,178617,,,5296498,[],CHEMBL1692068,Antibacterial activity against gshB deficient Escherichia coli JW2914-1,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687812,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338239,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,64.0
178618,178618,,,5296499,[],CHEMBL1692069,Antibacterial activity against gspS deficient Escherichia coli JW2956-1,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687812,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338239,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,64.0
178619,178619,,,5296500,[],CHEMBL1692070,"Antibacterial activity against ygiBC, yjfMC, gspS deficient Escherichia coli GD108",F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687812,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338239,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,64.0
178620,178620,,,5296501,[],CHEMBL1692071,"Antibacterial activity against tolC, speE deficient Escherichia coli GD106",F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687812,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338239,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
178621,178621,,,5296502,[],CHEMBL1692072,"Antibacterial activity against tolC, gshB deficient Escherichia coli GD107",F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687812,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338239,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
178622,178622,,,5296503,[],CHEMBL1692073,Antibacterial activity against wild type Escherichia coli BW25113 absence of glutathione,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687812,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338239,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,128.0
178623,178623,,,5296504,[],CHEMBL1692074,Antibacterial activity against wild type Escherichia coli BW25113 presence of 5 mM of glutathione,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687812,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338239,=,1,1,=,,MIC,ug.mL-1,,512.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,512.0
178624,178624,,,5296505,[],CHEMBL1692075,Antibacterial activity against wild type Escherichia coli BW25113 presence of 10 mM of glutathione,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687812,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338239,=,1,1,=,,MIC,ug.mL-1,,512.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,512.0
178625,178625,,,5296506,[],CHEMBL1692076,Antibacterial activity against wild type Escherichia coli BW25113 presence of 15 mM of glutathione,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687812,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338239,=,1,1,=,,MIC,ug.mL-1,,512.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,512.0
178626,178626,,,5296507,[],CHEMBL1692077,Antibacterial activity against tolC deficient Escherichia coli GD100 absence of glutathione,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687812,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338239,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.0
178627,178627,,,5296508,[],CHEMBL1692078,Antibacterial activity against tolC deficient Escherichia coli GD100 presence of 5 mM of glutathione,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687812,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338239,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.0
178628,178628,,,5296509,[],CHEMBL1692079,Antibacterial activity against tolC deficient Escherichia coli GD100 presence of 10 mM of glutathione,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687812,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338239,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.0
178629,178629,,Active,5296510,[],CHEMBL1692080,Antibacterial activity against tolC deficient Escherichia coli GD100 presence of 15 mM of glutathione,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687812,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1338239,,1,0,,,MIC,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,,,,
178630,178630,,,5296511,[],CHEMBL1692081,"Antibacterial activity against kanamycin-resistant acrAB, acrEF deficient Escherichia coli W4680AE absence of glutathione",F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687812,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338239,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.0
178631,178631,,,5296512,[],CHEMBL1692082,"Antibacterial activity against kanamycin-resistant acrAB, acrEF deficient Escherichia coli W4680AE presence of 5 mM of glutathione",F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687812,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338239,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.0
178632,178632,,,5296513,[],CHEMBL1692083,"Antibacterial activity against kanamycin-resistant acrAB, acrEF deficient Escherichia coli W4680AE presence of 10 mM of glutathione",F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687812,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338239,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
178633,178633,,,5296514,[],CHEMBL1692084,"Antibacterial activity against kanamycin-resistant acrAB, acrEF deficient Escherichia coli W4680AE presence of 15 mM of glutathione",F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687812,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338239,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,32.0
178634,178634,,,5298832,[],CHEMBL1689987,Antibacterial activity against methicillin-resistant Staphylococcus aureus M05/0060 harboring cfr-encoding conjugative pSCFS7 and fexA by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687819,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338431,>=,1,1,>=,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
178635,178635,,,5298833,[],CHEMBL1689986,Antibacterial activity against pSCFS7-deficient methicillin-resistant Staphylococcus aureus M05/0060-C1 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687819,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338431,>=,1,1,>=,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
178636,178636,,,5298834,[],CHEMBL1689984,Antibacterial activity against Staphylococcus aureus XU21 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687819,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338431,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
178637,178637,,,5298835,[],CHEMBL1689985,Antibacterial activity against Staphylococcus aureus XU21-T1 harboring cfr-encoding conjugative pSCFS7 and fexA by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687819,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338431,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
178638,178638,,,5304608,[],CHEMBL1695035,Antimicrobial activity against Neisseria gonorrhoeae clinical isolates assessed as percent susceptible isolates after 24 hrs by agar dilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687841,Antimicrob Agents Chemother,2011.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1338520,=,1,0,=,,Activity,%,,77.2,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,,Activity,%,UO_0000187,,77.2
178639,178639,,,5304609,[],CHEMBL1695040,Antimicrobial activity against Neisseria gonorrhoeae clinical isolates after 24 hrs by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687841,Antimicrob Agents Chemother,2011.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338520,<=,1,1,<=,,MIC50,ug.mL-1,,1.0,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,,MIC50,ug ml-1,UO_0000274,,1.0
178640,178640,,,5304610,[],CHEMBL1695040,Antimicrobial activity against Neisseria gonorrhoeae clinical isolates after 24 hrs by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687841,Antimicrob Agents Chemother,2011.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338520,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,,MIC90,ug ml-1,UO_0000274,,2.0
178641,178641,,,5304635,[],CHEMBL1695034,Antimicrobial activity against Neisseria gonorrhoeae clinical isolates assessed as percent resistant isolates after 24 hrs by agar dilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687841,Antimicrob Agents Chemother,2011.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1338520,=,1,0,=,,Activity,%,,22.8,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,,Activity,%,UO_0000187,,22.8
178642,178642,,,5304640,[],CHEMBL1695040,Antimicrobial activity against Neisseria gonorrhoeae clinical isolates after 24 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687841,Antimicrob Agents Chemother,2011.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338520,<=,1,1,<=,,MIC,ug.mL-1,,1.0,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,,MIC,ug ml-1,UO_0000274,,1.0
178643,178643,,,5304645,[],CHEMBL1695041,Antimicrobial activity against Streptococcus suis CA isolated from cerebrospinal fluid of patient with meningitis by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687842,Antimicrob Agents Chemother,2011.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338523,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,256.0
178644,178644,,,5304646,[],CHEMBL1695042,Antimicrobial activity against Streptococcus suis UD isolated from cerebrospinal fluid of patient with meningitis by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687842,Antimicrob Agents Chemother,2011.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338523,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,4.0
178645,178645,,,5305311,[],CHEMBL1695566,Antimicrobial activity against chromosomal rrn allele deficient-Escherichia coli TA531 after 15 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687727,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337298,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,128.0
178646,178646,,,5305312,[],CHEMBL1695567,Antimicrobial activity against Escherichia coli TA531 harboring 23S rRNA A2058G mutant after 15 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687727,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337298,>,1,1,>,,MIC,ug.mL-1,,500.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,500.0
178647,178647,,,5305313,[],CHEMBL1695568,Antimicrobial activity against Escherichia coli TA531 harboring 23S rRNA U2609C mutant after 15 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687727,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337298,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,128.0
178648,178648,,Not Active,5305320,[],CHEMBL1695576,Inhibition of poly(U)-dependent synthesis of poly(Phe) using Escherichia coli K-12 70S ribosome at 20 uM after 1 hr by liquid scintillation counting,B,,,BAO_0000201,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687727,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1337298,,1,0,,,Inhibition,%,,,CHEMBL2363135,Bacteria,Bacterial 70S ribosome,2.0,,,INH,,UO_0000187,,
178649,178649,,Active,5305323,[],CHEMBL1695577,Inhibition of poly(A)-dependent synthesis of poly(Lys) using Escherichia coli K-12 70S ribosome at 20 uM after 1 hr by liquid scintillation counting,B,,,BAO_0000201,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687727,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1337298,,1,0,,,Inhibition,%,,,CHEMBL2363135,Bacteria,Bacterial 70S ribosome,2.0,,,INH,,UO_0000187,,
178650,178650,,Not Active,5305327,[],CHEMBL1695580,Binding affinity to Escherichia coli K-12 70S ribosome Pi complex assessed as inhibition of AcPhe-puromycin synthesis at 10 uM after 2 mins by liquid scintillation counting,B,,,BAO_0000375,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687727,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1337298,,1,0,,,Activity,,,,CHEMBL612545,,Unchecked,,,,Activity,,,,
178651,178651,,,5305336,[],CHEMBL1695569,Displacement of [14C]-erythromycin from Escherichia coli K-12 70S ribosome after 10 mins by competitive binding assay,B,,,BAO_0000034,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687727,Antimicrob Agents Chemother,2009.0,"{'bei': '10.66', 'le': '0.21', 'lle': '6.03', 'sei': '4.03'}",CHEMBL532,ERYTHROMYCIN,CHEMBL532,7.82,0,http://www.openphacts.org/units/Nanomolar,1337298,=,1,1,=,,Kd,nM,,15.0,CHEMBL2363135,Bacteria,Bacterial 70S ribosome,2.0,,,Kd,nM,UO_0000065,,15.0
178652,178652,,Active,5305338,[],CHEMBL1695570,Binding affinity to Escherichia coli K-12 70S ribosome 23S rRNA A2062 mutant assessed as protection against DMS-induced modification of 23S rRNA domain V at nucleotides A2058 and A2059 by primer extension analysis,B,,,BAO_0000375,BAO_0000225,nucleic acid format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687727,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1337298,,1,0,,,Activity,,,,CHEMBL345,,Nucleic Acid,,,,Activity,,,,
178653,178653,,Active,5305343,[],CHEMBL1695573,Binding affinity to Escherichia coli K-12 70S ribosome 23S rRNA assessed as enhancement of DMS-induced modification of 23S rRNA domain II at nucleotides A752 by primer extension analysis,B,,,BAO_0000375,BAO_0000225,nucleic acid format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687727,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1337298,,1,0,,,Activity,,,,CHEMBL345,,Nucleic Acid,,,,Activity,,,,
178654,178654,,Not Active,5305344,[],CHEMBL1695574,Binding affinity to Escherichia coli K-12 70S ribosome 23S rRNA assessed as protection against DMS-induced modification of 23S rRNA domain V at nucleotides A789 by primer extension analysis,B,,,BAO_0000375,BAO_0000225,nucleic acid format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687727,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1337298,,1,0,,,Activity,,,,CHEMBL345,,Nucleic Acid,,,,Activity,,,,
178655,178655,,Not Active,5305345,[],CHEMBL1695575,Binding affinity to Escherichia coli K-12 70S ribosome 23S rRNA assessed as protection against CMCT-induced modification of 23S rRNA domain V at nucleotides U790 by primer extension analysis,B,,,BAO_0000375,BAO_0000225,nucleic acid format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687727,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1337298,,1,0,,,Activity,,,,CHEMBL345,,Nucleic Acid,,,,Activity,,,,
178656,178656,,Active,5305346,[],CHEMBL1696026,Binding affinity to Escherichia coli K-12 Pi complex of 70S ribosome Pi complex U2609C mutant assessed as blockade of tylosin-induced inhibition of AcPhe-puromycin synthesis at 10 uM after 2 mins by liquid scintillation counting,B,,,BAO_0000375,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687727,Antimicrob Agents Chemother,2009.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1337298,,1,0,,,Activity,,,,CHEMBL612545,,Unchecked,,,,Activity,,,,
178657,178657,,,5311215,[],CHEMBL1694182,Antimicrobial activity against Staphylococcus aureus clone 1-1 harboring staphylococcal cassette chromosome mec element type 4 assessed as percent susceptible isolates by kirby-bauer method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687786,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1337930,=,1,0,=,,Activity,%,,98.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,98.0
178658,178658,,,5311216,[],CHEMBL1693544,Antimicrobial activity against Staphylococcus aureus clone 1-1 harboring staphylococcal cassette chromosome mec element type 5 assessed as percent susceptible isolates by kirby-bauer method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687786,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1337930,=,1,0,=,,Activity,%,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,100.0
178659,178659,,,5311217,[],CHEMBL1694181,Antimicrobial activity against Staphylococcus aureus clone 1-1 harboring staphylococcal cassette chromosome mec element type U assessed as percent susceptible isolates by kirby-bauer method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687786,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1337930,=,1,0,=,,Activity,%,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,100.0
178660,178660,,,5311218,[],CHEMBL1693543,Antimicrobial activity against Staphylococcus aureus clone 2-2 harboring staphylococcal cassette chromosome mec element type 2 assessed as percent susceptible isolates by kirby-bauer method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687786,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1337930,=,1,0,=,,Activity,%,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,1.0
178661,178661,,,5311219,[],CHEMBL1694183,Antimicrobial activity against Staphylococcus aureus clone 2-2 harboring staphylococcal cassette chromosome mec element type 1 assessed as percent susceptible isolates by kirby-bauer method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687786,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1337930,=,1,0,=,,Activity,%,,67.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,67.0
178662,178662,,,5311220,[],CHEMBL1693542,Antimicrobial activity against Staphylococcus aureus clone 2-2 harboring staphylococcal cassette chromosome mec element type 4 assessed as percent susceptible isolates by kirby-bauer method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687786,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1337930,=,1,0,=,,Activity,%,,39.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,39.0
178663,178663,,,5311221,[],CHEMBL1694184,Antimicrobial activity against Staphylococcus aureus clone 2-2 harboring staphylococcal cassette chromosome mec element type 5 assessed as percent susceptible isolates by kirby-bauer method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687786,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1337930,=,1,0,=,,Activity,%,,89.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,89.0
178664,178664,,,5311222,[],CHEMBL1694185,Antimicrobial activity against Staphylococcus aureus clone 2-2 harboring staphylococcal cassette chromosome mec element type U3 assessed as percent susceptible isolates by kirby-bauer method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687786,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1337930,=,1,0,=,,Activity,%,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,100.0
178665,178665,,,5311223,[],CHEMBL1694300,Antimicrobial activity against Staphylococcus aureus clone 2-2 harboring staphylococcal cassette chromosome mec element type U5 assessed as percent susceptible isolates by kirby-bauer method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687786,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1337930,=,1,0,=,,Activity,%,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,100.0
178666,178666,,,5311224,[],CHEMBL1694301,Antimicrobial activity against Staphylococcus aureus clone 3-3 harboring staphylococcal cassette chromosome mec element type 4 assessed as percent susceptible isolates by kirby-bauer method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687786,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1337930,=,1,0,=,,Activity,%,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,0.0
178667,178667,,,5311225,[],CHEMBL1694302,Antimicrobial activity against Staphylococcus aureus clone 3-3 harboring staphylococcal cassette chromosome mec element type 1 assessed as percent susceptible isolates by kirby-bauer method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687786,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1337930,=,1,0,=,,Activity,%,,73.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,73.0
178668,178668,,,5311226,[],CHEMBL1694303,Antimicrobial activity against Staphylococcus aureus clone 3-3 harboring staphylococcal cassette chromosome mec element type 2 assessed as percent susceptible isolates by kirby-bauer method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687786,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1337930,=,1,0,=,,Activity,%,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,0.0
178669,178669,,,5311227,[],CHEMBL1694304,Antimicrobial activity against Staphylococcus aureus clone 3-3 harboring staphylococcal cassette chromosome mec element type 6 assessed as percent susceptible isolates by kirby-bauer method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687786,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1337930,=,1,0,=,,Activity,%,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,100.0
178670,178670,,,5311228,[],CHEMBL1694305,Antimicrobial activity against Staphylococcus aureus clone 3-3 harboring staphylococcal cassette chromosome mec element type U1 assessed as percent susceptible isolates by kirby-bauer method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687786,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1337930,=,1,0,=,,Activity,%,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,100.0
178671,178671,,,5311229,[],CHEMBL1694306,Antimicrobial activity against Staphylococcus aureus clone 3-3 harboring staphylococcal cassette chromosome mec element type U6 assessed as percent susceptible isolates by kirby-bauer method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687786,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1337930,=,1,0,=,,Activity,%,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,100.0
178672,178672,,,5311230,[],CHEMBL1694307,Antimicrobial activity against Staphylococcus aureus clone 3-3 harboring staphylococcal cassette chromosome mec element type U8 assessed as percent susceptible isolates by kirby-bauer method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687786,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1337930,=,1,0,=,,Activity,%,,50.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,50.0
178673,178673,,,5311231,[],CHEMBL1694308,Antimicrobial activity against Staphylococcus aureus clone 4-4 harboring staphylococcal cassette chromosome mec element type 1 assessed as percent susceptible isolates by kirby-bauer method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687786,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1337930,=,1,0,=,,Activity,%,,98.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,98.0
178674,178674,,,5311232,[],CHEMBL1694309,Antimicrobial activity against Staphylococcus aureus clone 4-4 harboring staphylococcal cassette chromosome mec element type 2 assessed as percent susceptible isolates by kirby-bauer method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687786,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1337930,=,1,0,=,,Activity,%,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,1.0
178675,178675,,,5311233,[],CHEMBL1694310,Antimicrobial activity against Staphylococcus aureus clone 4-4 harboring staphylococcal cassette chromosome mec element type 4 assessed as percent susceptible isolates by kirby-bauer method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687786,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1337930,=,1,0,=,,Activity,%,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,0.0
178676,178676,,,5311234,[],CHEMBL1694311,Antimicrobial activity against Staphylococcus aureus clone 4-4 harboring staphylococcal cassette chromosome mec element type 5 assessed as percent susceptible isolates by kirby-bauer method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687786,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1337930,=,1,0,=,,Activity,%,,33.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,33.0
178677,178677,,,5311235,[],CHEMBL1694312,Antimicrobial activity against Staphylococcus aureus clone 4-4 harboring staphylococcal cassette chromosome mec element type U3 assessed as percent susceptible isolates by kirby-bauer method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687786,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1337930,=,1,0,=,,Activity,%,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,100.0
178678,178678,,,5311236,[],CHEMBL1694313,Antimicrobial activity against Staphylococcus aureus clone 2-2 harboring staphylococcal cassette chromosome mec element type 6 assessed as percent susceptible isolates by kirby-bauer method,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687786,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1337930,=,1,0,=,,Activity,%,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,0.0
178679,178679,,,5311324,[],CHEMBL1694453,Antibacterial activity against quinupristin-dalfopristin resistant and ermB gene expressing Enterococcus faecium isolate JS79 containing streptogramin A resistance genes vatG and vgaD isolated from healthy human stool samples,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687788,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337943,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,256.0
178680,178680,,,5311325,[],CHEMBL1694331,Antibacterial activity against quinupristin-dalfopristin resistant and ermB gene expressing Enterococcus faecium isolate KS46 containing streptogramin A resistance genes vatG and vgaD isolated from healthy human stool samples,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687788,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337943,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,256.0
178681,178681,,,5311326,[],CHEMBL1694330,Antibacterial activity against quinupristin-dalfopristin resistant Enterococcus faecium isolate ES022 containing streptogramin A resistance genes vatG and vgaD isolated from swine stool samples,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687788,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337943,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,0.1
178682,178682,,,5311327,[],CHEMBL1694329,Antibacterial activity against quinupristin-dalfopristin resistant and ermB and vanA gene expressing Enterococcus faecium isolate A15 containing streptogramin A resistance genes vatG and vgaD isolated from poultry stool samples,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687788,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337943,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,256.0
178683,178683,,,5311328,[],CHEMBL1694328,Antibacterial activity against quinupristin-dalfopristin resistant and ermB and vanA gene expressing Enterococcus faecium isolate C19 containing streptogramin A resistance genes vatG and vgaD isolated from poultry stool samples,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687788,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337943,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,256.0
178684,178684,,,5311329,[],CHEMBL1694327,Antibacterial activity against quinupristin-dalfopristin resistant and ermB gene expressing Enterococcus faecium isolate AS115 containing streptogramin A resistance genes vatG and vgaD isolated from poultry stool samples,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687788,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337943,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,256.0
178685,178685,,,5311330,[],CHEMBL1694326,Antibacterial activity against quinupristin-dalfopristin resistant and ermB gene expressing Enterococcus faecium isolate CS098 containing streptogramin A resistance genes vatG and vgaD isolated from poultry stool samples,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687788,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337943,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,256.0
178686,178686,,,5311331,[],CHEMBL1694325,Antibacterial activity against quinupristin-dalfopristin resistant and ermB gene expressing Enterococcus faecium isolate CS103 containing streptogramin A resistance genes vatG and vgaD isolated from poultry stool samples,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687788,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337943,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,256.0
178687,178687,,,5311332,[],CHEMBL1694324,Antibacterial activity against quinupristin-dalfopristin resistant and ermB gene expressing Enterococcus faecium isolate CS106 containing streptogramin A resistance genes vatG and vgaD isolated from poultry stool samples,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687788,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337943,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,256.0
178688,178688,,,5311333,[],CHEMBL1694323,Antibacterial activity against quinupristin-dalfopristin resistant and ermB gene expressing Enterococcus faecium isolate CS121 containing streptogramin A resistance genes vatG and vgaD isolated from poultry stool samples,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687788,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337943,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,256.0
178689,178689,,,5311334,[],CHEMBL1694454,Antibacterial activity against quinupristin-dalfopristin resistant and vanA gene expressing Enterococcus faecium isolate GAV04 containing streptogramin A resistance genes vatG and vgaD isolated from chicken meat samples,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687788,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337943,<,1,1,<,,MIC,ug.mL-1,,1.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,1.0
178690,178690,,,5311335,[],CHEMBL1694455,Antibacterial activity against quinupristin-dalfopristin resistant and vanA gene expressing Enterococcus faecium isolate GAV12 containing streptogramin A resistance genes vatG and vgaD isolated from chicken meat samples,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687788,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337943,<,1,1,<,,MIC,ug.mL-1,,1.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,1.0
178691,178691,,,5311336,[],CHEMBL1694456,Antibacterial activity against quinupristin-dalfopristin abd erythromycin sensitive aEnterococcus faecium U201 transconjugants receiving ermB genes and vatG gene from quinupristin-dalfopristin resistant Enterococcus faecium isolate,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687788,Antimicrob Agents Chemother,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337943,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,256.0
178692,178692,,Positive,5315794,[],CHEMBL1697691,Literature-mined public compounds from Lowe et al phospholipidosis modelling dataset,A,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1697681,Mol Pharm,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1339602,,1,0,,,Phospholipidosis,,,,CHEMBL1626541,,Phospholipidosis,,,,Phospholipidosis,,,,
178693,178693,,WE: Weak evidence (<10 case reports) of human hepatotoxicity,5316026,[],CHEMBL1697722,Literature-mined public compounds from Greene et al multi-species hepatotoxicity modelling dataset,A,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1697692,Chem Res Toxicol,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1339844,,1,0,,,Hepatotoxicity,,,,CHEMBL1697861,,Hepatotoxicity,,,,Hepatotoxicity,,,,
178694,178694,,DILI negative (training set),5316605,[],CHEMBL1697730,Human drug-induced liver injury (DILI) modelling dataset from Ekins et al,A,,,BAO_0000179,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1697723,Drug Metab Dispos,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1340423,,1,0,,,Hepatotoxicity,,,,CHEMBL1697861,,Hepatotoxicity,,,,Hepatotoxicity,,,,
178695,178695,,drug-induced liver injury reported,5317349,[],CHEMBL1697778,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans",A,,,BAO_0000179,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1697731,Chem Res Toxicol,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1341135,,1,0,,,Hepatotoxicity,,,,CHEMBL1697861,,Hepatotoxicity,,,,Hepatotoxicity,,,,
178696,178696,,drug-induced liver injury reported,5318300,[],CHEMBL1697779,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents",A,,,BAO_0000179,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1697731,Chem Res Toxicol,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1341135,,1,0,,,Hepatotoxicity,,,,CHEMBL1697861,,Hepatotoxicity,,,,Hepatotoxicity,,,,
178697,178697,,no drug-induced liver injury reported,5319251,[],CHEMBL1697780,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents",A,,,BAO_0000179,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1697731,Chem Res Toxicol,2010.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1341135,,1,0,,,Hepatotoxicity,,,,CHEMBL1697861,,Hepatotoxicity,,,,Hepatotoxicity,,,,
178698,178698,,Active,5322104,[],CHEMBL1697797,"FDA HLAED, liver enzyme composite activity",A,,,BAO_0000179,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1342069,,1,0,,,Composite Activity - Score,,,,CHEMBL1697861,,Hepatotoxicity,,,,Composite Activity - Score,,,,
178699,178699,,,5322105,[],CHEMBL1697797,"FDA HLAED, liver enzyme composite activity",A,,,BAO_0000179,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1342069,=,1,0,=,,Composite Activity - Marginal,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,Composite Activity - Marginal,,,,0.0
178700,178700,,,5322106,[],CHEMBL1697797,"FDA HLAED, liver enzyme composite activity",A,,,BAO_0000179,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1342069,=,1,0,=,,Composite Activity - Active,,,3.0,CHEMBL1697861,,Hepatotoxicity,,,,Composite Activity - Active,,,,3.0
178701,178701,,Active,5322107,[],CHEMBL1697798,"FDA HLAED, alkaline phosphatase increase",A,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1342069,,1,0,,,Alkaline Phosphatase Increase - Activity Score,,,,CHEMBL1697861,,Hepatotoxicity,,,,Alkaline Phosphatase Increase - Activity Score,,,,
178702,178702,,,5322108,[],CHEMBL1697798,"FDA HLAED, alkaline phosphatase increase",A,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1342069,>=,1,0,>=,,Alkaline Phosphatase Increase - Number of Reports,,,4.0,CHEMBL1697861,,Hepatotoxicity,,,,Alkaline Phosphatase Increase - Number of Reports,,,,4.0
178703,178703,,,5322109,[],CHEMBL1697798,"FDA HLAED, alkaline phosphatase increase",A,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1342069,=,1,0,=,,Alkaline Phosphatase Increase - Index Value,,,7.3,CHEMBL1697861,,Hepatotoxicity,,,,Alkaline Phosphatase Increase - Index Value,,,,7.3
178704,178704,,Active,5322110,[],CHEMBL1697799,"FDA HLAED, serum glutamic oxaloacetic transaminase (SGOT) increase",A,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1342069,,1,0,,,SGOT Increase - Activity Score,,,,CHEMBL1697861,,Hepatotoxicity,,,,SGOT Increase - Activity Score,,,,
178705,178705,,,5322111,[],CHEMBL1697799,"FDA HLAED, serum glutamic oxaloacetic transaminase (SGOT) increase",A,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1342069,>=,1,0,>=,,SGOT Increase - Number of Reports,,,4.0,CHEMBL1697861,,Hepatotoxicity,,,,SGOT Increase - Number of Reports,,,,4.0
178706,178706,,,5322112,[],CHEMBL1697799,"FDA HLAED, serum glutamic oxaloacetic transaminase (SGOT) increase",A,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1342069,=,1,0,=,,SGOT Increase - Index Value,,,7.9,CHEMBL1697861,,Hepatotoxicity,,,,SGOT Increase - Index Value,,,,7.9
178707,178707,,Active,5322113,[],CHEMBL1697800,"FDA HLAED, serum glutamic pyruvic transaminase (SGPT) increase",A,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1342069,,1,0,,,SGPT Increase - Activity Score,,,,CHEMBL1697861,,Hepatotoxicity,,,,SGPT Increase - Activity Score,,,,
178708,178708,,,5322114,[],CHEMBL1697800,"FDA HLAED, serum glutamic pyruvic transaminase (SGPT) increase",A,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1342069,>=,1,0,>=,,SGPT Increase - Number of Reports,,,4.0,CHEMBL1697861,,Hepatotoxicity,,,,SGPT Increase - Number of Reports,,,,4.0
178709,178709,,,5322115,[],CHEMBL1697800,"FDA HLAED, serum glutamic pyruvic transaminase (SGPT) increase",A,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1342069,=,1,0,=,,SGPT Increase - Index Value,,,8.5,CHEMBL1697861,,Hepatotoxicity,,,,SGPT Increase - Index Value,,,,8.5
178710,178710,,Data Not Available,5322116,[],CHEMBL1697801,"FDA HLAED, lactate dehydrogenase (LDH) increase",A,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1342069,,1,0,,,LDH Increase - Index Value,,,,CHEMBL1697861,,Hepatotoxicity,,,,LDH Increase - Index Value,,,,
178711,178711,,Data Not Available,5322117,[],CHEMBL1697801,"FDA HLAED, lactate dehydrogenase (LDH) increase",A,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1342069,,1,0,,,LDH Increase - Number of Reports,,,,CHEMBL1697861,,Hepatotoxicity,,,,LDH Increase - Number of Reports,,,,
178712,178712,,Data Not Available,5322118,[],CHEMBL1697801,"FDA HLAED, lactate dehydrogenase (LDH) increase",A,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1342069,,1,0,,,LDH Increase - Activity Score,,,,CHEMBL1697861,,Hepatotoxicity,,,,LDH Increase - Activity Score,,,,
178713,178713,,Data Not Available,5322119,[],CHEMBL1697802,"FDA HLAED, gamma-glutamyl transferase (GGT) increase",A,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1342069,,1,0,,,GGT Increase - Index Value,,,,CHEMBL1697861,,Hepatotoxicity,,,,GGT Increase - Index Value,,,,
178714,178714,,Data Not Available,5322120,[],CHEMBL1697802,"FDA HLAED, gamma-glutamyl transferase (GGT) increase",A,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1342069,,1,0,,,GGT Increase - Number of Reports,,,,CHEMBL1697861,,Hepatotoxicity,,,,GGT Increase - Number of Reports,,,,
178715,178715,,Data Not Available,5322121,[],CHEMBL1697802,"FDA HLAED, gamma-glutamyl transferase (GGT) increase",A,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1342069,,1,0,,,GGT Increase - Activity Score,,,,CHEMBL1697861,,Hepatotoxicity,,,,GGT Increase - Activity Score,,,,
178716,178716,,Positive: strong inducer confirmed by electron microscopy,5328883,[],CHEMBL1697855,Literature-mined public compounds from Kruhlak et al phospholipidosis modelling dataset,A,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1697821,Toxicol Mech Methods,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1342461,,1,0,,,Phospholipidosis,,,,CHEMBL1626541,,Phospholipidosis,,,,Phospholipidosis,,,,
178717,178717,,Negative: based on the absence of positive reported data from WMDD,5328884,[],CHEMBL1697855,Literature-mined public compounds from Kruhlak et al phospholipidosis modelling dataset,A,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1697821,Toxicol Mech Methods,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1342462,,1,0,,,Phospholipidosis,,,,CHEMBL1626541,,Phospholipidosis,,,,Phospholipidosis,,,,
178718,178718,"{'action_type': 'SUBSTRATE', 'description': 'Carried by a transporter, possibly competing with the natural substrate for transport', 'parent_type': 'OTHER'}",Substrate,6074491,[],CHEMBL1743273,"Clinically relevant substrates of human liver microsomal P450 enzymes, isoform CYP3A4",A,,,BAO_0000375,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1743201,,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1394336,,1,0,,,Activity,,,,CHEMBL340,Homo sapiens,Cytochrome P450 3A4,9606.0,,,Activity,,,,
178719,178719,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",Inhibitor,6074641,[],CHEMBL1743282,"Clinically relevant inhibitors of human liver microsomal P450 enzymes, isoform CYP3A4",A,,,BAO_0000375,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1743201,,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1394336,,1,0,,,Activity,,,,CHEMBL340,Homo sapiens,Cytochrome P450 3A4,9606.0,,,Activity,,,,
178720,178720,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",Cytochrome P450 mechanistic inhibitor: PMID 9806945,6075191,[],CHEMBL1743463,Mechanism based inhibition of human cytochrome P450 3A4 measured by testosterone 6-beta hydroxylation,A,,,BAO_0000179,BAO_0000357,single protein format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1743341,Curr Drug Metab,2005.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1394578,,1,0,,,mechanism based inhibition,,,,CHEMBL340,Homo sapiens,Cytochrome P450 3A4,9606.0,,,mechanism based inhibition,,,,
178721,178721,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",Cytochrome P450 mechanistic inhibitor: PMID 10870985,6075228,[],CHEMBL1743474,Mechanism based inhibition of human cytochrome P450 3A4 measured by triazolam 4- hydroxylation using human liver microsomes,A,,,BAO_0000179,BAO_0000251,microsome format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1743341,Curr Drug Metab,2005.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1394578,=,1,0,=,,Kinact,min-1,,0.055,CHEMBL340,Homo sapiens,Cytochrome P450 3A4,9606.0,,,Kinact,min-1,,,0.055
178722,178722,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",Cytochrome P450 mechanistic inhibitor: PMID 10870985,6075229,[],CHEMBL1743475,Mechanism based inhibition of human cytochrome P450 3A4 measured by triazolam 4- hydroxylation using recombinant CYP3A4,A,,,BAO_0000179,BAO_0000357,single protein format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1743341,Curr Drug Metab,2005.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1394578,=,1,0,=,,Kinact,min-1,,0.097,CHEMBL340,Homo sapiens,Cytochrome P450 3A4,9606.0,,,Kinact,min-1,,,0.097
178723,178723,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",Cytochrome P450 mechanistic inhibitor: PMID 10870985,6075230,[],CHEMBL1743476,Mechanism based inhibition of human cytochrome P450 3A4 measured by triazolam alpha- hydroxylation using human liver microsomes,A,,,BAO_0000179,BAO_0000251,microsome format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1743341,Curr Drug Metab,2005.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1394578,=,1,0,=,,Kinact,min-1,,0.062,CHEMBL340,Homo sapiens,Cytochrome P450 3A4,9606.0,,,Kinact,min-1,,,0.062
178724,178724,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",Cytochrome P450 mechanistic inhibitor: PMID 10870985,6075231,[],CHEMBL1743477,Mechanism based inhibition of human cytochrome P450 3A4 measured by triazolam alpha- hydroxylation using recombinant CYP3A4,A,,,BAO_0000179,BAO_0000357,single protein format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1743341,Curr Drug Metab,2005.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1394578,=,1,0,=,,Kinact,min-1,,0.173,CHEMBL340,Homo sapiens,Cytochrome P450 3A4,9606.0,,,Kinact,min-1,,,0.173
178725,178725,,,6174416,[],CHEMBL1769836,Apparent permeability from apical to basolateral side of human Caco2 cells after 2 hrs by LC/MS/MS analysis,A,,,BAO_0000179,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1764994,Bioorg Med Chem,2011.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1415773,=,1,0,=,,logPapp,,,-5.49,CHEMBL614058,Homo sapiens,Caco-2,9606.0,,,logPapp,,,,-5.49
178726,178726,,,6174437,[],CHEMBL1769837,Apparent permeability from basolateral side to apical side of human Caco2 cells by LC/MS/MS analysis,A,,,BAO_0000179,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1764994,Bioorg Med Chem,2011.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1415773,=,1,0,=,,logPapp,,,-5.15,CHEMBL614058,Homo sapiens,Caco-2,9606.0,,,logPapp,,,,-5.15
178727,178727,,,6184836,[],CHEMBL1775524,Antiparasitic activity against Toxoplasma gondii 2F-1 expressing yellow fluorescent protein infected in HFF after 4 days,F,,,BAO_0000190,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1772948,J Med Chem,2011.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,4.03,0,http://www.openphacts.org/units/Nanomolar,1422188,=,1,1,=,,IC50,nM,,93000.0,CHEMBL612888,Toxoplasma gondii,Toxoplasma gondii,5811.0,,,IC50,uM,UO_0000065,,93.0
178728,178728,,,6184863,[],CHEMBL1775525,Antibacterial activity against Bacillus subtilis,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1772948,J Med Chem,2011.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/Nanomolar,1422188,=,1,1,=,,MIC,nM,,40.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,uM,UO_0000065,,0.04
178729,178729,,,6184894,[],CHEMBL1775526,Cytotoxicity against HFF after 48 hrs by MTS assay,A,,,BAO_0000187,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1772948,J Med Chem,2011.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/Nanomolar,1422188,=,1,1,=,,CC50,nM,,475000.0,CHEMBL614071,Homo sapiens,HFF,9606.0,,,CC50,uM,UO_0000065,,475.0
178730,178730,,,6203712,[],CHEMBL1781399,Agonist activity at motilin receptor in rabbit smooth muscle assessed as maximal possible tissue contraction,F,,,BAO_0000188,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1777727,Bioorg Med Chem Lett,2011.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,5.92,1,http://www.openphacts.org/units/Nanomolar,1423775,=,1,1,=,,EC50,nM,,1200.0,CHEMBL5306,Oryctolagus cuniculus,Motilin receptor,9986.0,,,EC50,nM,UO_0000065,,1200.0
178731,178731,,,6203732,[],CHEMBL1781400,Antimicrobial activity against erythromycin-sensitive Streptococcus pneumoniae ATCC 6301,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1777727,Bioorg Med Chem Lett,2011.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1423775,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.03
178732,178732,,,6203765,[],CHEMBL1781405,Agonist activity at motilin receptor,F,,,BAO_0000188,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1777727,Bioorg Med Chem Lett,2011.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,6.0,1,http://www.openphacts.org/units/Nanomolar,1423775,=,1,1,=,,EC50,nM,,1000.0,CHEMBL2203,Homo sapiens,Motilin receptor,9606.0,,,EC50,uM,UO_0000065,,1.0
178733,178733,,,6210446,[],CHEMBL1781298,Antimicrobial activity against Staphylococcus aureus FDA209P by CLSI method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1777670,Bioorg Med Chem Lett,2011.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424954,<=,1,1,<=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
178734,178734,,,6210447,[],CHEMBL1781300,Antimicrobial activity against Staphylococcus aureus Smith by CLSI method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1777670,Bioorg Med Chem Lett,2011.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424954,<=,1,1,<=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
178735,178735,,,6210448,[],CHEMBL1781301,Antimicrobial activity against Staphylococcus aureus 8325 (pEP2104) by CLSI method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1777670,Bioorg Med Chem Lett,2011.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424954,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
178736,178736,,,6210449,[],CHEMBL1781302,Antimicrobial activity against Staphylococcus epidermidis IFO12648 by CLSI method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1777670,Bioorg Med Chem Lett,2011.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424954,<=,1,1,<=,,MIC,ug.mL-1,,0.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.5
178737,178737,,,6210450,[],CHEMBL1781303,Antimicrobial activity against Micrococcus luteus ATCC 9341 by CLSI method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1777670,Bioorg Med Chem Lett,2011.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424954,<=,1,1,<=,,MIC,ug.mL-1,,0.5,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,,MIC,ug ml-1,UO_0000274,,0.5
178738,178738,,,6210451,[],CHEMBL1781304,Antimicrobial activity against Micrococcus luteus ATCC 21212 by CLSI method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1777670,Bioorg Med Chem Lett,2011.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424954,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,,MIC,ug ml-1,UO_0000274,,1.0
178739,178739,,,6210452,[],CHEMBL1781305,Antimicrobial activity against Escherichia coli NIHJ JC-2 by CLSI method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1777670,Bioorg Med Chem Lett,2011.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424954,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,64.0
178740,178740,,,6210453,[],CHEMBL1781306,Antimicrobial activity against Klebsiella pneumoniae NCTN9632 by CLSI method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1777670,Bioorg Med Chem Lett,2011.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424954,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,32.0
178741,178741,,,6210454,[],CHEMBL1781307,Antimicrobial activity against Serratia marcescens IFO12648 by CLSI method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1777670,Bioorg Med Chem Lett,2011.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424954,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC,ug ml-1,UO_0000274,,128.0
178742,178742,,,6210455,[],CHEMBL1781308,Antimicrobial activity against Enterobacter aerogenes NCTC10006 by CLSI method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1777670,Bioorg Med Chem Lett,2011.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424954,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,,MIC,ug ml-1,UO_0000274,,128.0
178743,178743,,,6210456,[],CHEMBL1781309,Antimicrobial activity against Acinetobacter calcoaceticus IFO2552 by CLSI method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1777670,Bioorg Med Chem Lett,2011.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424954,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614426,Acinetobacter calcoaceticus,Acinetobacter calcoaceticus,471.0,,,MIC,ug ml-1,UO_0000274,,4.0
178744,178744,,,6260297,[],CHEMBL1798349,"In-vivo serum to lung partition coefficients of the compound, logP(lung) in rat",A,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1795228,Eur J Med Chem,2008.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1437372,=,1,0,=,,logP(lung),,,1.62,CHEMBL612558,,ADMET,,,,logP(lung),,,,1.62
178745,178745,,,6265287,[],CHEMBL1798378,Antibacterial activity against erythromycin-susceptible Streptococcus pneumoniae ATCC 49619 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1795320,Eur J Med Chem,2011.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1436151,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.12
178746,178746,,,6265308,[],CHEMBL1798379,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae B1 expressing erm gene by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1795320,Eur J Med Chem,2011.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1436151,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,128.0
178747,178747,,,6265329,[],CHEMBL1798484,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae A22072 expressing mef gene by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1795320,Eur J Med Chem,2011.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1436151,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
178748,178748,,,6265350,[],CHEMBL1798531,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae AB11 expressing erm and mef gene by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1795320,Eur J Med Chem,2011.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1436151,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,256.0
178749,178749,,,6265371,[],CHEMBL1798532,Antibacterial activity against erythromycin-susceptible Staphylococcus aureus ATCC 25923 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1795320,Eur J Med Chem,2011.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1436151,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.12
178750,178750,,,6318888,[],CHEMBL1815789,Antibacterial activity against Staphylococcus aureus ATCC 6538P at 15 ug/disk after 24 hrs by agar diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1811775,J Nat Prod,2011.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Millimeter,1448280,=,1,1,=,,IZ,mm,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,IZ,mm,UO_0000016,,8.0
178751,178751,,,6335667,[],CHEMBL1819817,Antibacterial activity against Escherichia coli NCIM 2574 after 24 hrs by NCCLS method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1817642,Eur J Med Chem,2011.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451867,>,1,1,>,,MIC90,ug.mL-1,,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC90,ug ml-1,UO_0000274,,64.0
178752,178752,,,6335684,[],CHEMBL1819818,Antibacterial activity against Staphylococcus aureus NCIM 2122 after 24 hrs by NCCLS method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1817642,Eur J Med Chem,2011.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451867,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,32.0
178753,178753,,,6368699,[],CHEMBL1831401,Antibacterial activity against erythromycin-susceptible Streptococcus pneumoniae ATCC 49619 by the broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1828549,Eur J Med Chem,2011.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1457551,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.03
178754,178754,,,6368700,[],CHEMBL1831402,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae B1 expressing erm gene by the broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1828549,Eur J Med Chem,2011.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1457551,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,128.0
178755,178755,,,6368701,[],CHEMBL1831403,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae A22072 expressing mef gene by the broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1828549,Eur J Med Chem,2011.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1457551,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
178756,178756,,,6368702,[],CHEMBL1831404,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae AB11 expressing erm and mef gene by the broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1828549,Eur J Med Chem,2011.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1457551,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,256.0
178757,178757,,,6368703,[],CHEMBL1831405,Antibacterial activity against erythromycin-susceptible Staphylococcus aureus ATCC 25923 by the broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1828549,Eur J Med Chem,2011.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1457551,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
178758,178758,,,6368704,[],CHEMBL1831406,Antibacterial activity against penicillin-resistant Staphylococcus aureus by the broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1828549,Eur J Med Chem,2011.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1457551,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
178759,178759,,,6368705,[],CHEMBL1831407,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 29213 by the broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1828549,Eur J Med Chem,2011.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1457551,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.12
178760,178760,,inconclusive,6493375,[],CHEMBL1794345,"PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]",F,,,BAO_0000186,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1201862,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://www.openphacts.org/units/Nanomolar,1219500,,7,1,,,Potency,nM,,9285.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,Potency,uM,UO_0000065,,9.285
178761,178761,,,7566401,[],CHEMBL1908285,Apparent permeability (Papp) from apical to basolateral side determined in MDR1-MDCKII cells,A,,,BAO_0002808,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1908284,J Pharmacol Exp Ther,2001.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539077,=,1,0,=,,Papp,nm/s,,0.94,CHEMBL4302,Homo sapiens,P-glycoprotein 1,9606.0,,,Papp,nm/s,,,0.94
178762,178762,,,7566467,[],CHEMBL1908286,Apparent permeability (Papp) from basolateral to apical side determined in MDR1-MDCKII cells,A,,,BAO_0002808,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1908284,J Pharmacol Exp Ther,2001.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539077,=,1,0,=,,Papp,nm/s,,13.5,CHEMBL4302,Homo sapiens,P-glycoprotein 1,9606.0,,,Papp,nm/s,,,13.5
178763,178763,,Effluxed: Y,7566533,[],CHEMBL1908289,Ratio of apparent permeability from basolateral to apical side over apical to basolateral side determined in MDR1-MDCKII cells,A,,,BAO_0000179,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1908284,J Pharmacol Exp Ther,2001.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539077,=,1,0,=,,Ratio_Papp,,,14.4,CHEMBL4302,Homo sapiens,P-glycoprotein 1,9606.0,,,Ratio_Papp,,,,14.4
178764,178764,,ATPase Activator: Y,7566593,[],CHEMBL1908291,Drug-stimulated Pgp ATPase activity ratio determined in MDR1-Sf9 cell membranes with test compound at a concentration of 20uM,B,,,BAO_0000179,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1908284,J Pharmacol Exp Ther,2001.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539077,=,1,0,=,,Ratio_ATPase activity,,,2.27,CHEMBL4302,Homo sapiens,P-glycoprotein 1,9606.0,,,Ratio_ATPase activity,,,,2.27
178765,178765,,Calcein-AM Inhibitor: N,7566653,[],CHEMBL1908292,Inhibition of Pgp expressed in MDR1-MDCKII cells measured by calcein-AM assay,B,,,BAO_0000179,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1908284,J Pharmacol Exp Ther,2001.0,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,http://qudt.org/vocab/unit#Percent,1539077,=,1,0,=,,% maximum response,%,,4.35,CHEMBL4302,Homo sapiens,P-glycoprotein 1,9606.0,,,% maximum response,%,UO_0000187,,4.35
178766,178766,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7673562,[],CHEMBL1909212,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),B,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL220,Homo sapiens,Acetylcholinesterase,9606.0,,,IC50,,,,
178767,178767,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7673563,[],CHEMBL1909212,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),B,,,BAO_0000192,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL220,Homo sapiens,Acetylcholinesterase,9606.0,,,Ki,,,,
178768,178768,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7673564,[],CHEMBL1909213,DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL226,Homo sapiens,Adenosine A1 receptor,9606.0,,,IC50,,,,
178769,178769,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7673565,[],CHEMBL1909213,DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL226,Homo sapiens,Adenosine A1 receptor,9606.0,,,Ki,,,,
178770,178770,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7673566,[],CHEMBL1909214,DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL251,Homo sapiens,Adenosine A2a receptor,9606.0,,,IC50,,,,
178771,178771,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7673567,[],CHEMBL1909214,DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL251,Homo sapiens,Adenosine A2a receptor,9606.0,,,Ki,,,,
178772,178772,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7673568,[],CHEMBL1909215,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL256,Homo sapiens,Adenosine A3 receptor,9606.0,,,IC50,,,,
178773,178773,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7673569,[],CHEMBL1909215,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL256,Homo sapiens,Adenosine A3 receptor,9606.0,,,Ki,,,,
178774,178774,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7673570,[],CHEMBL1909084,DRUGMATRIX: Sodium/nucleoside co-transporter radioligand binding (ligand: nitrobenzylthioinosine),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
178775,178775,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7673571,[],CHEMBL1909084,DRUGMATRIX: Sodium/nucleoside co-transporter radioligand binding (ligand: nitrobenzylthioinosine),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
178776,178776,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7673572,[],CHEMBL1909085,DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL319,Rattus norvegicus,Alpha-1a adrenergic receptor,10116.0,,,IC50,,,,
178777,178777,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7673573,[],CHEMBL1909085,DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL319,Rattus norvegicus,Alpha-1a adrenergic receptor,10116.0,,,Ki,,,,
178778,178778,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7673574,[],CHEMBL1909086,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL315,Rattus norvegicus,Alpha-1b adrenergic receptor,10116.0,,,IC50,,,,
178779,178779,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7673575,[],CHEMBL1909086,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL315,Rattus norvegicus,Alpha-1b adrenergic receptor,10116.0,,,Ki,,,,
178780,178780,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7673576,[],CHEMBL1909087,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL223,Homo sapiens,Alpha-1d adrenergic receptor,9606.0,,,IC50,,,,
178781,178781,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7673577,[],CHEMBL1909087,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL223,Homo sapiens,Alpha-1d adrenergic receptor,9606.0,,,Ki,,,,
178782,178782,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7673578,[],CHEMBL1909088,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL1867,Homo sapiens,Alpha-2a adrenergic receptor,9606.0,,,IC50,,,,
178783,178783,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7673579,[],CHEMBL1909088,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL1867,Homo sapiens,Alpha-2a adrenergic receptor,9606.0,,,Ki,,,,
178784,178784,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7673580,[],CHEMBL1909089,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL1942,Homo sapiens,Alpha-2b adrenergic receptor,9606.0,,,IC50,,,,
178785,178785,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7673581,[],CHEMBL1909089,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL1942,Homo sapiens,Alpha-2b adrenergic receptor,9606.0,,,Ki,,,,
178786,178786,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7673582,[],CHEMBL1909090,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL1916,Homo sapiens,Alpha-2c adrenergic receptor,9606.0,,,IC50,,,,
178787,178787,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7673583,[],CHEMBL1909090,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL1916,Homo sapiens,Alpha-2c adrenergic receptor,9606.0,,,Ki,,,,
178788,178788,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7673584,[],CHEMBL1909091,DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL213,Homo sapiens,Beta-1 adrenergic receptor,9606.0,,,IC50,,,,
178789,178789,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7673585,[],CHEMBL1909091,DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL213,Homo sapiens,Beta-1 adrenergic receptor,9606.0,,,Ki,,,,
178790,178790,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7673586,[],CHEMBL1909092,DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL210,Homo sapiens,Beta-2 adrenergic receptor,9606.0,,,IC50,,,,
178791,178791,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7673587,[],CHEMBL1909092,DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL210,Homo sapiens,Beta-2 adrenergic receptor,9606.0,,,Ki,,,,
178792,178792,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7673588,[],CHEMBL1909093,DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL246,Homo sapiens,Beta-3 adrenergic receptor,9606.0,,,IC50,,,,
178793,178793,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7673589,[],CHEMBL1909093,DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL246,Homo sapiens,Beta-3 adrenergic receptor,9606.0,,,Ki,,,,
178794,178794,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7673590,[],CHEMBL1909094,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL222,Homo sapiens,Norepinephrine transporter,9606.0,,,IC50,,,,
178795,178795,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7673591,[],CHEMBL1909094,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL222,Homo sapiens,Norepinephrine transporter,9606.0,,,Ki,,,,
178796,178796,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7673592,[],CHEMBL1909095,DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde),B,,,BAO_0000190,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL2622,Rattus norvegicus,Aldose reductase,10116.0,,,IC50,,,,
178797,178797,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7673593,[],CHEMBL1909095,DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde),B,,,BAO_0000192,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL2622,Rattus norvegicus,Aldose reductase,10116.0,,,Ki,,,,
178798,178798,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7673594,[],CHEMBL1909096,DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A),B,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL4607,Homo sapiens,Angiotensin II type 2 (AT-2) receptor,9606.0,,,IC50,,,,
178799,178799,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7673595,[],CHEMBL1909096,DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A),B,,,BAO_0000192,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL4607,Homo sapiens,Angiotensin II type 2 (AT-2) receptor,9606.0,,,Ki,,,,
178800,178800,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7673596,[],CHEMBL1909097,"DRUGMATRIX: ATPase, Na+/K+ enzyme inhibition (substrate: ATP)",B,,,BAO_0000190,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
178801,178801,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7673597,[],CHEMBL1909097,"DRUGMATRIX: ATPase, Na+/K+ enzyme inhibition (substrate: ATP)",B,,,BAO_0000192,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
178802,178802,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7673598,[],CHEMBL1909098,DRUGMATRIX: Atrial Natriuretic Factor (ANF) radioligand binding (ligand: [125I] ANF (rat)),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
178803,178803,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675615,[],CHEMBL1909098,DRUGMATRIX: Atrial Natriuretic Factor (ANF) radioligand binding (ligand: [125I] ANF (rat)),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
178804,178804,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675616,[],CHEMBL1909099,DRUGMATRIX: beta-Lactamase enzyme inhibition (substrate: Nitrocefin),B,,,BAO_0000190,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
178805,178805,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675617,[],CHEMBL1909099,DRUGMATRIX: beta-Lactamase enzyme inhibition (substrate: Nitrocefin),B,,,BAO_0000192,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
178806,178806,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675618,[],CHEMBL1909100,DRUGMATRIX: Bradykinin B2 radioligand binding (ligand: [3H] Bradykinin),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL3157,Homo sapiens,Bradykinin B2 receptor,9606.0,,,IC50,,,,
178807,178807,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675619,[],CHEMBL1909100,DRUGMATRIX: Bradykinin B2 radioligand binding (ligand: [3H] Bradykinin),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL3157,Homo sapiens,Bradykinin B2 receptor,9606.0,,,Ki,,,,
178808,178808,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675620,[],CHEMBL1909101,DRUGMATRIX: Calcitonin radioligand binding (ligand: [125I] Calcitonin (salmon)),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL1832,Homo sapiens,Calcitonin receptor,9606.0,,,IC50,,,,
178809,178809,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675621,[],CHEMBL1909101,DRUGMATRIX: Calcitonin radioligand binding (ligand: [125I] Calcitonin (salmon)),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL1832,Homo sapiens,Calcitonin receptor,9606.0,,,Ki,,,,
178810,178810,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675622,[],CHEMBL1909102,"DRUGMATRIX: Calcium Channel Type L, Benzothiazepine radioligand binding (ligand: [3H] Diltiazem)",B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
178811,178811,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675623,[],CHEMBL1909102,"DRUGMATRIX: Calcium Channel Type L, Benzothiazepine radioligand binding (ligand: [3H] Diltiazem)",B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
178812,178812,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675624,[],CHEMBL1909103,"DRUGMATRIX: Calcium Channel Type L, Dihydropyridine radioligand binding (ligand: [3H] Nitrendipine)",B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
178813,178813,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675625,[],CHEMBL1909103,"DRUGMATRIX: Calcium Channel Type L, Dihydropyridine radioligand binding (ligand: [3H] Nitrendipine)",B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
178814,178814,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675626,[],CHEMBL1909121,"DRUGMATRIX: Calcium Channel Type L, Phenylalkylamine radioligand binding (ligand: [3H] (-)-Desmethoxyverapamil (D-888))",B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
178815,178815,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675627,[],CHEMBL1909121,"DRUGMATRIX: Calcium Channel Type L, Phenylalkylamine radioligand binding (ligand: [3H] (-)-Desmethoxyverapamil (D-888))",B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
178816,178816,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675628,[],CHEMBL1909122,DRUGMATRIX: Cannabinoid CB1 radioligand binding (ligand: [3H] SR141716A),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL218,Homo sapiens,Cannabinoid CB1 receptor,9606.0,,,IC50,,,,
178817,178817,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675629,[],CHEMBL1909122,DRUGMATRIX: Cannabinoid CB1 radioligand binding (ligand: [3H] SR141716A),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL218,Homo sapiens,Cannabinoid CB1 receptor,9606.0,,,Ki,,,,
178818,178818,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675630,[],CHEMBL1909123,DRUGMATRIX: Carbonic Anhydrase II enzyme inhibition (substrate: 4-Nitrophenyl acetate (4-NPA)),B,,,BAO_0000190,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL205,Homo sapiens,Carbonic anhydrase II,9606.0,,,IC50,,,,
178819,178819,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675631,[],CHEMBL1909123,DRUGMATRIX: Carbonic Anhydrase II enzyme inhibition (substrate: 4-Nitrophenyl acetate (4-NPA)),B,,,BAO_0000192,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL205,Homo sapiens,Carbonic anhydrase II,9606.0,,,Ki,,,,
178820,178820,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675632,[],CHEMBL1909124,DRUGMATRIX: Chemokine CCR2B radioligand binding (ligand: [125I] MCP-1),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL4015,Homo sapiens,C-C chemokine receptor type 2,9606.0,,,IC50,,,,
178821,178821,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675633,[],CHEMBL1909124,DRUGMATRIX: Chemokine CCR2B radioligand binding (ligand: [125I] MCP-1),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL4015,Homo sapiens,C-C chemokine receptor type 2,9606.0,,,Ki,,,,
178822,178822,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675634,[],CHEMBL1909125,DRUGMATRIX: Chemokine CCR4 radioligand binding (ligand: [125I] TARC),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL2414,Homo sapiens,C-C chemokine receptor type 4,9606.0,,,IC50,,,,
178823,178823,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675635,[],CHEMBL1909125,DRUGMATRIX: Chemokine CCR4 radioligand binding (ligand: [125I] TARC),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL2414,Homo sapiens,C-C chemokine receptor type 4,9606.0,,,Ki,,,,
178824,178824,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675636,[],CHEMBL1909126,DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL274,Homo sapiens,C-C chemokine receptor type 5,9606.0,,,IC50,,,,
178825,178825,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675637,[],CHEMBL1909126,DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL274,Homo sapiens,C-C chemokine receptor type 5,9606.0,,,Ki,,,,
178826,178826,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675638,[],CHEMBL1909127,DRUGMATRIX: Chemokine CXCR1 (IL-8A),B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL4029,Homo sapiens,Interleukin-8 receptor A,9606.0,,,IC50,,,,
178827,178827,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675639,[],CHEMBL1909127,DRUGMATRIX: Chemokine CXCR1 (IL-8A),B,,,BAO_0000192,BAO_0000357,single protein format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL4029,Homo sapiens,Interleukin-8 receptor A,9606.0,,,Ki,,,,
178828,178828,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675640,[],CHEMBL1909128,DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL2434,Homo sapiens,Interleukin-8 receptor B,9606.0,,,IC50,,,,
178829,178829,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675641,[],CHEMBL1909128,DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL2434,Homo sapiens,Interleukin-8 receptor B,9606.0,,,Ki,,,,
178830,178830,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675642,[],CHEMBL1909129,"DRUGMATRIX: Cholecystokinin CCKA radioligand binding (ligand: [3H] L-364,718)",B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL1901,Homo sapiens,Cholecystokinin A receptor,9606.0,,,IC50,,,,
178831,178831,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675643,[],CHEMBL1909129,"DRUGMATRIX: Cholecystokinin CCKA radioligand binding (ligand: [3H] L-364,718)",B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL1901,Homo sapiens,Cholecystokinin A receptor,9606.0,,,Ki,,,,
178832,178832,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675644,[],CHEMBL1909130,DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid),B,,,BAO_0000190,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL221,Homo sapiens,Cyclooxygenase-1,9606.0,,,IC50,,,,
178833,178833,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675645,[],CHEMBL1909130,DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid),B,,,BAO_0000192,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL221,Homo sapiens,Cyclooxygenase-1,9606.0,,,Ki,,,,
178834,178834,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675646,[],CHEMBL1909131,DRUGMATRIX: Cyclooxygenase COX-2 enzyme inhibition (substrate: Arachidonic acid),B,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL230,Homo sapiens,Cyclooxygenase-2,9606.0,,,IC50,,,,
178835,178835,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675647,[],CHEMBL1909131,DRUGMATRIX: Cyclooxygenase COX-2 enzyme inhibition (substrate: Arachidonic acid),B,,,BAO_0000192,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL230,Homo sapiens,Cyclooxygenase-2,9606.0,,,Ki,,,,
178836,178836,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675648,[],CHEMBL1909132,"DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL3356,Homo sapiens,Cytochrome P450 1A2,9606.0,,,IC50,,,,
178837,178837,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675649,[],CHEMBL1909132,"DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000192,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL3356,Homo sapiens,Cytochrome P450 1A2,9606.0,,,Ki,,,,
178838,178838,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675650,[],CHEMBL1909133,"DRUGMATRIX: CYP450, 2A6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL5282,Homo sapiens,Cytochrome P450 2A6,9606.0,,,IC50,,,,
178839,178839,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675651,[],CHEMBL1909133,"DRUGMATRIX: CYP450, 2A6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000192,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL5282,Homo sapiens,Cytochrome P450 2A6,9606.0,,,Ki,,,,
178840,178840,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675652,[],CHEMBL1909134,"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL3622,Homo sapiens,Cytochrome P450 2C19,9606.0,,,IC50,,,,
178841,178841,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675653,[],CHEMBL1909134,"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000192,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL3622,Homo sapiens,Cytochrome P450 2C19,9606.0,,,Ki,,,,
178842,178842,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675654,[],CHEMBL1909135,"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL3397,Homo sapiens,Cytochrome P450 2C9,9606.0,,,IC50,,,,
178843,178843,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675655,[],CHEMBL1909135,"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000192,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL3397,Homo sapiens,Cytochrome P450 2C9,9606.0,,,Ki,,,,
178844,178844,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675656,[],CHEMBL1909136,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL289,Homo sapiens,Cytochrome P450 2D6,9606.0,,,IC50,,,,
178845,178845,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675657,[],CHEMBL1909136,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000192,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL289,Homo sapiens,Cytochrome P450 2D6,9606.0,,,Ki,,,,
178846,178846,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675658,[],CHEMBL1909137,"DRUGMATRIX: CYP450, 2E1 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL5281,Homo sapiens,Cytochrome P450 2E1,9606.0,,,IC50,,,,
178847,178847,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675659,[],CHEMBL1909137,"DRUGMATRIX: CYP450, 2E1 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000192,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL5281,Homo sapiens,Cytochrome P450 2E1,9606.0,,,Ki,,,,
178848,178848,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675660,[],CHEMBL1909138,"DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin)",B,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL340,Homo sapiens,Cytochrome P450 3A4,9606.0,,,IC50,,,,
178849,178849,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675661,[],CHEMBL1909138,"DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin)",B,,,BAO_0000192,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL340,Homo sapiens,Cytochrome P450 3A4,9606.0,,,Ki,,,,
178850,178850,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675662,[],CHEMBL1909139,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL2056,Homo sapiens,Dopamine D1 receptor,9606.0,,,IC50,,,,
178851,178851,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675663,[],CHEMBL1909139,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL2056,Homo sapiens,Dopamine D1 receptor,9606.0,,,Ki,,,,
178852,178852,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675664,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606.0,,,IC50,,,,
178853,178853,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675665,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606.0,,,Ki,,,,
178854,178854,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675666,[],CHEMBL1909141,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL234,Homo sapiens,Dopamine D3 receptor,9606.0,,,IC50,,,,
178855,178855,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675667,[],CHEMBL1909141,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL234,Homo sapiens,Dopamine D3 receptor,9606.0,,,Ki,,,,
178856,178856,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675668,[],CHEMBL1909142,DRUGMATRIX: Dopamine D4.2 radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL219,Homo sapiens,Dopamine D4 receptor,9606.0,,,IC50,,,,
178857,178857,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675669,[],CHEMBL1909142,DRUGMATRIX: Dopamine D4.2 radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL219,Homo sapiens,Dopamine D4 receptor,9606.0,,,Ki,,,,
178858,178858,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675670,[],CHEMBL1909143,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL238,Homo sapiens,Dopamine transporter,9606.0,,,IC50,,,,
178859,178859,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675671,[],CHEMBL1909143,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL238,Homo sapiens,Dopamine transporter,9606.0,,,Ki,,,,
178860,178860,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675672,[],CHEMBL1909144,DRUGMATRIX: Endothelin ETA radioligand binding (ligand: [125I] Endothelin-1),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL252,Homo sapiens,Endothelin receptor ET-A,9606.0,,,IC50,,,,
178861,178861,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675673,[],CHEMBL1909144,DRUGMATRIX: Endothelin ETA radioligand binding (ligand: [125I] Endothelin-1),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL252,Homo sapiens,Endothelin receptor ET-A,9606.0,,,Ki,,,,
178862,178862,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675674,[],CHEMBL1909145,DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol),B,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL206,Homo sapiens,Estrogen receptor alpha,9606.0,,,IC50,,,,
178863,178863,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675675,[],CHEMBL1909145,DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol),B,,,BAO_0000192,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL206,Homo sapiens,Estrogen receptor alpha,9606.0,,,Ki,,,,
178864,178864,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675676,[],CHEMBL1909146,DRUGMATRIX: Estrogen ERbeta radioligand binding (ligand: [3H] Estradiol),B,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL242,Homo sapiens,Estrogen receptor beta,9606.0,,,IC50,,,,
178865,178865,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675677,[],CHEMBL1909146,DRUGMATRIX: Estrogen ERbeta radioligand binding (ligand: [3H] Estradiol),B,,,BAO_0000192,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL242,Homo sapiens,Estrogen receptor beta,9606.0,,,Ki,,,,
178866,178866,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675678,[],CHEMBL1909147,"DRUGMATRIX: GABAA, Muscimol, Central radioligand binding (ligand: [3H] Muscimol)",B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
178867,178867,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675679,[],CHEMBL1909147,"DRUGMATRIX: GABAA, Muscimol, Central radioligand binding (ligand: [3H] Muscimol)",B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
178868,178868,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675680,[],CHEMBL1909148,"DRUGMATRIX: GABAA, Flunitrazepam, Central radioligand binding (ligand: [3H] Flunitrazepam)",B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
178869,178869,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675681,[],CHEMBL1909148,"DRUGMATRIX: GABAA, Flunitrazepam, Central radioligand binding (ligand: [3H] Flunitrazepam)",B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
178870,178870,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675682,[],CHEMBL1909149,"DRUGMATRIX: GABAA, Chloride Channel, TBOB radioligand binding (ligand: [3H] TBOB)",B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
178871,178871,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675683,[],CHEMBL1909149,"DRUGMATRIX: GABAA, Chloride Channel, TBOB radioligand binding (ligand: [3H] TBOB)",B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
178872,178872,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675684,[],CHEMBL1909150,DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone),B,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL2034,Homo sapiens,Glucocorticoid receptor,9606.0,,,IC50,,,,
178873,178873,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675685,[],CHEMBL1909150,DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone),B,,,BAO_0000192,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL2034,Homo sapiens,Glucocorticoid receptor,9606.0,,,Ki,,,,
178874,178874,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675686,[],CHEMBL1909151,"DRUGMATRIX: Glutamate, AMPA radioligand binding (ligand: [3H] AMPA)",B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
178875,178875,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675687,[],CHEMBL1909151,"DRUGMATRIX: Glutamate, AMPA radioligand binding (ligand: [3H] AMPA)",B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
178876,178876,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675688,[],CHEMBL1909152,"DRUGMATRIX: Glutamate, Kainate radioligand binding (ligand: [3H] Kainic acid)",B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
178877,178877,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675689,[],CHEMBL1909152,"DRUGMATRIX: Glutamate, Kainate radioligand binding (ligand: [3H] Kainic acid)",B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
178878,178878,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675690,[],CHEMBL1909153,"DRUGMATRIX: Glutamate, NMDA, Agonism radioligand binding (ligand: [3H] CGP-39653)",B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
178879,178879,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675691,[],CHEMBL1909153,"DRUGMATRIX: Glutamate, NMDA, Agonism radioligand binding (ligand: [3H] CGP-39653)",B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
178880,178880,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675692,[],CHEMBL1909154,"DRUGMATRIX: Glutamate, NMDA, Phencyclidine radioligand binding (ligand: [3H] TCP)",B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
178881,178881,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675693,[],CHEMBL1909154,"DRUGMATRIX: Glutamate, NMDA, Phencyclidine radioligand binding (ligand: [3H] TCP)",B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
178882,178882,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675694,[],CHEMBL1909155,"DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine)",B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL3392921,Rattus norvegicus,Glycine receptor,10116.0,,,IC50,,,,
178883,178883,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675695,[],CHEMBL1909155,"DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine)",B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL3392921,Rattus norvegicus,Glycine receptor,10116.0,,,Ki,,,,
178884,178884,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675696,[],CHEMBL1909156,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL231,Homo sapiens,Histamine H1 receptor,9606.0,,,IC50,,,,
178885,178885,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675697,[],CHEMBL1909156,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL231,Homo sapiens,Histamine H1 receptor,9606.0,,,Ki,,,,
178886,178886,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675698,[],CHEMBL1909157,DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL1941,Homo sapiens,Histamine H2 receptor,9606.0,,,IC50,,,,
178887,178887,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675699,[],CHEMBL1909157,DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL1941,Homo sapiens,Histamine H2 receptor,9606.0,,,Ki,,,,
178888,178888,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675700,[],CHEMBL1909158,DRUGMATRIX: HMG-CoA Reductase enzyme inhibition (substrate: [14C]HMG-CoA),B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL402,Homo sapiens,HMG-CoA reductase,9606.0,,,IC50,,,,
178889,178889,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675701,[],CHEMBL1909158,DRUGMATRIX: HMG-CoA Reductase enzyme inhibition (substrate: [14C]HMG-CoA),B,,,BAO_0000192,BAO_0000357,single protein format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL402,Homo sapiens,HMG-CoA reductase,9606.0,,,Ki,,,,
178890,178890,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675702,[],CHEMBL1909159,"DRUGMATRIX: Imidazoline I2, Central radioligand binding (ligand: [3H] Idazoxan)",B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
178891,178891,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675703,[],CHEMBL1909159,"DRUGMATRIX: Imidazoline I2, Central radioligand binding (ligand: [3H] Idazoxan)",B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
178892,178892,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675704,[],CHEMBL1909160,DRUGMATRIX: Insulin radioligand binding (ligand: [125I] Insulin),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL5486,Rattus norvegicus,Insulin receptor,10116.0,,,IC50,,,,
178893,178893,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675705,[],CHEMBL1909160,DRUGMATRIX: Insulin radioligand binding (ligand: [125I] Insulin),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL5486,Rattus norvegicus,Insulin receptor,10116.0,,,Ki,,,,
178894,178894,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675706,[],CHEMBL1909161,DRUGMATRIX: Interleukin IL-1 radioligand binding (ligand: [125I] interleukin 1beta),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
178895,178895,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675707,[],CHEMBL1909161,DRUGMATRIX: Interleukin IL-1 radioligand binding (ligand: [125I] interleukin 1beta),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
178896,178896,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675708,[],CHEMBL1909162,"DRUGMATRIX: Leukotriene, BLT (LTB4) radioligand binding (ligand: [3H]LTB4)",B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
178897,178897,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675709,[],CHEMBL1909162,"DRUGMATRIX: Leukotriene, BLT (LTB4) radioligand binding (ligand: [3H]LTB4)",B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
178898,178898,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675710,[],CHEMBL1909163,DRUGMATRIX: Leukotriene LTC4 Synthase enzyme inhibition (substrate: LTA4),B,,,BAO_0000190,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL1909043,Cavia porcellus,Leukotriene C4 synthase,10141.0,,,IC50,,,,
178899,178899,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675711,[],CHEMBL1909163,DRUGMATRIX: Leukotriene LTC4 Synthase enzyme inhibition (substrate: LTA4),B,,,BAO_0000192,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL1909043,Cavia porcellus,Leukotriene C4 synthase,10141.0,,,Ki,,,,
178900,178900,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675712,[],CHEMBL1909164,DRUGMATRIX: Cysteinyl leukotriene receptor 1 radioligand binding (ligand: [3H]LTD4),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL1798,Homo sapiens,Cysteinyl leukotriene receptor 1,9606.0,,,IC50,,,,
178901,178901,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675713,[],CHEMBL1909164,DRUGMATRIX: Cysteinyl leukotriene receptor 1 radioligand binding (ligand: [3H]LTD4),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL1798,Homo sapiens,Cysteinyl leukotriene receptor 1,9606.0,,,Ki,,,,
178902,178902,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675714,[],CHEMBL1909165,DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid),B,,,BAO_0000190,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL4358,Oryctolagus cuniculus,Arachidonate 15-lipoxygenase,9986.0,,,IC50,,,,
178903,178903,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675715,[],CHEMBL1909165,DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid),B,,,BAO_0000192,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL4358,Oryctolagus cuniculus,Arachidonate 15-lipoxygenase,9986.0,,,Ki,,,,
178904,178904,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675716,[],CHEMBL1909166,DRUGMATRIX: Melanocortin MC3 radioligand binding (ligand: [125I] NDP-alpha-MSH),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL4644,Homo sapiens,Melanocortin receptor 3,9606.0,,,IC50,,,,
178905,178905,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675717,[],CHEMBL1909166,DRUGMATRIX: Melanocortin MC3 radioligand binding (ligand: [125I] NDP-alpha-MSH),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL4644,Homo sapiens,Melanocortin receptor 3,9606.0,,,Ki,,,,
178906,178906,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675718,[],CHEMBL1909167,DRUGMATRIX: Melanocortin MC4 radioligand binding (ligand: [125I] NDP-alpha-MSH),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL259,Homo sapiens,Melanocortin receptor 4,9606.0,,,IC50,,,,
178907,178907,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675719,[],CHEMBL1909167,DRUGMATRIX: Melanocortin MC4 radioligand binding (ligand: [125I] NDP-alpha-MSH),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL259,Homo sapiens,Melanocortin receptor 4,9606.0,,,Ki,,,,
178908,178908,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675720,[],CHEMBL1909168,DRUGMATRIX: Melanocortin MC5 radioligand binding (ligand: [125I] NDP-alpha-MSH),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL4608,Homo sapiens,Melanocortin receptor 5,9606.0,,,IC50,,,,
178909,178909,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675721,[],CHEMBL1909168,DRUGMATRIX: Melanocortin MC5 radioligand binding (ligand: [125I] NDP-alpha-MSH),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL4608,Homo sapiens,Melanocortin receptor 5,9606.0,,,Ki,,,,
178910,178910,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675722,[],CHEMBL1909169,DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine),B,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL1951,Homo sapiens,Monoamine oxidase A,9606.0,,,IC50,,,,
178911,178911,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675723,[],CHEMBL1909169,DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine),B,,,BAO_0000192,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL1951,Homo sapiens,Monoamine oxidase A,9606.0,,,Ki,,,,
178912,178912,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675724,[],CHEMBL1909170,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL216,Homo sapiens,Muscarinic acetylcholine receptor M1,9606.0,,,IC50,,,,
178913,178913,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675725,[],CHEMBL1909170,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL216,Homo sapiens,Muscarinic acetylcholine receptor M1,9606.0,,,Ki,,,,
178914,178914,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675726,[],CHEMBL1909171,DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL211,Homo sapiens,Muscarinic acetylcholine receptor M2,9606.0,,,IC50,,,,
178915,178915,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675727,[],CHEMBL1909171,DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL211,Homo sapiens,Muscarinic acetylcholine receptor M2,9606.0,,,Ki,,,,
178916,178916,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675728,[],CHEMBL1909172,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL245,Homo sapiens,Muscarinic acetylcholine receptor M3,9606.0,,,IC50,,,,
178917,178917,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675729,[],CHEMBL1909172,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL245,Homo sapiens,Muscarinic acetylcholine receptor M3,9606.0,,,Ki,,,,
178918,178918,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675730,[],CHEMBL1909173,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL1821,Homo sapiens,Muscarinic acetylcholine receptor M4,9606.0,,,IC50,,,,
178919,178919,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675731,[],CHEMBL1909173,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL1821,Homo sapiens,Muscarinic acetylcholine receptor M4,9606.0,,,Ki,,,,
178920,178920,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675732,[],CHEMBL1909174,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL2035,Homo sapiens,Muscarinic acetylcholine receptor M5,9606.0,,,IC50,,,,
178921,178921,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675733,[],CHEMBL1909174,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL2035,Homo sapiens,Muscarinic acetylcholine receptor M5,9606.0,,,Ki,,,,
178922,178922,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675734,[],CHEMBL1909175,DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL4777,Homo sapiens,Neuropeptide Y receptor type 1,9606.0,,,IC50,,,,
178923,178923,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675735,[],CHEMBL1909175,DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL4777,Homo sapiens,Neuropeptide Y receptor type 1,9606.0,,,Ki,,,,
178924,178924,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675736,[],CHEMBL1909176,DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL4018,Homo sapiens,Neuropeptide Y receptor type 2,9606.0,,,IC50,,,,
178925,178925,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675737,[],CHEMBL1909176,DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL4018,Homo sapiens,Neuropeptide Y receptor type 2,9606.0,,,Ki,,,,
178926,178926,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675738,[],CHEMBL1909177,DRUGMATRIX: Nicotinic Acetylcholine radioligand binding (ligand: [125I] Epibatidine),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
178927,178927,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675739,[],CHEMBL1909177,DRUGMATRIX: Nicotinic Acetylcholine radioligand binding (ligand: [125I] Epibatidine),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
178928,178928,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675740,[],CHEMBL1909178,"DRUGMATRIX: Nitric Oxide Synthase, Neuronal (nNOS) radioligand binding (ligand: [3H]L-Arginine)",B,,,BAO_0000190,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL3048,Rattus norvegicus,"Nitric-oxide synthase, brain",10116.0,,,IC50,,,,
178929,178929,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675741,[],CHEMBL1909178,"DRUGMATRIX: Nitric Oxide Synthase, Neuronal (nNOS) radioligand binding (ligand: [3H]L-Arginine)",B,,,BAO_0000192,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL3048,Rattus norvegicus,"Nitric-oxide synthase, brain",10116.0,,,Ki,,,,
178930,178930,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675742,[],CHEMBL1909179,"DRUGMATRIX: Nitric Oxide Synthase, Inducible (iNOS) enzyme inhibition (substrate: L-Arginine)",B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL3464,Mus musculus,"Nitric oxide synthase, inducible",10090.0,,,IC50,,,,
178931,178931,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675743,[],CHEMBL1909179,"DRUGMATRIX: Nitric Oxide Synthase, Inducible (iNOS) enzyme inhibition (substrate: L-Arginine)",B,,,BAO_0000192,BAO_0000357,single protein format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL3464,Mus musculus,"Nitric oxide synthase, inducible",10090.0,,,Ki,,,,
178932,178932,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675744,[],CHEMBL1909180,"DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole)",B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL236,Homo sapiens,Delta opioid receptor,9606.0,,,IC50,,,,
178933,178933,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675745,[],CHEMBL1909180,"DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole)",B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL236,Homo sapiens,Delta opioid receptor,9606.0,,,Ki,,,,
178934,178934,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7677743,[],CHEMBL1909181,"DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine)",B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL237,Homo sapiens,Kappa opioid receptor,9606.0,,,IC50,,,,
178935,178935,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7677744,[],CHEMBL1909181,"DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine)",B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL237,Homo sapiens,Kappa opioid receptor,9606.0,,,Ki,,,,
178936,178936,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7677745,[],CHEMBL1909182,"DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine)",B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL233,Homo sapiens,Mu opioid receptor,9606.0,,,IC50,,,,
178937,178937,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7677746,[],CHEMBL1909182,"DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine)",B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL233,Homo sapiens,Mu opioid receptor,9606.0,,,Ki,,,,
178938,178938,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7677747,[],CHEMBL1909183,DRUGMATRIX: Phorbol Ester radioligand binding (ligand: [3H] PDBu),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
178939,178939,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7677748,[],CHEMBL1909183,DRUGMATRIX: Phorbol Ester radioligand binding (ligand: [3H] PDBu),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
178940,178940,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7677749,[],CHEMBL1909184,DRUGMATRIX: Phosphodiesterase PDE3 enzyme inhibition (substrate: [3H]cAMP + cAMP),B,,,BAO_0000190,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
178941,178941,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7677750,[],CHEMBL1909184,DRUGMATRIX: Phosphodiesterase PDE3 enzyme inhibition (substrate: [3H]cAMP + cAMP),B,,,BAO_0000192,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
178942,178942,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7677751,[],CHEMBL1909185,DRUGMATRIX: Phosphodiesterase PDE4 enzyme inhibition (substrate: [3H]cAMP + cAMP),B,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
178943,178943,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7677752,[],CHEMBL1909185,DRUGMATRIX: Phosphodiesterase PDE4 enzyme inhibition (substrate: [3H]cAMP + cAMP),B,,,BAO_0000192,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
178944,178944,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7677753,[],CHEMBL1909186,DRUGMATRIX: Phosphodiesterase PDE5 enzyme inhibition (substrate: [3H]cGMP + cGMP),B,,,BAO_0000190,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL1827,Homo sapiens,Phosphodiesterase 5A,9606.0,,,IC50,,,,
178945,178945,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7677754,[],CHEMBL1909186,DRUGMATRIX: Phosphodiesterase PDE5 enzyme inhibition (substrate: [3H]cGMP + cGMP),B,,,BAO_0000192,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL1827,Homo sapiens,Phosphodiesterase 5A,9606.0,,,Ki,,,,
178946,178946,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7677755,[],CHEMBL1909187,DRUGMATRIX: Platelet Activating Factor (PAF) radioligand binding (ligand: [3H] PAF),B,,,BAO_0000190,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL250,Homo sapiens,Platelet activating factor receptor,9606.0,,,IC50,,,,
178947,178947,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7677756,[],CHEMBL1909187,DRUGMATRIX: Platelet Activating Factor (PAF) radioligand binding (ligand: [3H] PAF),B,,,BAO_0000192,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL250,Homo sapiens,Platelet activating factor receptor,9606.0,,,Ki,,,,
178948,178948,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7677757,[],CHEMBL1909188,DRUGMATRIX: Platelet-Derived Growth Factor (PDGF) radioligand binding (ligand: [125I] PDGF),B,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
178949,178949,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7677758,[],CHEMBL1909188,DRUGMATRIX: Platelet-Derived Growth Factor (PDGF) radioligand binding (ligand: [125I] PDGF),B,,,BAO_0000192,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
178950,178950,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7677759,[],CHEMBL1909189,DRUGMATRIX: Potassium Channel [KATP] radioligand binding (ligand: [3H] Glyburide),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
178951,178951,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7677760,[],CHEMBL1909189,DRUGMATRIX: Potassium Channel [KATP] radioligand binding (ligand: [3H] Glyburide),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
178952,178952,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7677761,[],CHEMBL1909190,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL240,Homo sapiens,HERG,9606.0,,,IC50,,,,
178953,178953,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7677762,[],CHEMBL1909190,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL240,Homo sapiens,HERG,9606.0,,,Ki,,,,
178954,178954,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7677763,[],CHEMBL1909191,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),B,,,BAO_0000190,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL1909044,Bos taurus,Progesterone receptor,9913.0,,,IC50,,,,
178955,178955,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7677764,[],CHEMBL1909191,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),B,,,BAO_0000192,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL1909044,Bos taurus,Progesterone receptor,9913.0,,,Ki,,,,
178956,178956,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7677765,[],CHEMBL1909192,"DRUGMATRIX: Peptidase, Angiotensin Converting Enzyme enzyme inhibition (substrate: FAPGG)",B,,,BAO_0000190,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL4074,Oryctolagus cuniculus,Angiotensin-converting enzyme,9986.0,,,IC50,,,,
178957,178957,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7677766,[],CHEMBL1909192,"DRUGMATRIX: Peptidase, Angiotensin Converting Enzyme enzyme inhibition (substrate: FAPGG)",B,,,BAO_0000192,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL4074,Oryctolagus cuniculus,Angiotensin-converting enzyme,9986.0,,,Ki,,,,
178958,178958,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7677767,[],CHEMBL1909193,"DRUGMATRIX: Protease, Caspase 1 enzyme inhibition (substrate: Ac-YVAD-AMC)",B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL4801,Homo sapiens,Caspase-1,9606.0,,,IC50,,,,
178959,178959,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7677768,[],CHEMBL1909193,"DRUGMATRIX: Protease, Caspase 1 enzyme inhibition (substrate: Ac-YVAD-AMC)",B,,,BAO_0000192,BAO_0000357,single protein format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL4801,Homo sapiens,Caspase-1,9606.0,,,Ki,,,,
178960,178960,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7677769,[],CHEMBL1909194,"DRUGMATRIX: Protease, Cathepsin G enzyme inhibition (substrate: Suc-Ala-Ala-Pro-Phe-AMC)",B,,,BAO_0000190,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL4071,Homo sapiens,Cathepsin G,9606.0,,,IC50,,,,
178961,178961,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7677770,[],CHEMBL1909194,"DRUGMATRIX: Protease, Cathepsin G enzyme inhibition (substrate: Suc-Ala-Ala-Pro-Phe-AMC)",B,,,BAO_0000192,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL4071,Homo sapiens,Cathepsin G,9606.0,,,Ki,,,,
178962,178962,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7677771,[],CHEMBL1909195,"DRUGMATRIX: Peptidase, ELA2 (Neutrophil Elastase 2) enzyme inhibition (substrate: N-MeOSuc-Ala-Ala-Pro-Val-pNA)",B,,,BAO_0000190,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL248,Homo sapiens,Leukocyte elastase,9606.0,,,IC50,,,,
178963,178963,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7677772,[],CHEMBL1909195,"DRUGMATRIX: Peptidase, ELA2 (Neutrophil Elastase 2) enzyme inhibition (substrate: N-MeOSuc-Ala-Ala-Pro-Val-pNA)",B,,,BAO_0000192,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL248,Homo sapiens,Leukocyte elastase,9606.0,,,Ki,,,,
178964,178964,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7677773,[],CHEMBL1909196,"DRUGMATRIX: Peptidase, Matrix Metalloprotease-1 (MMP-1) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2)",B,,,BAO_0000190,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL332,Homo sapiens,Matrix metalloproteinase-1,9606.0,,,IC50,,,,
178965,178965,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7677774,[],CHEMBL1909196,"DRUGMATRIX: Peptidase, Matrix Metalloprotease-1 (MMP-1) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2)",B,,,BAO_0000192,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL332,Homo sapiens,Matrix metalloproteinase-1,9606.0,,,Ki,,,,
178966,178966,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7677775,[],CHEMBL1909197,"DRUGMATRIX: Protease, Matrix Metalloprotease-9 (MMP-9) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2)",B,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL321,Homo sapiens,Matrix metalloproteinase 9,9606.0,,,IC50,,,,
178967,178967,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7677776,[],CHEMBL1909197,"DRUGMATRIX: Protease, Matrix Metalloprotease-9 (MMP-9) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2)",B,,,BAO_0000192,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL321,Homo sapiens,Matrix metalloproteinase 9,9606.0,,,Ki,,,,
178968,178968,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7677777,[],CHEMBL1909198,DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone),B,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL299,Homo sapiens,Protein kinase C alpha,9606.0,,,IC50,,,,
178969,178969,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7677778,[],CHEMBL1909198,DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone),B,,,BAO_0000192,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL299,Homo sapiens,Protein kinase C alpha,9606.0,,,Ki,,,,
178970,178970,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7677779,[],CHEMBL1909199,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein)",B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL3385,Homo sapiens,MAP kinase ERK1,9606.0,,,IC50,,,,
178971,178971,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7677780,[],CHEMBL1909199,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein)",B,,,BAO_0000192,BAO_0000357,single protein format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL3385,Homo sapiens,MAP kinase ERK1,9606.0,,,Ki,,,,
178972,178972,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7677781,[],CHEMBL1909200,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK2 enzyme inhibition (substrate: Myelin Basic Protein)",B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL4040,Homo sapiens,MAP kinase ERK2,9606.0,,,IC50,,,,
178973,178973,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7677782,[],CHEMBL1909200,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK2 enzyme inhibition (substrate: Myelin Basic Protein)",B,,,BAO_0000192,BAO_0000357,single protein format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL4040,Homo sapiens,MAP kinase ERK2,9606.0,,,Ki,,,,
178974,178974,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7677783,[],CHEMBL1909201,"DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)",B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL260,Homo sapiens,MAP kinase p38 alpha,9606.0,,,IC50,,,,
178975,178975,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7677784,[],CHEMBL1909201,"DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)",B,,,BAO_0000192,BAO_0000357,single protein format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL260,Homo sapiens,MAP kinase p38 alpha,9606.0,,,Ki,,,,
178976,178976,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7677785,[],CHEMBL1909202,"DRUGMATRIX: Protein Serine/Threonine Phosphatase, PPP3CA (Calcineurin, PP2B) enzyme inhibition (substrate: DiFMUP)",B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL4445,Homo sapiens,"Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform",9606.0,,,IC50,,,,
178977,178977,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7677786,[],CHEMBL1909202,"DRUGMATRIX: Protein Serine/Threonine Phosphatase, PPP3CA (Calcineurin, PP2B) enzyme inhibition (substrate: DiFMUP)",B,,,BAO_0000192,BAO_0000357,single protein format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL4445,Homo sapiens,"Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform",9606.0,,,Ki,,,,
178978,178978,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7677787,[],CHEMBL1909203,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",B,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL203,Homo sapiens,Epidermal growth factor receptor erbB1,9606.0,,,IC50,,,,
178979,178979,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7677788,[],CHEMBL1909203,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",B,,,BAO_0000192,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL203,Homo sapiens,Epidermal growth factor receptor erbB1,9606.0,,,Ki,,,,
178980,178980,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7677789,[],CHEMBL1909204,"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))",B,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL1841,Homo sapiens,Tyrosine-protein kinase FYN,9606.0,,,IC50,,,,
178981,178981,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7677790,[],CHEMBL1909204,"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))",B,,,BAO_0000192,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL1841,Homo sapiens,Tyrosine-protein kinase FYN,9606.0,,,Ki,,,,
178982,178982,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7677791,[],CHEMBL1909205,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",B,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL1824,Homo sapiens,Receptor protein-tyrosine kinase erbB-2,9606.0,,,IC50,,,,
178983,178983,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7677792,[],CHEMBL1909205,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",B,,,BAO_0000192,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL1824,Homo sapiens,Receptor protein-tyrosine kinase erbB-2,9606.0,,,Ki,,,,
178984,178984,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7677793,[],CHEMBL1909206,"DRUGMATRIX: Protein Tyrosine Kinase, LCK enzyme inhibition (substrate: Poly(Glu:Tyr))",B,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL258,Homo sapiens,Tyrosine-protein kinase LCK,9606.0,,,IC50,,,,
178985,178985,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7677794,[],CHEMBL1909206,"DRUGMATRIX: Protein Tyrosine Kinase, LCK enzyme inhibition (substrate: Poly(Glu:Tyr))",B,,,BAO_0000192,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL258,Homo sapiens,Tyrosine-protein kinase LCK,9606.0,,,Ki,,,,
178986,178986,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7677795,[],CHEMBL1909207,"DRUGMATRIX: Protein Tyrosine Phosphatase, PTPRC (CD45) enzyme inhibition (substrate: DiFMUP)",B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL3243,Homo sapiens,Leukocyte common antigen,9606.0,,,IC50,,,,
178987,178987,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7677796,[],CHEMBL1909207,"DRUGMATRIX: Protein Tyrosine Phosphatase, PTPRC (CD45) enzyme inhibition (substrate: DiFMUP)",B,,,BAO_0000192,BAO_0000357,single protein format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL3243,Homo sapiens,Leukocyte common antigen,9606.0,,,Ki,,,,
178988,178988,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7677797,[],CHEMBL1909208,"DRUGMATRIX: Purinergic P2X radioligand binding (ligand: [3H] alpha, beta-Methylene-ATP)",B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
178989,178989,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7677798,[],CHEMBL1909208,"DRUGMATRIX: Purinergic P2X radioligand binding (ligand: [3H] alpha, beta-Methylene-ATP)",B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
178990,178990,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7677799,[],CHEMBL1909209,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL273,Rattus norvegicus,Serotonin 1a (5-HT1a) receptor,10116.0,,,IC50,,,,
178991,178991,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7677800,[],CHEMBL1909209,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL273,Rattus norvegicus,Serotonin 1a (5-HT1a) receptor,10116.0,,,Ki,,,,
178992,178992,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7677801,[],CHEMBL1909210,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL3459,Rattus norvegicus,Serotonin 1b (5-HT1b) receptor,10116.0,,,IC50,,,,
178993,178993,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7677802,[],CHEMBL1909210,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL3459,Rattus norvegicus,Serotonin 1b (5-HT1b) receptor,10116.0,,,Ki,,,,
178994,178994,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7677803,[],CHEMBL1909211,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL224,Homo sapiens,Serotonin 2a (5-HT2a) receptor,9606.0,,,IC50,,,,
178995,178995,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7677804,[],CHEMBL1909211,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL224,Homo sapiens,Serotonin 2a (5-HT2a) receptor,9606.0,,,Ki,,,,
178996,178996,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7677805,[],CHEMBL1909104,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL1833,Homo sapiens,Serotonin 2b (5-HT2b) receptor,9606.0,,,IC50,,,,
178997,178997,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7677806,[],CHEMBL1909104,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL1833,Homo sapiens,Serotonin 2b (5-HT2b) receptor,9606.0,,,Ki,,,,
178998,178998,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7677807,[],CHEMBL1909105,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL225,Homo sapiens,Serotonin 2c (5-HT2c) receptor,9606.0,,,IC50,,,,
178999,178999,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7677808,[],CHEMBL1909105,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,Ki,,,,CHEMBL225,Homo sapiens,Serotonin 2c (5-HT2c) receptor,9606.0,,,Ki,,,,
